Sommaire

• • ·Poster Exhibit Task Force

    Page :A1

    Plan Plan
• • ·Editorial board

    Page :A2

    
• • ·Poster Abstracts

    Page :A4

    
• • ·33931 Inpatient dermatology services are associated with lower mortality and readmission rates: A nationally representative analysis of 30,900 hospitalizations

    Page :AB1

    Pranav Puri, Benjamin D. Pollock, Miranda Yousif

    
• • ·33121 Do loading doses in systemic therapy for psoriasis improve clinical outcomes?

    Page :AB1

    Charlotte Greif, Ruby Gibson, Martina Porter

    
• • ·33827 Hospitalization outcomes in patients with CTCL: A multicenter study

    Page :AB1

    George Glinos, Grace Wei, Michi Shinohara

    
• • ·31752 Inflammation in hidradenitis suppurativa extends to healthy-appearing perilesional skin and is therapeutically targetable with IL-17RA blockade

    Page :AB1

    Kristina Navrazhina, Sandra Garcet, David Grand

    
• • ·32414 Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: A multicentre retrospective cohort study

    Page :AB2

    Brian D. Rankin, Jorge-Ryan Georgakopoulos, Muskaan Sachdeva

    
• • ·32823 Single-cell transcriptomic analysis of cutaneous T cells in psoriasis

    Page :AB2

    Samuel Yeroushalmi, Samuel Alber, Jared Liu

    
• • ·34334 Access to dermatologic care as a predictor of melanoma staging and prognosis

    Page :AB3

    Ailynna Chen, Faraaz S. Zafar, Margaret Carrel

    
• • ·33648 Assessing health literacy in the homeless and its application in dermatology

    Page :AB3

    Andrea Francis, Richard Wagner

    
• • ·33114 Dermatologist awareness of scalp cooling for chemotherapy-induced alopecia

    Page :AB3

    Lu Yin, Katerina Svigos, Elizabeth J. Klein

    
• • ·32206 Evaluating chargemaster price transparency for dermatologic procedures: A national analysis

    Page :AB3

    Kevin Yang, Lara Drake, Shilpa Ghatnekar

    
• • ·34682 Immune-mediated diseases and subsequent risk of alopecia areata in a prospective study of US women

    Page :AB4

    Isabelle H. Moseley, Jordan M. Thompson, Elisabeth A. George

    
• • ·32571 Intensive dutasteride mesotherapy protocol (IDMP) with oral minoxidil as an alternative to antiandrogens in AGA. A retrospective analysis of a hair restoration center

    Page :AB4

    Estefania Boland-RodrÍguez, César Daniel Villarreal-Villarreal, Abraham Benjamín Álfaro-Sánchez

    
• • ·34852 Medication-induced hair texture change: A systematic review

    Page :AB4

    Celine H. Phong, Gabrielle T. Baker, Melody Esmaeili

    
• • ·34222 Prospective study of surgical deroofing in the management of hidradenitis suppurativa

    Page :AB4

    Trang T. Vu, Laura Soong

    
• • ·34649 Racial/ethnic differences in treatment efficacy and safety for moderate-to-severe plaque-psoriasis: A systematic review

    Page :AB5

    Jessica Elizabeth Ferguson, Edward W. Seger

    
• • ·33263 Rare cutaneous adverse effects of botulinumtoxin A: A review

    Page :AB5

    Charles Dunn, Timothy Nyckowski, Austin Ambur

    
• • ·33282 Retrospective study of wound infection and healing following minor dermatologic procedures in the ambulatory setting

    Page :AB5

    Michael Seth Flynn, Simon Jiang, Taylor Stauffer

    
• • ·32304 Risk of skin cancer in sexual minority patients compared with heterosexual patients: A retrospective cohort study

    Page :AB5

    Jessika Sanz, Julia L. Gao

    
• • ·33303 The Sarcoidosis app: A mobile app study of impact of disease on quality of life and physical activity

    Page :AB6

    Brian Chu, Daniel O’Connor, Marilyn Wan

    
• • ·34745 US and EU sunscreens: A review of ultraviolet (UV) filters and safety data

    Page :AB6

    Nikita Wong, Molly N. Pantelic, Michael Kwa

    
• • ·34109 A case of aleukemic leukemia cutis mistaken for sarcoidosis

    Page :AB7

    Diana V. Rodríguez-Rivera, José Cuesta-Camunas, Alvaro J. Ramos-Rodriguez

    
• • ·35385 A case of Conradi-Hunermann-Happle syndrome

    Page :AB7

    Quoc-Bao Nguyen, Kevin Lee, Raghavendra Girijala

    
• • ·33327 A case of reed syndrome with an unusually extensive cutaneous burden

    Page :AB7

    Sara Holt, Brooke Walls, Scott Walter

    
• • ·34188 A case of systemic anaplastic large cell lymphoma with secondary cutaneous involvement

    Page :AB7

    Sarah Stano, Andie Bulbin, Kalliope Kyriakides

    
• • ·32748 A case series of pediatric cellular neurothekeomas and a review of the histologic spectrum

    Page :AB8

    Nicole Dacy, Allie Preston, Peter Nguyen

    
• • ·34242 A comparison of acne products advertised on Instagram to American Academy of Dermatology evidence-based guidelines

    Page :AB8

    Anthony Concilla, Chandler W. Rundle, Michelle Militello, Kayd J. Pulsipher, Taylor Harp, Mindy Szeto, Colby L. Presley, Larissa Rodriguez-Homs, Olivia Jew, Robert P. Dellavalle

    
• • ·33631 A cost comparison of over the counter acne products available for “spot treatment”

    Page :AB8

    Alexa Kimball, Kate Boer

    
• • ·32891 A cross-sectional study of dermatology articles in preprint servers

    Page :AB8

    Michelle J. Chang, Shari R. Lipner

    
• • ·34481 A dual regimen skincare treatment for hyperpigmented and photodamaged facial skin

    Page :AB9

    Sofia Iglesia, Alisar Zahr, Tatiana Kononov

    
• • ·31963 A Medicaid pharmacy concierge program: A model for reducing the burden of prior authorizations in dermatology

    Page :AB9

    Deega Omar, Jessica Brown-Korsah, Susan Taylor

    
• • ·35067 A national analysis of racial discrepancies within infantile hemangioma in children using the Kids’ Inpatient Database

    Page :AB9

    Keshav D. Kumar, Amar D. Desai, Shari R. Lipner

    
• • ·34016 A national analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in children using the Kids’ Inpatient Database

    Page :AB9

    Amar D. Desai, Vraj P. Shah, Shari R. Lipner

    
• • ·32772 A neonate with a violaceous lesion on the shoulder: Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon

    Page :AB10

    Joseph S. Aleshaki, Hope E. Barone, Molly J. Buckland

    
• • ·33247 A patient survey to identify atopic dermatitis prescription treatment access barriers

    Page :AB10

    Allison R. Loiselle, Isabelle J.C. Thibau, Michele Guadalupe

    
• • ·32283 A phase I study of CX-4945 administered orally twice daily to patients with advanced basal cell carcinoma

    Page :AB10

    Daniel McCormick, Zeynep Eroglu, Charles Lance Cowey

    
• • ·33385 A polymeric emulsion of halobetasol propionate and tazarotene in the treatment of palmoplantar psoriasis

    Page :AB10

    Caroline R. Campbell, Folawiyo O. Babalola, Jenna E. Yousif

    
• • ·32320 A prospective study of nerve conduction changes in leprosy patients before and after MDT

    Page :AB11

    Karthik Sunki, Padmaja Pinjala

    
• • ·33665 A randomized, evaluator-blinded study to evaluate facial harmony and subject satisfaction after treatment with HADEF using a stepwise treatment approach

    Page :AB11

    Corey Hartman, Steven Dayan, Carlo di Gregorio

    
• • ·33984 A rare genodermatosis with an unusual presentation: A case of Galli-Galli

    Page :AB11

    Rebecca Goldberg, Roya Nazarian, Daiva Mattis

    
• • ·33907 A retrospective chart review of management strategies for lichenoid eruptions associated with immune-checkpoint inhibitor therapy from a single institution

    Page :AB11

    Wylie Masterson, Alexandria Brown, May Al Ameri

    
• • ·34195 A SEER analysis of stage IV melanoma of unknown primary: The influence of income and population size on rates of surgery and survival

    Page :AB12

    Michaela Clausen, Connor Tupper, Peter Silberstein

    
• • ·32457 A simplified scoring system to assess disease severity of cutaneous lichen planus: lpCAILS

    Page :AB12

    Puneet Bhullar, Blake Boudreaux, Nan Zhang

    
• • ·34141 A survey of health-related quality of life disparities in cutaneous T-cell lymphoma patients with skin of color

    Page :AB12

    Grace Wei, Jaclyn Abraham, Seemal R. Desai

    
• • ·34763 A survey study: Examining dermatology residents’ attitudes towards pursuing a career in dermatopathology

    Page :AB12

    Shruti Agrawal, Melissa Piliang

    
• • ·32625 A systematic review of hidradenitis suppurativa and hyperhidrosis

    Page :AB13

    Terri Shih, Katrina Lee, Justine Seivright

    
• • ·34583 A systematic review of the current treatment modalities for hypertrophic scars and keloids

    Page :AB13

    McKenzie A. Dirr, Brandon Worley, Kathyrn Kim

    
• • ·33190 Acral hemorrhagic Darier disease: A case report of a rare variant and literature review

    Page :AB13

    Alba Posligua, Ronghua Hu, Emily Hong

    
• • ·32626 Addition of intravenous immunoglobulin therapy to facilitate resolution of steroid-refractory DRESS syndrome

    Page :AB13

    Anusha M. Kumar, Justin Besen, Maria Aleshin

    
• • ·31405 Addressing barriers to diversity: Introducing underrepresented minority students to dermatologic careers and resources

    Page :AB14

    Marie Vu, Wendi Wohltmann

    
• • ·32359 Adoption of newly FDA-approved targeted immunomodulatory therapies for Plaque Psoriasis by Dermatologists: An analysis of Medicare Part D claims from 2013-2018.

    Page :AB14

    Owen Dean, Francisco Tausk, Partik Singh

    
• • ·34946 Adverse events of noninvasive body contouring: Analysis of the FDA MAUDE database

    Page :AB14

    Christopher Nguyen, Quoc-Bao Nguyen

    
• • ·31243 Age requirements for regarding indoor UV tanning in Colorado

    Page :AB14

    Melissa R. Laughter, Jaclyn B. Anderson

    
• • ·34993 Aggressive squamous cell carcinoma in setting of Huriez syndrome

    Page :AB15

    Alison Huber, Jonathan Dyer, Ahdarsh Vallabhaneni

    
• • ·35230 AI-ADL: A relevant tool for assessing the burden of adult acne

    Page :AB15

    Brigitte Dreno

    
• • ·32731 Alopecia in COVID-19 patients: Systematic review and meta-analysis

    Page :AB15

    Betty Nguyen, Antonella Tosti

    
• • ·33540 Altered expression of soluble and membrane-bound programmed death receptors and ligands may cause activated state of cytotoxic T lymphocytes in patients having alopecia areata

    Page :AB15

    Vignesh Narayan R, Niharika Srivastava

    
• • ·35047 Altmetric scoring in dermatopathology: How do these high-scoring articles differ with other citation metrics?

    Page :AB16

    Jaclyn B. Anderson, Melissa R. Laughter, Atif Saleem

    
• • ·33571 An international cohort study on a ceramide-containing cleanser and moisturizer used for diabetes mellitus-related xerosis

    Page :AB16

    Robert S. Kirsner, Sanaa Alaoui Bensaid, Javier Arellano

    
• • ·34945 An in vitro evaluation of a niacinamide-panthenol-glycerin complex on skin barrier function, hydration, and neuroinflammation

    Page :AB16

    Dillon Nussbaum, Adam Friedman, Nicolas Joly-Tonetti

    
• • ·35305 An updated reference for empiric antibiotic therapy in hidradenitis suppurativa

    Page :AB16

    Paige Hoyer, Fareen Momin, Elizabeth Ellison

    
• • ·34431 Analysis of adverse events with sclerosants reported to the United States Food and Drug Administration

    Page :AB17

    Christopher Nguyen, Quoc-Bao Nguyen

    
• • ·33490 Analysis of geographic distribution of internationally educated dermatologists

    Page :AB17

    Catherina X. Pan, Vinod E. Nambudiri

    
• • ·34368 Analysis of MAUDE database reports involving dermal fillers from 2014-2020

    Page :AB17

    Michelle Xiong, Christine Chen, Yuliia Sereda

    
• • ·32381 Analysis of utilization of skin cancer screenings and screening motivations among national SPOT Skin Cancer program screenees from 2018 to 2019

    Page :AB17

    David X. Gao, Susan M. Swetter, Elena B. Hawryluk

    
• • ·35423 ASIA syndrome following deoxycholic acid injection

    Page :AB18

    Soraya Azzawi, Miranda Rosenberg, Robert S. Kirsner

    
• • ·34774 Assessing penetration, delivery, and mode of action of dissolving microneedle patches for reducing under-eye wrinkles using reflectance confocal microscopy

    Page :AB18

    Samantha Ouellette, Shazli Razi, Attiya Haroon

    
• • ·34902 Assessing the efficacy of imiquimod use in patients with persistent locally advanced melanoma in situ

    Page :AB18

    Caroline Ward, Danielle DePalo, Nupur Patel

    
• • ·35215 Assessment of lifestyle and microbiome contributions to vitiligo development

    Page :AB18

    Yasmeen Ali, Madeleine R. Belback

    
• • ·35302 Assessment of the impact of Cates plot on patient comprehension of patch test predictive value

    Page :AB19

    Yujie Linda Liou, Katelyn Urban

    
• • ·33498 Association between age of symptom onset and severity of hidradenitis suppurativa in older patients

    Page :AB19

    Simon W. Jiang, Amy J. Petty, Jennifer L. Jacobs

    
• • ·32702 Association between atopic dermatitis and delinquent behavior in childhood and adolescence: A longitudinal study

    Page :AB19

    Jaya Manjunath, Jonathan I. Silverberg

    
• • ·35351 Association between prurigo nodularis and gastrointestinal and hepatobiliary diseases in adults: A national cross-sectional study.

    Page :AB19

    Waleed Adawi, Nishadh Sutaria, Varsha Parthasarathy

    
• • ·35402 Association between rosacea and gastroesophageal reflux disease (GERD): Systematic review and meta-analysis

    Page :AB20

    Rahul Raiker, Joshua Horeczko, Haig Pakhchanian

    
• • ·34679 Association of adult atopic dermatitis severity with decreased physical activity: A cross-sectional study

    Page :AB20

    Gabrielle Schwartzman, Donald Lei, Adnan Ahmed

    
• • ·33815 Association of autoimmune comorbidities with lichen planus: A case-control study in the All of Us research program

    Page :AB20

    Ryan Fan, Audrey C. Leasure, Jeffrey M. Cohen

    
• • ·32993 Association of pigment contrast on multispectral dermatoscopic imaging with pigmented lesion histopathologic diagnosis

    Page :AB20

    Katherine B. Lee, Sabrina H. Tran

    
• • ·32867 Association of sun-protective behaviors with bone mineral density and osteoporotic bone fractures in the United States: National Health and Nutrition Examination Survey 2017-18

    Page :AB21

    Mohsen Afarideh, Julio C. Sartori-Valinotti, Megha M. Tollefson

    
• • ·34305 Associations between exposure to air pollutants and the risk of developing psoriasis in the general population

    Page :AB21

    Hyun Min Seo, Yun Jung Huh, Se Uk Oh

    
• • ·33843 Atopic dermatitis polypharmacy and out-of-pocket health care expenses in the United States

    Page :AB21

    Raj Chovatiya, Wendy Smith Begolka, Isabelle J.C. Thibau

    
• • ·32950 Autoantibody profiles of bullous immune-related cutaneous adverse events from immune checkpoint blockade may present with atypical or typical antibody serologies

    Page :AB21

    Alyce M. Kuo, Lukas Kraehenbuehl, Helen C. Haliasos

    
• • ·35078 Autoimmune blistering diseases and dupilumab

    Page :AB22

    Austinn Miller, Susuana Adjei, Laurie A. Temiz

    
• • ·34468 Autoimmune progesterone dermatitis following infertility treatment

    Page :AB22

    Alyson McKinnon, Sophia Ly, Andrea Mabry

    
• • ·32853 Baby moisturizers: Prices, allergens, and marketing claims

    Page :AB22

    Jonathan W. Rick, Austin G. Morgan, Devea R. De

    
• • ·34560 Barriers to care: Insurance delays in the approval of biologic medications for patients with moderate-severe psoriasis and psoriatic arthritis

    Page :AB22

    Thomas Vazquez, Mahtab Forouzandeh, Deborah Lin

    
• • ·32240 Baseline characteristics and comorbid conditions in patients with moderate-to-severe plaque psoriasis enrolled in the Psoriasis Study of Health Outcomes (PSoHO)

    Page :AB23

    Lluís Puig, Adam Reich, Shirin Zaheri

    
• • ·35181 Baseline disease and population characteristics associated with a diagnosis of COVID 19: Data from the PURE registry

    Page :AB23

    Lorne Albrecht, Melinda Gooderham, Charles Lynde

    
• • ·34329 Baseline patient demographics and comorbidities in patients with atopic dermatitis from the GLOBOSTAD registry

    Page :AB23

    Piergiacomo Calzavara-Pinton, Jarmila Čelakovská, Hilde Lapeere

    
• • ·33730 Beyond beauty: The skin as a site of exposure, merging, and multiplicity in Modernist poetry

    Page :AB23

    Fadwa Ahmed

    
• • ·31341 BIIB059 reduces disease activity over 16 weeks in active cutaneous lupus erythematosus (CLE): Results from part B of phase 2 LILAC study

    Page :AB24

    Victoria P. Werth, Richard Furie, Sandra Navarra

    
• • ·34314 Bimekizumab comparative efficacy in psoriasis: Number needed to treat analyses of phase 3/3b trial data

    Page :AB24

    Craig Leonardi, April Armstrong, Kilian Eyerich

    
• • ·31085 Bimekizumab early treatment response translates into cumulative benefits in health-related quality of life in patients with moderate to severe plaque psoriasis: Pooled results from three multicenter, randomized, double-blinded phase 3 trials

    Page :AB24

    Kenneth B. Gordon, Michael Sebastian, Steven R. Feldman

    
• • ·34379 Bimekizumab response maintenance in high-impact areas in patients with moderate to severe plaque psoriasis: Pooled results through 96 weeks of the BE SURE, BE READY, and BE RADIANT phase 3/3b trials

    Page :AB24

    Joseph F. Merola, Richard B. Warren, George Han

    
• • ·34356 Bimekizumab versus secukinumab in plaque psoriasis: Psoriasis Symptoms and Impacts Measure (P-SIM) responses accompanying achievement of complete skin clearance in the phase 3b BE RADIANT trial

    Page :AB25

    Alice B. Gottlieb, Richard G. Langley, Richard B. Warren

    
• • ·31069 Bimekizumab versus secukinumab in plaque psoriasis: Reduction in body surface area affected by psoriasis translates into benefits in patient-perceived itching, skin pain, and scaling and health-related quality of life in the BE RADIANT phase 3b trial

    Page :AB25

    Matthias Augustin, Melinda Gooderham, Alice B. Gottlieb

    
• • ·34366 Buffalopox virus infection: An emerging cutaneous disease in humans

    Page :AB25

    Tiffany Hinojosa, Daniel J. Lewis, Stephen K. Tyring

    
• • ·35292 Bullous eosinophilic cellulitis: A new case series of a rare variant

    Page :AB25

    Arash Babadjouni, Addie Walker, Ruzica Z. Conic

    
• • ·33399 C3 immunoperoxidase staining in the diagnosis of bullous pemphigoid: A retrospective diagnostic test accuracy study

    Page :AB26

    Lily Guo, Heidi C. Vaughan, Rebecca N. Jacobson

    
• • ·33371 Can dermatology practices play a role in combatting vaccine hesitance?

    Page :AB26

    Charles Dunn, Nicole Vesely, Yasser Faraj

    
• • ·35274 Can educational pamphlets and dermatologist counseling influence tobacco use behavior and patient knowledge?

    Page :AB26

    Vruta Kansara, Kavita Darji, Mitchell Gibbons

    
• • ·35323 Case of granular cell tumor presenting as a mobile axillary nodule in a 33-year-old African American man

    Page :AB26

    Deborah Moon, Bonnie Lee

    
• • ·34941 Case report: Hair care routine to treat the telogen effluvium associated with post–COVID-19 infection

    Page :AB27

    Gabriela Juncá Trindade Pires

    
• • ·35128 Cerebrovascular accident events associated with IL-23 inhibition: Pharmacovigilance analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) from the RADAR (Research on Adverse Drug Events And Reports) Program

    Page :AB27

    Negar Kahen, Yasmeen Ali, Dennis P. West

    
• • ·33563 Change in Cutibacterium acnes phylotype diversity and improvement of clinical parameters using a new dermocosmetic product containing Myrtus communis and Celastrol-enriched plant cell culture extracts in patients with acne vulgaris

    Page :AB27

    Valerie Mengeaud, Celine Mias, Marie-Dominique Thouvenin

    
• • ·35393 Changes in the geographic distribution of dermatology matching during the COVID-19 Cycle: A proxy for the value of away rotations

    Page :AB27

    Joseph Younis, Bryan T. Carroll

    
• • ·34971 Characteristics and survival of primary mucosal melanoma of the oral cavity

    Page :AB28

    Amar D. Desai, Jennifer M. Fernandez

    
• • ·32948 Characteristics of physicians accepting Medicaid for Mohs micrographic surgery: A cross-sectional analysis

    Page :AB28

    Eric J. Beltrami, Jette Hooper, Vijay Kodumudi

    
• • ·34984 Characteristics of the efficacy response trajectory among patients who did not flare during the maintenance phase of JADE REGIMEN

    Page :AB28

    Raj Chovatiya, Maria Concetta Fargnoli, Brett King

    
• • ·35097 Characterization of B cell dynamics in hidradenitis suppurativa: Evidence for antigen-driven pathophysiology

    Page :AB28

    Gordon A. Dale, Jason Barron, Patrick Speck

    
• • ·35226 Characterization of pain in prurigo nodularis: An online survey-based study

    Page :AB29

    Prachi Aggarwal, Emily Boozalis, Varsha Parthasarathy

    
• • ·34704 Characterization of pruritic eruptions in a patch test–negative cohort of older adults

    Page :AB29

    Janell Tully, Shreya Sreekantaswamy, Nina Botto

    
• • ·32736 Characterizing calciphylaxis-like lesions in mice predisposed to vascular calcification

    Page :AB29

    Lesley Santos, Lara Tong, Olga Savinova

    
• • ·34417 Characterizing nipple skin injuries in postpartum women

    Page :AB29

    Ananya Munjal, Chaorong Wu, Stephanie Radke

    
• • ·33597 Checkpoint inhibitor–induced vitiligo in nonmelanoma patients

    Page :AB30

    Hannah L. Hanania, Monika Keiser, Jonathan Lo

    
• • ·32763 Cleansing efficacy of mild facial cleansers for sensitive skin

    Page :AB30

    Jonghun Lee, Naven Sekhon, Hongwei Shen

    
• • ·34428 Clinical and biophysical assessment of the effects of daily use of a nature-based, broad-spectrum mineral sunscreen containing bakuchiol in photoaged skin

    Page :AB30

    Zoe Diana Draelos, Hemali B. Gunt, Stanley B. Levy

    
• • ·32333 Clinical and pharmacokinetic results of upadacitinib in Chinese healthy subjects and subjects with moderate-to-severe atopic dermatitis

    Page :AB30

    Min Zheng, Chunlei Zhang, Hong Fang

    
• • ·32811 Clinical and temporal characteristics of malignancy-associated prurigo nodularis: A systematic review

    Page :AB31

    Maxwell Green, Laura Williams, Drew Kuraitis

    
• • ·33316 Clinical and therapeutic course in head variant linear morphea in adults

    Page :AB31

    Winnie Fan, Rebecca Jacobson, Anna Haemel

    
• • ·32659 Clinical assessment of a lip care product for evaluating performance and increasing attribute expectations in the mask wearing era

    Page :AB31

    Nalini Kaul, Elsie Kohoot, Barrie Drewitt

    
• • ·34138 Clinical characterization and histopathologic correlation of erythroderma: A retrospective review

    Page :AB31

    Allison Yan, Catherine Chung

    
• • ·34863 Clinical clues to differentiate dermatophytoma onychomycosis and dermatophytoma-like traumatic onychodystrophy

    Page :AB32

    Sumanas Bunyaratavej, Penvadee Pattanaprichakul

    
• • ·34920 Clinical immunogenicity of daxibotulinumtoxinA for injection (DAXI) in glabellar lines including subjects with multiple exposures: Pooled data from the SAKURA phase 3 trials

    Page :AB32

    Shannon Humphrey, Jeffrey S. Dover, Ronald R. Bowsher

    
• • ·35334 Clinical usage data demonstrates appropriate use of the prognostic 40-gene expression profile (40-GEP) test for cutaneous squamous cell carcinoma with one or more risk factors

    Page :AB32

    Aaron S. Farberg, Alison Fitzgerald, Jennifer J. Siegel

    
• • ·33565 Clinically proven antiaging effects of a new skincare line and retinol tolerance building guidance for Asian consumers

    Page :AB32

    Li Ma, Summer Sun, Hugo Kerriou

    
• • ·33005 Clinically significant improvements in patient-reported outcomes (PROs) in patients with a generalized pustular psoriasis (GPP) flare treated with spesolimab

    Page :AB33

    Alexander A. Navarini, Manuelle Viguier, Tsen-Fang Tsai

    
• • ·32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2

    Page :AB33

    Brett King, Manabu Ohyama, Arash Mostaghimi

    
• • ·32897 Combination of oral acitretin and topical triamcinolone is more efficacious than topical triamcinolone monotherapy in symptomatic oral lichen planus: A double blind placebo controlled randomized trial

    Page :AB33

    Vinay Keshavamurthy, Sheetanshu Kumar, Vishal Thakur

    
• • ·35301 Comfort in performing cosmetic and surgical procedures for skin of color patients: A national survey among U.S. dermatology residents

    Page :AB33

    Paige Hoyer, Gregory Ugoh, Lindy Ross

    
• • ·34885 Common practices in platelet-rich plasma: A prospective multi-center survey

    Page :AB34

    Noor Anvery, Bianca Y. Kang, Clarissa C. Wong

    
• • ·33777 Comorbidities and treatment patterns in pemphigus: A retrospective US claims database study

    Page :AB34

    Jonathan Silverberg, Julia S. Lehman, Animesh A. Sinha

    
• • ·34548 Comorbidities in patients with central centrifugal cicatricial alopecia, a retrospective chart review of 53 patients

    Page :AB34

    Bonnie W. Leung, Linsey Lindley, Joan S. Reisch

    
• • ·34269 Comparison of survival in women with melanoma by race and ethnicity: An analysis of the National Cancer Database 2004-2018

    Page :AB34

    Jennifer M. Fernandez, Kevin R. Kwan, Adam Sutton

    
• • ·32584 Comparison study of periorificial dermatitis between children and adults

    Page :AB35

    Tae Rim Kim, Kyung-Nam Bae, Jin-Hwa Son

    
• • ·32728 Compiling a registry of free clinics providing dermatologic care

    Page :AB35

    Parth Patel, Agnes Kim, Kim Le

    
• • ·33586 Complete freedom from chronic spontaneous urticaria signs and symptoms is associated with sleep and dermatology quality-of-life improvements: Data from the phase 2b ligelizumab study

    Page :AB35

    Jonathan A. Bernstein, Ana Giménez-Arnau, Michihiro Hide

    
• • ·33608 Connecting the dots: A potential mechanism for increased rates of nasopharyngitis in secukinumab-treated patients

    Page :AB35

    Sophie Hélène Guenin, Abigail Cline, Alexandra Schulz

    
• • ·34181 Consultation of other services delays dermatologic care for inpatient skin disease

    Page :AB36

    Andrew D. King, Andrew S. Kao, Redina Bardhi

    
• • ·33724 Cosmetic outcome and viability of right angle paramedian forehead flaps: A retrospective chart review

    Page :AB36

    Ilya Mukovozov, Alexandre Laroche, Aaron Wong

    
• • ·33677 Crawling into septic shock: A case report of septic shock secondary to untreated myiasis in malignant melanoma

    Page :AB36

    Martha Lodyga, Haley Schachter, Olga Postovitenko

    
• • ·35228 C-reactive protein levels and circulating blood inflammatory markers are associated with poor outcomes in hidradenitis suppurativa patients: A multicenter cohort study

    Page :AB36

    Varsha Parthasarathy, Junwen Deng, Zachary Bordeaux

    
• • ·34821 Cross-sectional analysis of paronychias in the National Electronic Injury Surveillance System 1999-2018

    Page :AB37

    Amar D. Desai, Yu Wang, Cajeton Clint Nadarajah

    
• • ·35036 Cutaneous angiosarcoma of the phalanx resembling a pyogenic granuloma: Case report

    Page :AB37

    Nohemi Trejo Chavira, Jorge Armando Enríquez Rojas, Maricruz Soto Morales

    
• • ·35264 Cutaneous immune-related adverse events occurrence among melanoma subtypes: A multi-institutional cohort study

    Page :AB37

    Pearl Ugwu-Dike, Nga Nguyen, Neel Raval

    
• • ·34625 Cutaneous manifestations of a rare RASopathy: Costello syndrome

    Page :AB37

    Lauren Prusinski Fernung, Morgan W. Thakore

    
• • ·34954 Cutaneous microbial markers of squamous cell carcinoma risk in solid organ transplant recipients

    Page :AB38

    Megan V. Ha, Iman Salem, Hilmi Al-Shakhshir

    
• • ·32388 Demographic and socioeconomic factors drive disparate outcomes in mycosis fungoides

    Page :AB38

    Connor R. Buechler, Ethan Sagher, Aaron Tisack

    
• • ·33446 Demographics of melanoma knowledge among middle and high schoolers in Texas

    Page :AB38

    Dina H. Zamil, Shangyi Fu, Zahra Majd

    
• • ·31812 Dermatologic adverse events in acute myeloid leukemia patients treated with IDH inhibitors ivosidenib and enasidenib

    Page :AB38

    Rose Parisi, Joseph Stoll, Haoling Zhu

    
• • ·32877 Dermatology clinical trials: Analysis of investments by the top 10 pharmaceutical companies

    Page :AB39

    Jonathan W. Rick, Nikhil Nair, Devea R. De

    
• • ·34144 Dermatology eConsults for triaging suspected skin cancers: A retrospective cost analysis

    Page :AB39

    Pallavi Basu, Jimmy Lam, Joseph K. Kvedar

    
• • ·34926 Dermatology education for medical students in the era of COVID-19

    Page :AB39

    Monika F. Keiser, Quoc-Bao D. Nguyen, Kelly C. Nelson

    
• • ·33651 Dermatology journal advisory boards and editorial independence

    Page :AB39

    Heidi Bai, Gloria Lin, Jane M. Grant-Kels

    
• • ·33331 Dermatology residency home match incidence during the COVID-19 pandemic

    Page :AB40

    Rewan M. Abdelwahab, Luis A. Antezana, Katherine Z. Xie

    
• • ·33906 Dermatology rural outreach clinics are feasible and decrease barriers to care in patients with skin cancer

    Page :AB40

    Eleonora Marcacci, Amanda Truong, Christopher Hull

    
• • ·33351 Dermoscopy of the diverse spectrum of cutaneous tuberculosis

    Page :AB40

    Rashmi Mittal, Payal Chauhan

    
• • ·33044 Desmoplastic melanoma vs dermatofibroma: A challenging histopathologic case

    Page :AB40

    Jasmine Mann, Anusha Panthagani, Brinder Chohan RCPath

    
• • ·33214 Determining photoprotective effectiveness of face mask during COVID-19 pandemic

    Page :AB41

    Sung Jin Park, Jun Hyuk Cho, Min Seok Ham

    
• • ·34507 Deucravacitinib exposure-response analyses in patients with moderate to severe psoriasis

    Page :AB41

    Jun Shen, Mark Lovern, Matt Maloney

    
• • ·34668 Deucravacitinib, a selective tyrosine kinase 2 (TYK2) inhibitor, versus placebo and apremilast in psoriasis: Reductions in individual component scores and body regions of the Psoriasis Area and Severity Index in the phase 3 POETYK PSO-1 and PSO-2 trials

    Page :AB41

    Jeffrey M. Sobell, Kilian Eyerich, Andrew Blauvelt

    
• • ·34660 Deucravacitinib, an oral, selective tyrosine kinase 2 (TYK2) inhibitor, versus placebo and apremilast in moderate to severe plaque psoriasis: Achievement of absolute PASI thresholds in the phase 3 POETYK PSO-1 and PSO-2 trials

    Page :AB41

    Mark Lebwohl, Melinda Gooderham, Richard B. Warren

    
• • ·33219 Development of an in vitro model to study fibrotic response in skin disorders

    Page :AB42

    Signe Holm Nielsen, Sofie F. Madsen, Morten Karsdal

    
• • ·34243 Diagnosis of metaplastic synovial cysts in clinical dermatology

    Page :AB42

    Paayal Vora, Sonam Rama, Stephen Olsen

    
• • ·32593 Diagnosis of mosaic tuberous sclerosis complex using next-generation sequencing of subtle or unusual cutaneous findings

    Page :AB42

    Alison Treichel, Barbara Ogorek, Chyi-Chia Richard Lee

    
• • ·34439 Diagnostic dermoscopic features of nevus depigmentosus vs ash leaf macules

    Page :AB42

    Ananya Sharma, Binod K. Khaitan, Vishal Gupta

    
• • ·34684 Diet and quality of life in acne: A gut-brain-skin axis approach

    Page :AB43

    David A, Maria J

    
• • ·35257 DISCERN scores of morphea information on YouTube

    Page :AB43

    Elizabeth M. Rao, Gideon P. Smith

    
• • ·32890 Disparities in telemedicine satisfaction among older and nonwhite dermatology patients: A cross-sectional study

    Page :AB43

    Michelle J. Chang, Shari R. Lipner

    
• • ·34255 Disparity exists between urban versus rural reach of teledermatology following COVID-19

    Page :AB43

    Alison Romisher, Alexa Cohen, Elizabeth Jones

    
• • ·33945 DNA copy number variations associated with different clinical phenotypes of psoriasis and paradoxical anti-TNF induced palmoplantar pustulosis

    Page :AB44

    Ester Muñoz-Aceituno, Alejandra Reolid, Antonio Sahuquillo-Torralba

    
• • ·34094 Do psychological and educational interventions improve atopic dermatitis outcomes? A systematic review

    Page :AB44

    Lori S. Kim, Tammy Hua, Muhammad Yousaf

    
• • ·33831 Doxycycline hyclate vs monohydrate: What is being prescribed and what are patients receiving

    Page :AB44

    Katherine Jolin, Daniella Reimann, Laura Williams

    
• • ·33894 Drug survival 2.0 – Real-world dosing of biologics for psoriasis

    Page :AB44

    David Thein, Nana A.L. Rosenø

    
• • ·32846 Dual study: Trifarotene plus doxycycline has proven efficacy and safety in severe acne vulgaris

    Page :AB45

    James Del Rosso, JDR Dermatology, Sandra Marchese Johnson, Todd Schlesinger

    
• • ·32929 Dupilumab decreases concomitant therapy use in adults with atopic dermatitis (AD): Long-term data from the RELIEVE-AD study

    Page :AB45

    Dimittri Delevry, Jingdong Chao, Chien-Chia Chuang

    
• • ·35296 Dupilumab for prurigo nodularis: Our experience

    Page :AB45

    Ingrid Hiltun, Iñigo Martínez-de-Espronceda, Jorge Aróstegui

    
• • ·34297 Dupilumab provides long-term improvement in sleep loss in children, adolescents, and adults with atopic dermatitis

    Page :AB45

    Amy S. Paller, Robert H. Lurie, Jonathan I. Silverberg, Jacob P. Thyssen

    
• • ·33558 Dupilumab significantly improves sleep disturbance in adults with moderate-to-severe atopic dermatitis: Results of the DUPISTAD study

    Page :AB46

    Joseph F. Merola, Albert S. Chiou, Emmanuel During

    
• • ·33004 Dupilumab significantly reduces itch and hives in patients with chronic spontaneous urticaria (CSU) who remain symptomatic despite use of standard-of-care antihistamines: Results from a phase 3 trial (LIBERTY-CSU CUPID study A)

    Page :AB46

    Marcus Maurer, Thomas B. Casale, Sarbjit S. Saini

    
• • ·32390 Duration and recurrence of pityriasis rosea-like reactions following COVID-19 vaccination: A registry based study of 27 cases

    Page :AB46

    Devon McMahon, Sonya Prasad, George Hruza

    
• • ·33696 Dyschromatosis symmetrica hereditaria disguised as lentigines

    Page :AB46

    Samantha Sears, Jyoti Burruss

    
• • ·34020 Dyshidrosiform bullous pemphigoid: A case series of an uncommon variant

    Page :AB47

    Pedro Miguel Garrido, Luís Soares-Almeida, Paulo Filipe

    
• • ·33120 Early and sustained improvement in atopic dermatitis (AD) disease control and treatment satisfaction with dupilumab in clinical practice: Long-term data from the RELIEVE-AD study

    Page :AB47

    Bruce Strober, Jingdong Chao, Chien-Chia Chuang

    
• • ·33904 Early onset Merkel cell carcinoma in patients with XMEN disease

    Page :AB47

    Noreen Mohsin, Austin J. Jabbour, Paul Nghiem

    
• • ·33566 Early response with ixekizumab predicts long-term outcomes up to 5 years in psoriasis by unsupervised and supervised machine learning analyses

    Page :AB47

    Alexander Egeberg, Carle Paul, Andrew Blauvelt

    
• • ·31201 Early treatment initiation improves outcomes in nevus of Ota: A 10-year retrospective study

    Page :AB48

    Petchlada Achavanuntakul, Woraphong Manuskiatti, Rungsima Wanitphakdeedecha

    
• • ·34720 Ectyma and Majocchi's granuloma mimicking a worsening of Sézary syndrome

    Page :AB48

    Ariany Tomaz de Aquino Saran Denofre, Mirena Ide, Camila Cristina Salazar Torres

    
• • ·33632 Educational interventions may improve sun protection and skin cancer awareness in outdoor occupational workers

    Page :AB48

    Ana Preda-Naumescu, Sydney Weir, Josiah W. Sowell

    
• • ·32433 Effect of COVID-19 on head and neck NMSC at OU Dermatology

    Page :AB48

    Justin M. McLawhorn, Lindsey Collins

    
• • ·33442 Effectiveness in real world practice after 4 weeks of Risankizumab treatment for patients with moderate-to-severe psoriasis: 15-patient cohort.

    Page :AB49

    Pedro J. Navarro-Guillamon, Ana Carmona-Olveira, Enrique Herrera-Acosta

    
• • ·34323 Effects of DS101 cream on mild-to-moderate rosacea: results from an open-label study

    Page :AB49

    Moayed Hamza MBBcH, Zoe Diana Draelos, Adam Lafferty

    
• • ·33065 Effects of treatment with risankizumab on reducing pain and inflammation in patients with psoriatic arthritis: An analysis of the KEEPsAKE -1 and -2 trials

    Page :AB49

    Andrew Ostor, Shawn Kwatra, Chudi Nduaka

    
• • ·34781 Efficacy and safety of 1% clascoterone cream through 12 weeks in patients ≥12 years of age with facial acne vulgaris

    Page :AB49

    Martina Cartwright, Luigi Moro, Enrico Fragasso

    
• • ·32970 Efficacy and safety of a fixed-dose clindamycin 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15% gel for moderate-to-severe acne: Randomized phase 2 and phase 3 studies of the first triple-combination drug

    Page :AB50

    Linda Stein Gold, Leon H. Kircik, Physicians Skin Care, PLLC, Emil A. Tanghetti

    
• • ·33142 Efficacy and safety of apremilast for the treatment of Japanese patients with palmoplantar pustulosis: Results from a phase 2, randomized, placebo-controlled study

    Page :AB50

    Tadashi Terui, Yukari Okubo, Satomi Kobayashi

    
• • ·34007 Efficacy and safety of baricitinib in adult patients with severe alopecia areata with or without an atopic background from 2 randomized, placebo-controlled, phase 3 trials

    Page :AB50

    Natasha Atanaskova Mesinkovska, Taisuke Ito, Maryanne Senna

    
• • ·35187 Efficacy and safety of ruxolitinib cream for the treatment of vitiligo by patient demographics and baseline clinical characteristics: Pooled subgroup analysis from two randomized phase 3 studies

    Page :AB50

    David Rosmarin, Khaled Ezzedine, Seemal R. Desai

    
• • ·34789 Efficacy and safety of ruxolitinib cream for the treatment of vitiligo: Week 24 pooled analysis of the TRuE-V phase 3 studies

    Page :AB51

    David Rosmarin, Khaled Ezzedine, Seemal R. Desai

    
• • ·33180 Efficacy and safety of the oral JAK3/TEC inhibitor ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO Phase 2b/3 randomized, double-blind, placebo-controlled trial

    Page :AB51

    Maria K. Hordinsky, Adelaide Hebert, Melinda Gooderham

    
• • ·33283 Efficacy and tolerability of a double-conjugated retinoid eye cream in subjects with fine to moderate wrinkles of the periorbital region

    Page :AB51

    Joely Kaufman, Valerie Callender, Glenn Dale, Cherie M. Young

    
• • ·33431 Efficacy of 80 mg/week dose of adalimumab (Humira) in treatment of hidradenitis suppurativa

    Page :AB51

    Saadeddine S. Saad, Christopher Haley, Jess Hatfield

    
• • ·34901 Efficacy of anti-IL23 treatment in patients with plaque psoriasis who failed IL17 inhibitors.

    Page :AB52

    Nikolaos Fekkas, Kleidona Ileana Afroditi, Nikolaidou Electra

    
• • ·33926 Efficacy of apremilast in mild to moderate psoriasis: Subgroup analysis stratified by baseline TSQM global satisfaction levels

    Page :AB52

    Yukari Okubo, Hidetoshi Takahashi, Ryosuke Hino

    
• • ·33764 Efficacy of Avène hydrotherapy on chronic pruritus in patients with plaque psoriasis: A 29-week comparative study

    Page :AB52

    Ariadna Ortiz Brugues

    
• • ·33766 Efficacy of baricitinib in patients with various degrees of alopecia areata severity: Results from BRAVE-AA1 and BRAVE-AA2

    Page :AB52

    Susan C. Taylor, Neill J. Korman, Tsen-Fang Tsai

    
• • ·33073 Efficacy of brodalumab in moderate-to-severe plaque psoriasis after failure of previous biologic therapies: A phase IV, multicenter, open-label study

    Page :AB53

    Kim Papp, Vimal H. Prajapati, Catherine Maari

    
• • ·32516 Efficacy of intravenous immunoglobulins (IVIG) in improving muscle and skin symptoms in dermatomyositis patients. Results of a large, randomized, placebo-controlled international phase III trial (ProDERM)

    Page :AB53

    Victoria Werth, Margitta Worm, Rohit Aggarwal

    
• • ·33284 Efficacy of nemolizumab in atopic dermatitis: Rapid impact on EASI and SCORAD components

    Page :AB53

    Jean-David Bouaziz, Andreas Pinter, Afsaneh Alavi

    
• • ·34587 Efficacy of ruxolitinib cream for the treatment of atopic dermatitis by anatomic region: Pooled analysis from two randomized phase 3 studies

    Page :AB53

    Eric L. Simpson, Robert Bissonnette, Linda F. Stein Gold

    
• • ·33007 Efficacy of spesolimab for the treatment of GPP flares across prespecified patient subgroups in the Effisayil 1 study

    Page :AB54

    A. David Burden, Yukari Okubo, Min Zheng

    
• • ·33183 Efficacy of the oral JAK3/TEC inhibitor ritlecitinib (PF-06651600) in patients with alopecia areata over 48 weeks: Results from the ALLEGRO Phase 2b/3 randomized, double-blind, placebo-controlled trial

    Page :AB54

    Natasha Mesinkovska, Jerry Shapiro, Brett King

    
• • ·35165 Efficacy, tolerability, and cosmetic acceptability of an acne regimen specifically designed for sensitive skin

    Page :AB54

    James Q. Del Rosso, Christine Emesiani, Thu Nguyen

    
• • ·32956 Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: A post hoc analysis of EXCEED

    Page :AB54

    Gurjit S. Kaeley, Georg Schett, Philip G. Conaghan

    
• • ·34293 Epidemiologic study of tinea cruris and decremental trend of Epidermophyton floccosum infection: A 12-year retrospective review

    Page :AB55

    Ya-Nin Nokdhes, Charussri Leeyaphan, Bawonpak Pongkittilar

    
• • ·34728 Epidermolysis bullosa in the pediatric population: Analysis of the KID database

    Page :AB55

    Amar D. Desai, Yssra Soliman, Sara Behbahani

    
• • ·33630 Erythema nodosum leprosum: A rare cause of testicular nodules

    Page :AB55

    Adriana C. Figueroa-Diaz, Camila M. Cordero-Pacheco

    
• • ·32177 Estimating the diagnosed prevalence of 2 rare photodermatoses in the United States by race and ethnicity: An analysis using claims data and electronic health records

    Page :AB55

    Sunali Goonesekera

    
• • ·31783 Etanercept in toxic epidermal necrolysis: In support of standard of care

    Page :AB56

    Nicola Natsis, Ogechi Ikediobi, Robert Dorschner

    
• • ·33358 Evaluating etanercept in the management of SJS and SJS/TEN overlap patients

    Page :AB56

    Urmila Sivagnanalingam, Cameron Sean Nichols, Abraham Hussein Abdulhak

    
• • ·32060 Evaluating provider perceptions and attitudes about the unique needs of older adult patients in dermatology clinics

    Page :AB56

    Jaya Manjunath, Adam Friedman

    
• • ·34284 Evaluating the association between poor sleep and myocardial infarction in patients with psoriasis

    Page :AB56

    Tina Bhutani, Marwa Hakimi

    
• • ·33231 Evaluating the efficacy of a live virtual chalk talk as a teaching tool on a dermatology clerkship

    Page :AB57

    Kelsey Gradwohl, Severine Cao, Frank Wang

    
• • ·31718 Evaluating the prognostic capability and demographic variability of lactate dehydrogenase (LDH) in advanced stage IV melanoma of the skin

    Page :AB57

    Amar Desai, Sree Chinta, Christopher Yeh

    
• • ·35412 Evaluating the risk in postoperative complications among patients with pre-existing hypothyroidism who underwent Mohs micrographic surgery

    Page :AB57

    Edward Hochman, Haig Pakhchanian, Rahul Raiker

    
• • ·32355 Evaluation of a dermatology mentoring program for medical students

    Page :AB57

    Marie Vu, Ryan H. Wealther, Robert Gilson

    
• • ·33186 Evaluation of cannabis and cannabinoid product use, knowledge, and attitudes in the eczema community

    Page :AB58

    Cleo Whiting, Xuejing Duan, Adam Friedman

    
• • ·32920 Examining the association between the number of mild, moderate, and severe atypical/dysplastic nevi and melanoma

    Page :AB58

    Sarah Shareef, Kurt Ashack

    
• • ·35399 Examining the safety and efficacy of COVID-19 vaccination among atopic dermatitis patients

    Page :AB58

    Haig Pakhchanian, Rahul Raiker, Melanie Wolf

    
• • ·34647 Exploring differences in treatment patterns between adult and pediatric psoriasis patients: Results from a real-world survey

    Page :AB58

    Elizabeth (Lisa) Swanson, William Malatestinic, James Lucas

    
• • ·33251 Exploring temporal disease progression and comorbidities in psoriatic disease

    Page :AB59

    Nana A.L. Rosenø, Erik Hillo Lørup, Ivette Alarcon

    
• • ·35186 Exploring the association between frontal fibrosing alopecia sunscreen and moisturizers

    Page :AB59

    Jalal Maghfour, Justin Olson

    
• • ·32339 Expression of interleukin 36 receptor antagonist in a patient with generalized pustular psoriasis harboring the p.Pro82Leu variant in the IL36RN gene

    Page :AB59

    Itsumi Mizukawa, Masahiro Kamata, Hideaki Uchida

    
• • ·33914 Extraocular sebaceous carcinoma in a patient on long-term methotrexate therapy

    Page :AB59

    Richa Nagpal, Vinoo Sekhri, Rajiv Sekhri

    
• • ·32513 Eyelash dyeing for poliosis of eyelashes in patients with vitiligo

    Page :AB60

    Soo Hyung Kim, Seo Gyeong Lee, Ro Woo Lee

    
• • ·33609 Factors associated with sentinel lymph node status in elderly melanoma patients: A real practice cohort

    Page :AB60

    Pedro Rodriguez Jimenez, Ana Reymundo, Yolanda Delgado

    
• • ·35327 Fibroproliferative and microvasculopathic signatures uncovered in African Americans with diffuse systemic sclerosis

    Page :AB60

    Zachary A. Bordeaux, Nishadh Sutaria, Varsha Parthasarathy

    
• • ·33511 Financial insecurity among U.S. patients with atopic dermatitis

    Page :AB60

    David X. Zheng, Thomas B. Cwalina, Tarun K. Jella

    
• • ·35042 Five year analysis of dermatology safety reports in an academic medical center

    Page :AB61

    Christina G. Lopez, Bina Kassamali, Kevin Yang

    
• • ·34257 Focal epidermodysplasia verruciformis-like pathologic changes in cutaneous neoplasms

    Page :AB61

    Nessa Aghazadeh Mohandesi, Rewan M, Michael J Camilleri

    
• • ·33221 Further clinical outcomes in patients with moderate-to-severe chronic plaque psoriasis receiving adalimumab reference product continuously or switching between BI 695501 and adalimumab RP in the phase III, randomized, interchangeability VOLTAIRE-X trial

    Page :AB61

    Alan Menter, Dorothy McCabe, Benjamin Lang

    
• • ·33612 Geographic disparities in access to immunotherapy trials for metastatic melanoma

    Page :AB61

    Kathleen M. Mulligan, David X. Zheng, Christopher R. Cullison

    
• • ·32947 Geographic practice preferences of diverse graduating medical students pursuing careers in dermatology

    Page :AB62

    Travis Fulk, Matthew Mansh

    
• • ·33961 Geographic practice preferences of sexual minority medical students in the United States

    Page :AB62

    Rachit Gupta, Mitchell R. Lunn, Juno Obedin-Maliver

    
• • ·33970 Glutathione amino acids precursors protect skin from UV-induced skin darkening and redness

    Page :AB62

    Tingyan Mi, Xiao Cui, Xuelan Gu

    
• • ·33952 GNAS mutations: Case report and relevant updates

    Page :AB62

    Anisha Bhanot, Nicole Papac, Courtney Cook

    
• • ·35201 Granulomatous periorificial dermatitis with genital involvement

    Page :AB63

    Michael McBride, Michael Lavery, Daniela Russi

    
• • ·34108 Hair loss in a gender diverse population—A retrospective chart review within an academic health center

    Page :AB63

    Rumbidzai Ngonyama, Gretchen Bellefeuille, Katherine Plampton

    
• • ·33255 Handwash formulations containing 12-hydroxystearic acid provide long-lasting protection against bacteria in vivo

    Page :AB63

    Morris Waskar, Xuelan Gu

    
• • ·32270 Health insurance coverage of injectable fillers and neurotoxins for gender affirmation

    Page :AB63

    Karin Roszell, Frank Wang

    
• • ·33220 Health care resource utilization among adults with chronic spontaneous urticaria in the United States

    Page :AB64

    Maria-Magdalena Balp, Yvonne Geissbühler, Aine Mcconnon

    
• • ·33288 Hidradenitis suppurativa and dermatologic comorbidities in adults: A national-cross sectional study

    Page :AB64

    Isabelle Brown, Waleed Adawi, Kala Perkins-Holstclaw

    
• • ·33921 Hidradenitis suppurativa on Reddit: Natural language processing for thematic analysis

    Page :AB64

    Karan Rajalingam, Jennifer Hsiao, Nicole Levin

    
• • ·33555 High concentration (15%) vitamin C (ascorbic acid) stabilized in unique aqueous vehicle with feverfew, polyhydroxy acid (PHA) and epigallocatechin gallate (EGCG) provides clinical benefits for hyperpigmentation in a diverse population

    Page :AB64

    Marisa Dufort, Brenda L. Edison, Neena K. Tierney

    
• • ·35046 Home phototherapy: Improving access to dermatologic care

    Page :AB65

    Fatima Bawany, Julie Ryan Wolf, Francisco Tausk

    
• • ·32793 How can we teach clerkship medical students the multidisciplinary aspects of dermatology? A medical education initiative

    Page :AB65

    Chaocheng Liu, Megan Chan, Vivienne Beard

    
• • ·33306 Identification of risk factors associated with benzoate/benzoic acid reactivity in patch tested patients

    Page :AB65

    Penelope Kim-Lim, Sydney Sullivan, Lauren Hastings

    
• • ·35224 Identifying a correlation between preceding trauma and development of dermatofibrosarcoma protuberans: A review of the literature

    Page :AB65

    Brittani Jones, Jesse Veenstra, David Ozog

    
• • ·33676 Identifying factors associated with multibiologic use at an academic center

    Page :AB66

    Edward Hadeler, Samuel Yeroushalmi, Sugandh Kumar

    
• • ·32622 Imaging technologies for presurgical margin assessment of basal cell carcinoma

    Page :AB66

    Krishan Parashar, Angeli Eloise Torres

    
• • ·33834 Impact of chronic spontaneous urticaria on health-related quality of life in the United States

    Page :AB66

    Karen Freedle, Dhaval Patil, Maria-Magdalena Balp

    
• • ·34291 Impact of COVID-19 pandemic on dermatology patient pharmacy preferences

    Page :AB66

    Ailia Ali, Uros Rakita, Rima Ghamravi

    
• • ·33536 Impact of day-to-day sleep disruption on the burden of disease in moderate-severe adult atopic dermatitis patients

    Page :AB67

    Evangeline Pierce, C. Elise Kleyn, Susanne Grond

    
• • ·32917 Impact of full solar spectrum irradiation on skin cells from infant or children compared with adults

    Page :AB67

    Stéphanie Bredif, Gaelle Bellemere, Caroline Baudouin

    
• • ·34737 Impact of histology and immunohistochemistry findings on sebaceous carcinoma patient outcomes

    Page :AB67

    Steven Koller, Zoe Brown-Joel, Kara Young

    
• • ·33950 Impact of psoriasis in special areas on patient quality-of-life outcomes and depression screening: Findings from the multinational UPLIFT survey

    Page :AB67

    Richard G. Langley, Matthias Augustin, Sandy McBride

    
• • ·32244 Impact of risankizumab on achieving minimal clinically important differences in patient-reported disease activity, fatigue, and pain among patients with active psoriatic arthritis: Analysis of 2 phase 3 clinical trials

    Page :AB68

    Lars Erik Kristensen, Ahmed Soliman, Kim Papp

    
• • ·32681 Impact of risankizumab on improving health-related quality of life, work productivity, and reducing fatigue among patients with active psoriatic arthritis: A pooled analysis of two phase 3 clinical trials

    Page :AB68

    Lars Erik Kristensen, Ahmed M. Soliman, Kim Papp

    
• • ·33198 Improved patient understanding of dermatology providers’ training results in increased willingness to treat

    Page :AB68

    Katherine R. Salisbury, Varun K. Ranpariya, Steven R. Feldman

    
• • ·34313 Improvement in disease severity and quality of life in patients with atopic dermatitis (AD) treated with dupilumab for up to 18 months: Real-world evidence from the PROSE registry

    Page :AB68

    Jerry Bagel, Gil Yosipovitch, David M. Pariser

    
• • ·33280 Improvement in patient-reported hair loss outcome measures in patients with alopecia areata treated with ritlecitinib: 48-week results from the ALLEGRO phase 2b/3 randomized, double-blind, placebo-controlled trial

    Page :AB69

    Rodney Sinclair, Natasha Mesinkovska

    
• • ·33054 Improvement in touch avoidance in patients with genital psoriasis treated with ixekizumab: 52-week results of a phase 3 clinical trial in patients with moderate-to-severe genital psoriasis (IXORA-Q)

    Page :AB69

    Jennifer Soung, Jennifer Clay Cather, Melinda Gooderham

    
• • ·34503 Improvements in facial redness and inflammation: An open-label, single center clinical study including low molecular weight heparan sulfate (HSA) in patients with sensitive skin

    Page :AB69

    Joel L. Cohen, Valerie D. Callender, Glenn Dale, Angel S. Byrd

    
• • ·33008 Improving clinical trial experience for patients and investigators through a simulated trial in palmoplantar pustulosis (PPP)

    Page :AB69

    David Trigos, Andreas Pinter, Christian Boisvert-Huneault

    
• • ·33125 Improving quality of life for elderly patients with xerosis with an easy-to-use, ceramide-containing skincare routine

    Page :AB70

    Federica Filippi, Annalisa Patrizi, Marco Adriano Chessa

    
• • ·34617 Imsidolimab in the treatment of adult subjects with generalized pustular psoriasis: Design of a pivotal phase 3 clinical trial and a long-term extension study

    Page :AB70

    Johann E. Gudjonsson, Bruce Randazzo, Jihao Zhou

    
• • ·34223 Incidence and prognosis of COVID-19 in patients with psoriasis on apremilast: A multicenter retrospective cohort study

    Page :AB70

    Yuliya Lytvyn, Jorge R. Georgakopoulos, Asfandyar Mufti

    
• • ·33244 Increased risk of hyperkalemia in older women taking spironolactone for female pattern hair loss

    Page :AB70

    Maya Collins, Shaheir Ali, Isabel M. Pupo Wiss

    
• • ·33476 Increased risk of local recurrence of melanomas located on the face, ears, and scalp

    Page :AB71

    Claudia Quarshie, Margaret Y. Huang, Gabrielle Barajas

    
• • ·33458 Infantile sucking bruise to the lip could be easily mistaken for nonaccidental injury

    Page :AB71

    Alex Gan, Caroline Brown, Jane C. Ravenscroft

    
• • ·35376 Inflammatory linear verrucous epidermal nevi. A therapeutic proposal

    Page :AB71

    Marielva Castro-González, Abraham Benjamín Alfaro-Sánchez, Rebeca Rodríguez-Cabral

    
• • ·32579 Influence of anatomic locations of T1b melanomas and patient age on outcomes

    Page :AB71

    Margaret Y. Huang, Gabrielle Barajas, Rahul Masson

    
• • ·34232 Inhibition of tissue resident memory-T cells as a therapy for contact hypersensitivity

    Page :AB72

    Touraj Khosravi-Hafshejani, Mehran Ghoreishi, Jan Peter Dutz

    
• • ·33537 Inhibitory effects of ME3183, a novel phosphodiesterase-4 inhibitor, on stimulants-induced production of proinflammatory cytokines and chemokines in whole blood cell cultures of patients with plaque psoriasis

    Page :AB72

    Chizuko Kaji, Kenji Suzuki, Akiko Kano

    
• • ·33238 Initial psychometric evaluation of the eczema symptom and impact diary in patients with moderate to severe atopic dermatitis from a phase 2 trial

    Page :AB72

    Shanshan Qin, Lori McLeod, Jia Ma

    
• • ·34655 Integrated analysis of abrocitinib for the treatment of adolescents with moderate-to-severe atopic dermatitis from the phase 3 clinical trial program

    Page :AB72

    Amy Paller, Lawrence F. Eichenfield, Michael J. Cork

    
• • ·32483 Integrating implementation science frameworks to guide teledermatology implementation in an academic medical setting

    Page :AB73

    Ethan D. Borre, Meenal K. Kheterpal, Matilda W. Nicholas

    
• • ·34296 Introduction of BELCOMID: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases

    Page :AB73

    Tom Hillary, An Van Laethem, Francisca Castelijns

    
• • ·34466 Invasive melanoma among Veterans: A comparative analysis with the SEER registry, 2009-2017

    Page :AB73

    Nicole Trepanowski, Michael S. Chang, Jennifer La

    
• • ·35132 Investigating the progression of melanoma and squamous cell carcinomas before and after the COVID-19 lockdown

    Page :AB73

    Laura Russell, Eric Du, Kara Signorelli

    
• • ·34266 Is generalized granuloma annulare truly associated with diabetes mellitus, hyperlipidemia, thyroid disorders, and malignancy? A systematic review

    Page :AB74

    Muhammad Osto, Salam Smidi, Amira Alnabolsi

    
• • ·34543 Isotretinoin counseling amid the COVID-19 pandemic

    Page :AB74

    Ayezel Munoz, Renat Ahatov, Emily Williams

    
• • ·33108 Ixekizumab achieved and sustained nail psoriasis resolution regardless of disease severity through 5 years: Results from Uncover-3

    Page :AB74

    Alexander Egeberg, Lars Erik Kristensen, Ronald Vender

    
• • ·34238 Laser revision of periareolar scarring following masculinizing chest surgery: A case report

    Page :AB74

    James T. Pathoulas, Matthew Mansh, Ronda S. Farah

    
• • ·32526 Laser-assisted drug delivery for treatment of lichen sclerosus: A promising and novel approach

    Page :AB75

    Jacqueline Jones, Meagan Simpson

    
• • ·33965 Learn2Derm: A community-based pilot program assessing beliefs surrounding skin cancer risk factors, presentation, and prevention strategies

    Page :AB75

    Sarah H. Millan, Deega Omar, Stella Caldas

    
• • ·33514 Learning practical dermatology skills through animated vignettes: An effective medical school educational intervention to support the dissemination of national guidelines

    Page :AB75

    Chaocheng Liu, Seungwon (Sara) Choi, Bei Yuan (Ethan) Zhang

    
• • ·32479 Level of evidence of COVID-19 articles in dermatology literature

    Page :AB75

    Mehdi Farshchian, Muhammad Osto, Jane M. Grant-Kels

    
• • ·34860 Levels of evidence within dermatology; bibliometric trends compared with general medicine and general surgery from 2008-2017: A bibliometric systematic review

    Page :AB76

    Diya Ramanathan, Panayiota Govas, Andrea Ketchum

    
• • ·33441 Line-field confocal optical coherence tomography: A new noninvasive technique for the in vivo diagnosis of common viral infections of the skin

    Page :AB76

    Francesco Lacarrubba, Anna Elisa Verzì, Francesco Piscazzi

    
• • ·31840 Local recurrence rates of extramammary Paget disease are lower following Mohs micrographic surgery compared with wide local excision: A systematic review and meta-analysis

    Page :AB76

    Grace Y. Kim, Elliott H. Campbell, Patricia J. Erwin

    
• • ·33624 Long-term cutaneous manifestations in COVID-19 patients: A systematic review

    Page :AB76

    Abhinav Grover, Franchesca Choi, Sheng Pei-Wang

    
• • ·32703 Longitudinal course of sleep disturbance in adult atopic dermatitis in clinical practice

    Page :AB77

    Jaya Manjunath, Donald Lei, Adnan Ahmed

    
• • ·33233 Long-term efficacy (to 68 weeks) of baricitinib in adult patients with moderate to severe atopic dermatitis (AD) who were treatment responders or partial responders and originally included in the combination topical corticosteroids study BREEZE-AD7

    Page :AB77

    Jonathan I. Silverberg, Eric L. Simpson, Jacob P. Thyssen

    
• • ·32264 Long-term efficacy and safety of ixekizumab in a phase III, randomized, double-blind, placebo-controlled study in pediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS) up to 108 weeks

    Page :AB77

    A.S. Paller, M.M.B. Seyger, G.A. Magariños

    
• • ·33270 Long-term efficacy and safety of risankizumab (RZB) for the treatment of moderate to-severe plaque psoriasis: Interim analysis of results from the LIMMitless open-label extension trial beyond 4 years of follow-up

    Page :AB77

    Kim A. Papp, Mark G. Lebwohl, Lluís Puig

    
• • ·33882 Long-term persistence of first-line biologics for psoriasis and psoriatic arthritis: A cohort study of 23,423 patients from the French health insurance database (SNDS)

    Page :AB78

    Laura Pina Vegas, Laetitia Penso, Pascal Claudepierre

    
• • ·34914 Long-term safety of risankizumab in patients with psoriatic disease: Findings from integrated analyses of 17 clinical trials in psoriasis and 4 in psoriatic arthritis

    Page :AB78

    Kenneth B. Gordon, Andrew Blauvelt, Hervé Bachelez

    
• • ·31764 LRP1B expression is correlated with age and perineural invasion in metastatic cutaneous squamous cell carcinoma: A pilot study

    Page :AB78

    Marissa Lobl, Corey Georgesen, Jennifer Black

    
• • ·33987 Machine learning artificial intelligence guided management robotic articulated arm laser

    Page :AB78

    Michael Abrouk

    
• • ·34039 Maintenance of skin clearance in a long-term open-label study of fixed-combination halobetasol propionate and tazarotene lotion for psoriasis in participants with prior use of topical treatments

    Page :AB79

    Linda Stein Gold, Javier Alonso-Llamazares, Joshua Zeichner

    
• • ·31256 Malignancy rates through 5 years of follow-up in guselkumab-treated patients with moderate to severe psoriasis: Results from the VOYAGE 1 and 2 trials and comparisons to general populations

    Page :AB79

    Andrew Blauvelt, Richard G. Langley, Vincent Ho

    
• • ·31772 Malignancy risk among children and adults with atopic dermatitis in a population-based cohort

    Page :AB79

    Joy Wan, Daniel B. Shin, Maha N. Syed

    
• • ·34691 Management of common scabies and post-scabetic itch in adults: Lessons learned from a single-center retrospective cohort study

    Page :AB79

    Le Wen Chiu, Tim G. Berger, Aileen Y. Chang

    
• • ·33870 Mechlorethamine gel as a maintenance treatment regimen in patients with mycosis fungoides

    Page :AB80

    Emily Correia, Shalini Krishnasamy, Jayson Suriano

    
• • ·34979 Medical therapies and commercial products used by transgender men to enhance facial and body hair

    Page :AB80

    James T. Pathoulas, Kelly E. Flanagan, Chloe J. Walker

    
• • ·34997 Melanocytic staining of focal acantholytic dyskeratosis and epidermolytic hyperkeratosis within dysplastic nevi

    Page :AB80

    Kayley Erickson, Bethany Rohr

    
• • ·32543 Melanoma in pregnancy: Profiling the tumor microenvironment

    Page :AB80

    Maha Kazmi, Maija Kiuru, Jessica Terrell

    
• • ·33379 Melanophages save the day: A case of generalized bullous fixed drug eruption

    Page :AB81

    Brayden Healey, Michael DeWall, Barry Auster

    
• • ·34689 Merkel cell carcinoma: The effect of facility type on patient outcomes

    Page :AB81

    Maleka Najmi, Sarah Mazal, Eyas Alkhalili

    
• • ·33979 Minimum resection margins for fibrohistiocytic tumors: A systematic review to inform a probability model

    Page :AB81

    Rachel E. Christensen, Brandon Worley, Atieh Jibbe

    
• • ·34504 Mixed methods validation of a patient-centered educational atopic dermatitis mobile health application

    Page :AB81

    Nickoo Merati, Gaurav Isola

    
• • ·35209 Mohs surgery on the superior helix resulting in ulceration of an untouched anti-helix

    Page :AB82

    Alex Harrison, Amanda Stallings, Taylor Gray

    
• • ·33156 Molecular linkage between psoriasis vulgaris and inflammation in adipose tissue: Modulation by secukinumab treatment in the ObePso study

    Page :AB82

    Sandra Garcet, Andrew Blauvelt, Elisa Muscianisi

    
• • ·35317 More than meets the eye: Regression of locally advanced recurrent SCC

    Page :AB82

    Suraj Venna, Chelsea Stahl, Sekwon Jang

    
• • ·35249 More than skin deep: Dermatitis and general health in the National Health and Nutrition Examination Survey

    Page :AB82

    Yong Lee, Morgan Ye, Kerob Delphine

    
• • ·33760 Mortality in patients with pemphigus: a retrospective US claims database study

    Page :AB83

    Jonathan Silverberg, Julia S. Lehman, Animesh A. Sinha

    
• • ·35283 Mucocutaneous lichen planus following Moderna COVID-19 vaccination

    Page :AB83

    Elnara Muradova, Erica Negrini, Adrienne Berke

    
• • ·32967 Mucosal melanoma and organ-specific metastasis: Differences in survival outcomes between tumor primary sites

    Page :AB83

    Kathleen M. Mulligan, Christopher R. Cullison, David X. Zheng

    
• • ·32481 Mycosis fungoides palmaris et plantaris: A case series

    Page :AB83

    Alexander S. Bang, Yuna Oh, Alison J. Moskowitz

    
• • ·34722 Nail-patella syndrome: An early dermatologic diagnosis

    Page :AB84

    Sandra Oska, Kelly Kennelly, Vinod Misra

    
• • ·33615 Nasosinusal mucosal melanoma

    Page :AB84

    Mariano Marini, Luis Berrocal, Carolina Galvis

    
• • ·35359 New clinical methodology directed for lesion count in patients with truncal acne

    Page :AB84

    Loan Towersey

    
• • ·33111 New onset scrotal lesions in a patient with herpes simplex virus treated with foscarnet

    Page :AB84

    Rebecca Wang, Ben J. Friedman

    
• • ·33699 Nodular melanoma of the nipple in a male with in-transit and satellite metastases

    Page :AB85

    Hope Barone DO, Karen Heidelberg

    
• • ·35253 Nonmelanoma skin cancers in skin of color solid organ transplant recipients

    Page :AB85

    Jaimie Lin, Sabah Osmani, Jiasen Wang

    
• • ·33396 Nonuremic calciphylaxis precipitated by COVID 19 infection

    Page :AB85

    Nate Messenger, Christina E. Artz, Pranita V. Rambhatla

    
• • ·33967 Nourishing fatty acid moisturizers provide superior barrier benefits in ex vivo skin

    Page :AB85

    John Nip, Hilal Ilarslan, Ana Villa

    
• • ·33530 Novel serological biomarkers are associated with disease severity and systemic inflammation in patients with hidradenitis suppurativa

    Page :AB86

    Solveig Skovlund Groen, Valdemar Wendelboe Nielsen, Astrid-Helene Ravn Jørgensen

    
• • ·34095 Observed and projected prevalence of prurigo nodularis in a commercially and Medicare-insured U.S. population

    Page :AB86

    Sylvie Gabriel, Shawn G. Kwatra, Jorge Puelles

    
• • ·31288 Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases

    Page :AB86

    Maria C. Schneeweiss, Julien Kirchgesner, Richard Wyss

    
• • ·34205 Ocular manifestations of vitiligo: A systematic review

    Page :AB86

    Tessa LeWitt, Robert Tauscher, Gracious Obiofuma

    
• • ·35421 Online dermatology curriculum experiences among U.S. dermatology residents and faculty

    Page :AB87

    Quoc-Bao Nguyen, Caroline Starling, Misha Koshelev

    
• • ·33569 Optimization of common hand cleansers for protection from viral spread and occupational hand dermatoses

    Page :AB87

    Natalie Winder, Michael Cork

    
• • ·33266 Optimizing treatment cost for psoriasis patients: Oral vs. subcutaneous methotrexate

    Page :AB87

    Katherine Jolin, Laura Williams

    
• • ·31891 Oral metronidazole use in mucosal lichen planus

    Page :AB87

    Alison Nancy Hollis, Donna Aline Culton

    
• • ·33792 Outcomes in organ transplants from donors with melanoma: A systematic review

    Page :AB88

    William Hao Syuen Ng, David John Curchin, BBus(Hon), Saxon D. Smith

    
• • ·33567 Overview of the systematic reviews with network meta-analysis evaluating the efficacy or safety of the systemic treatments in moderate-to-severe psoriasis

    Page :AB88

    Robin Guelimi, Sivem Afach, Jean-Philippe Regnaux

    
• • ·35396 Pain, discomfort, unpleasant sensations: The impact of scars

    Page :AB88

    J.M. Amici

    
• • ·34307 Paleo prurigo

    Page :AB88

    Laura Adams, Anusha Panthagani, Raja Hamaoui

    
• • ·33507 Parking fees: A significant financial burden for phototherapy patients

    Page :AB89

    Kyaw Zin Htet, Theresa Bui, Andrea Murina

    
• • ·33265 Paternal safety of psoriasis treatment

    Page :AB89

    Hazel H. Oon, Edward XW. Hui, Xiaoling Huang

    
• • ·32834 Patient and dermatologist perspectives on unmet needs in hidradenitis suppurativa

    Page :AB89

    Vivian Y. Shi, Joslyn S. Kirby, Jennifer L. Hsiao

    
• • ·33340 Patient and provider experience with synchronous teledermatology during the COVID-19 pandemic

    Page :AB89

    Saniya Shaikh, Eric Armbrecht, Vruta Kansara

    
• • ·33720 Patient demographics and risk of metastases in Latino patients with melanomas

    Page :AB90

    Rahul Masson, Claudia Quarshie

    
• • ·31478 Patient perspectives and the illness experience among skin of color patients with mycosis fungoides/Sézary syndrome: A qualitative analysis

    Page :AB90

    Jaclyn Abraham, Grace Wei, Seemal Desai

    
• • ·31494 Patient-reported quality of life impact of hidradenitis suppurativa: Real-world experience from EU5 and US

    Page :AB90

    John R. Ingram, Vincenzo Bettoli, Jasmine I. Espy

    
• • ·33583 Patients treated with ligelizumab achieve freedom from signs and symptoms of chronic spontaneous urticaria regardless of the angioedema status at baseline

    Page :AB90

    Karl Sitz, Weily Soong, Jonathan A. Bernstein

    
• • ·34341 Patterns and determinants of adult dermatologic care in the United States: An evaluation of the National Ambulatory Medical Care Survey

    Page :AB91

    Kevin A. Nguyen, Ladan Afifi, Daniel Bach

    
• • ·34347 Patterns and determinants of pediatric dermatologic care in the United States: An evaluation of the National Ambulatory Medical Care Survey

    Page :AB91

    Kevin A. Nguyen, Ladan Afifi, Daniel Bach

    
• • ·34328 Performance of electrical impedance spectroscopy in patients with atypical mole syndrome (AMS)

    Page :AB91

    Zaeem Nazir, Rachel Manci, Stephen Dusza

    
• • ·34304 Persistence and adherence to ixekizumab treatment in patients with moderate-to-severe psoriasis before and during COVID-19 pandemic: Results from the Canadian Patient Support Program

    Page :AB91

    Wayne Gulliver, Melinda Gooderham, Catherine Reed

    
• • ·34420 Perspective of patients with erythropoietic protoporphyria treated with dersimelagon, a selective melanocortin-1 receptor agonist: Results of the ENDEAVOR study exit questionnaire

    Page :AB92

    Kirstine Belongie, Fumihiro Takahashi, Susan Martin

    
• • ·32994 Pezadeftide is a potent antifungal peptide with rapid fungicidial activity via a unique mechanism of action

    Page :AB92

    Nicole L. Van der Weerden, James McKenna, Kathy Parisi

    
• • ·33765 Phase 1b randomized, double-blind, placebo-controlled study evaluating the safety, tolerability, and efficacy of GLPG3667 in patients with moderate-to-severe plaque psoriasis

    Page :AB92

    Diamant Thaçi, Judit Molnar, Helen Timmis

    
• • ·34817 Physician counseling among adults with high-risk UV behaviors in the United States

    Page :AB92

    Matthew T. Taylor, Jordan Safran, Johns S. Barbieri

    
• • ·34101 Pilot survey project on methods used to assess dermatology resident clinical reasoning

    Page :AB93

    Aliya Rodriguez, Kayla A. Clark, Melanie Rosado

    
• • ·32460 Pityriasis rubra pilaris transcriptomics identifies mechanisms of treatment resistance

    Page :AB93

    Blake Boudreaux, Puneet Bhullar, Meera Patel

    
• • ·31865 Pooled efficacy and safety results from the DERMIS-1 and DERMIS-2 phase 3 trials of once-daily roflumilast cream 0.3% for treatment of chronic plaque psoriasis

    Page :AB93

    Mark Lebwohl, Melinda J, Scott T. Guenthner

    
• • ·33701 Porokeratotic eccrine ostial and dermal duct nevus caused by a second-hit postzygotic GJB2 mutation

    Page :AB93

    Hsing-San Yang, Yi-Han Chang, Julia Yu-Yun Lee

    
• • ·32315 Postoperative care consideration: Cold panniculitis induced by cooling device after knee surgery

    Page :AB94

    Amy Zavell, Ashley Jenkins

    
• • ·34633 Postoperative dermatologic sequelae of breast cancer: A systematic literature review

    Page :AB94

    Yana Kost, Beth N. McLellan

    
• • ·32015 Practice patterns on the management of pemphigus – An international survey study

    Page :AB94

    Idy Tam, Gabriela A. Cobos, Erin X. Wei

    
• • ·33482 Predictors of survival outcomes for cutaneous giant cell sarcoma include patient sex and race, lesion size and stage, and receipt of surgical intervention

    Page :AB94

    Fatima N. Mirza, Sara Yumeen, Humza N. Mirza

    
• • ·33159 Predictors of use of Mohs micrographic surgery in the treatment of dermatofibrosarcoma protuberans of the head and neck: An analysis of the National Cancer Database

    Page :AB95

    Amar D. Desai, Sara Behbahani, Vraj P. Shah

    
• • ·33841 Pregnancy dermatosis clinical scoring system: How to predict between pemphigoid gestationis and polymorphic eruption of pregnancy

    Page :AB95

    Fangyi Xie, Farah Baban, Emma F. Johnson

    
• • ·33826 Prevalence and clinical profile of patients with chronic spontaneous urticaria in the USA

    Page :AB95

    Dhaval Patil, Karen Freedle, Maria-Magdalena Balp

    
• • ·33552 Prevalence and severity of atopic dermatitis and hand eczema, and associated lifestyle factors in the Dutch general population

    Page :AB95

    Junfen Zhang, Laura Loman, Angelique N. Voorberg

    
• • ·33432 Prevalence estimates for alopecia areata in the United States

    Page :AB96

    Jonathan Lavian, Andrew Strunk, Amit Garg

    
• • ·32318 Prevalence of skin diseases in methamphetamine users

    Page :AB96

    Alexander S. Bang, Adam Zakaria, Erin H. Amerson

    
• • ·33011 Prevalence, comorbidities and mortality of generalized pustular psoriasis (GPP): A literature review

    Page :AB96

    Manuelle Viguier, Siew Eng Choon, Christopher Griffiths

    
• • ·32514 Primary cutaneous marginal zone B-cell lymphoma involution with anetoderma

    Page :AB96

    Ala Haqiqi, Siobhán McCarthy, Anastasia Therianou

    
• • ·33202 Prurigo nodularis and mental health disorders among hospitalized patients in the United States

    Page :AB97

    Thomas K. Le, Katherine A. Whang, Nishadh Sutaria

    
• • ·34806 Pseudoxanthoma elasticum-like papillary dermal elastolysis: A histopathologic diagnosis

    Page :AB97

    Xavier A. Rice, Caroline Hagan, Brandon Goodwin

    
• • ·34963 Psychosocial burden of verruca vulgaris: A cross-sectional survey

    Page :AB97

    Nagasai C. Adusumilli, Ezra Shoen, Adam J. Friedman

    
• • ·33366 Public knowledge of at-home mole checks: Implications for patient education to reduce morbidity and mortality of melanoma

    Page :AB97

    Abigail Marriott, Victoria D’Acunto, Abigail Cline

    
• • ·34442 Pustular psoriasis of pregnancy: A unique presentation

    Page :AB98

    Olivia Negris, Nithin Reddy, Alexandra Rzepecki

    
• • ·32573 Pyoderma gangrenosum: Ulcerative to pustular variety

    Page :AB98

    Estefania Boland-Rodriguez, Circe Ancona-Castro, César Daniel Villarreal-Villarreal

    
• • ·32849 Quality and utility of patient-initiated store-and-forward teledermatology images

    Page :AB98

    Simon W. Jiang, M. Seth Flynn, Jeffery T. Kwock

    
• • ·34038 Race associated with delays in time to initial treatment and radiation for patients with mycosis fungoides: A retrospective, cross-sectional analysis of the National Cancer Database from 2004-2017

    Page :AB98

    Jessica Brown-Korsah, Susan C. Taylor, Paul L. Haun

    
• • ·32886 Race, education, and employment status are associated with patients’ willingness to pay for prescription acne treatment

    Page :AB99

    Jennifer J. Su, Varun K. Ranpariya, Steven R. Feldman

    
• • ·35091 Racial differences in anatomic sites of metastatic melanoma: An analysis of the National Cancer Database 2004-2018

    Page :AB99

    Jennifer M. Fernandez, Kevin R. Kwan, Sara Behbahani

    
• • ·34998 Racial factors regarding diagnosis and treatment of head lice in pediatric patients

    Page :AB99

    McCall E. Torpey, Marissa Contento, Abigail Cline

    
• • ·34086 Rapid response of truncal acne with oral sarecycline

    Page :AB99

    Angela Moore

    
• • ·33680 Readability of patient charts in dermatology compared with other specialties

    Page :AB100

    Pavane L. Gorrepati, Gideon P. Smith

    
• • ·35250 Real-time feedback during an interactive online skin cancer training game “Whack-a-Mole” is key to increasing confidence in performing skin self-examination at home.

    Page :AB100

    Margaret I. Sanchez, Nicholas Carcioppolo, Soyoon Kim

    
• • ·34387 Real-time molecular skin fluorescent imaging for detecting tissue remodeling in atypical moles

    Page :AB100

    Catherine Shachaf, Kevin Manbeck, Amit Shachaf

    
• • ·34326 Real-world analysis of skin infections and antimicrobial use among patients with atopic dermatitis before and after initiation of dupilumab treatment

    Page :AB100

    Peck Ong, Michael J. Cork, April Armstrong

    
• • ·31854 Real-world experience of dupilumab treatment for atopic dermatitis

    Page :AB101

    Jaime Martinez Mariscal, Raquel Cabana-Navia, Alicia Martinez-Fernandez

    
• • ·33748 Real-world insights into quality improvement in atopic dermatitis care

    Page :AB101

    Eric L. Simpson, Jonathan Corren, Laura K. Ferris

    
• • ·34940 Real-world patient-reported outcomes with risankizumab in patients with moderate to severe psoriasis from the CorEvitas Psoriasis Registry

    Page :AB101

    Bruce Strober, Laura K. Ferris, Kristina Callis Duffin

    
• • ·33172 Real-world treatment patterns of adults with psoriasis initiated on apremilast or biologics

    Page :AB101

    Jashin J. Wu, Ann (Ching An) Wang

    
• • ·33635 Recalcitrant bullous rash presenting in a pediatric patient, ultimately responsive to dupilimab

    Page :AB102

    Kimberly Shao

    
• • ·35360 Recalcitrant pediatric bullous erythema multiforme responsive to oral tofacitinib

    Page :AB102

    Sasank Konda, Nayha Shetty, Jesse Liu

    
• • ·33505 Reddit and dermatology: Analyzing user-submitted posts seeking dermatologic advice on r/SkincareAddiction and r/DermatologyQuestions

    Page :AB102

    Kevin Lee, Nader Aboul-Fettouh, Natalie Kash

    
• • ·34888 Refractory pustular psoriasis treated successfully with IL-23 inhibitors. Report of 1 patient with generalized pustular psoriasis and 4 patients with palmoplantar pustulosis

    Page :AB102

    Maria Politou, Kleidona Ileana Afroditi, Nikolaidou Electra

    
• • ·33933 Relationship between skin involvement and disease burden in patients with mild to moderate plaque psoriasis: Real-world findings From CorEvitas’ Psoriasis Registry

    Page :AB103

    Alexis Ogdie, Bruce Strober, Mark Lebwohl

    
• • ·31412 Response and local control in patients treated with low-dose radiotherapy for tumoral mycosis fungoides

    Page :AB103

    Joseph Pena, Deborah Cull, Lindsay Strowd

    
• • ·32102 Response in the placebo group in randomized controlled trials for moderate-to-severe psoriasis

    Page :AB103

    Sivem Afach, Laurence Le Cleach, Emilie Sbidian

    
• • ·35124 Response to systemic therapies for erythromelalgia with reduced epidermal neurite density

    Page :AB103

    Andressa Akabane, Gideon Piers Smith

    
• • ·34508 Retinoids: A cross-sectional study of YouTube videos including DISCERN scores

    Page :AB104

    Christine Duvenjian, Jennifer Laborada, Amanda F. Marsch

    
• • ·33805 Retrospective cohort study of scalp cooling in breast cancer patients

    Page :AB104

    Lucy Rose, Brittany Dulmage

    
• • ·33813 Retrospective study of the prevalence of hyperkalemia in women taking spironolactone for acne, hair loss, and hirsutism

    Page :AB104

    Rachel Hill, Yu Wang, Shari R. Lipner

    
• • ·34398 Risk factors for the development of acne in health care workers during the COVID-19 pandemic

    Page :AB104

    Advika Dani, Amarachi Eseonu, Kristin Bibee

    
• • ·32559 Risk of hidradenitis suppurativa and hyperhidrosis in transgender patients on hormone therapy compared with cisgender patients

    Page :AB105

    Julia Gao, Jessika Sanz, Erica Dommasch

    
• • ·33304 Ritlecitinib (PF-06651600), an oral JAK3/TEC inhibitor, shows efficacy in patients with active nonsegmental vitiligo and either a lighter or darker Fitzpatrick skin type: Results from a phase 2b, randomized, dose-ranging study with an extension period

    Page :AB105

    Elena Peeva, Yuji Yamaguchi, Brett King

    
• • ·33300 Ritlecitinib (PF-06651600), an oral JAK3/TEC inhibitor, stabilizes active lesions and promotes repigmentation of stable lesions in patients with active nonsegmental vitiligo: Results from a phase 2b, randomized, placebo-controlled, dose-ranging study

    Page :AB105

    Yuji Yamaguchi, Elena Peeva, Ronald Shore

    
• • ·33460 Roflumilast foam 0.3% treatment of seborrheic dermatitis is effective and safe and improves patient quality of life: Results from a phase 2 study

    Page :AB105

    Zoe D. Draelos, Seth B. Forman, Lawrence J. Green

    
• • ·35304 Safety and efficacy of COVID-19 vaccination in psoriasis patients

    Page :AB106

    Mairead Baker, Kristen Russomanno, Rahul Raiker

    
• • ·33150 Safety of guselkumab in patients with moderate-to-severe psoriasis: Pooled analyses across clinical studies

    Page :AB106

    Mark Lebwohl, Katelyn Rowland, Megan Miller

    
• • ·34367 Safety of long-term dupilumab treatment in adults with moderate-to-severe atopic dermatitis: Results from an open-label extension (OLE) trial up to 4 years

    Page :AB106

    Andreas Wollenberg, Weily Soong, Melinda Goooderham

    
• • ·33182 Safety of the oral JAK3/TEC inhibitor ritlecitinib (PF-06651600) in patients with alopecia areata: Results from the ALLEGRO phase 2b/3, randomized, double-blind, placebo-controlled trial

    Page :AB106

    Brett King, Jacek C. Szepietowski, Paul Farrant

    
• • ·34051 Scalp biopsy increases diagnostic accuracy and treatment outcomes in African American females with alopecia

    Page :AB107

    Alison Romisher, Alexa Cohen, Annyella Douglas

    
• • ·31789 Scleroderma associated with immune checkpoint inhibitor durvalumab

    Page :AB107

    Alexandria Brown, Ian Watson, Erin Boh

    
• • ·33596 Secukinumab demonstrated sustained retention and safety in a real-world setting in patients with moderate to severe plaque psoriasis: Long-term results from an interim analysis of the SERENA study

    Page :AB107

    Matthias Augustin, Ralph von Kiedrowski, Dimitris Rigopoulos

    
• • ·33257 Secukinumab effects on cardiovascular risk factors in patients with psoriasis, psoriatic arthritis and axial spondyloarthritis: Results from post hoc analyses of pooled data from 19 phase 3/4 clinical studies

    Page :AB107

    Joseph F. Merola, Iain B. McInnes, Atul A. Deodhar

    
• • ·32428 Secukinumab is effective and safe in the treatment of recalcitrant palmar-plantar psoriasis and palmar-plantar pustular psoriasis in a daily practice setting

    Page :AB108

    Alejandra Reolid, Susana Armesto, Antonio Sahuquillo-Torralba

    
• • ·35098 Secukinumab versus guselkumab in the treatment of ustekinumab-resistant psoriatic plaques: 16-week randomized, open-label, multicenter ARROW study

    Page :AB108

    James Krueger, Richard Langley, Simon Nigen

    
• • ·34843 Serious adverse events associated with hormonal contraceptive use for acne treatment, based on reporting to the FDA Adverse Events Reporting Database

    Page :AB108

    Elizabeth M. Rao, Bryan T. Carroll

    
• • ·33124 Severe infections, confirmed extended major adverse cardiovascular events, and malignancies over 5 years of treatment with tildrakizumab in terms of number needed to harm: Pooled analyses from the reSURFACE 1 and reSURFACE 2 phase 3 trials

    Page :AB108

    Andreas Pinter, Jean-Philippe Lacour, Alexander Egeberg

    
• • ·34687 Sex differences in treatment patterns of severe hidradenitis suppurativa exacerbations

    Page :AB109

    Nicole Mona Golbari, Kelsey Flood

    
• • ·34910 Shared decision making in patients with breast and gynecologic malignancies receiving chemotherapy regimens associated with persistent alopecia

    Page :AB109

    Azael Freites-Martinez, Roisin E. O’Cearbhaill, Claire Frances Friedman

    
• • ·32432 Significant nail improvement occurs as early as 24 weeks and lasts long-term through 5 years in ixekizumab treated patients with moderate-to-severe psoriasis and significant nail involvement

    Page :AB109

    Bruce Strober, Joseph F. Merola, April Armstrong

    
• • ·33047 Simultaneous improvements in skin signs and quality of life in pediatric patients with psoriasis receiving secukinumab over 52 weeks

    Page :AB109

    John Browning, Vivian Laquer, Nina Magnolo

    
• • ·32827 Simultaneous nail and skin clearance in 5 ixekizumab head-to-head trials for moderate-to-severe psoriasis and psoriatic arthritis

    Page :AB110

    Boni E. Elewski, Andrew Blauvelt, Gaia Gallo

    
• • ·35030 Simultaneous palmoplantar erythrodysesthesia and eruptive hyperpigmentation induced by capecitabine

    Page :AB110

    Adalberto Santana-Gutiérrez, Emmanuel Sánchez-Meza, Lucía T. Fernández

    
• • ·33980 Skin cancer risk factors and screening among Asian Americans: Pooled cross-sectional surveys from 2000 to 2015

    Page :AB110

    Krittin J. Supapannachart, Yu Wang, Suephy C. Chen

    
• • ·32782 Skin of color associated with worse outcomes and lower probability of treatment in cutaneous squamous cell carcinoma: A case-control study

    Page :AB110

    Sophia A. Ederaine

    
• • ·34394 Skin of color dermatology on TikTok: An analysis of popular social media content and sources

    Page :AB111

    Jadesola T. Olayinka, Mindy D. Szeto, Robert P. Dellavalle

    
• • ·33824 Skin of color representation in Google image searches of common nail conditions

    Page :AB111

    Julianne M. Falotico, Shari R. Lipner

    
• • ·35218 Sleep disturbance in adults with prurigo nodularis is associated with increased circulating C-reactive protein levels and adverse cardiovascular outcomes

    Page :AB111

    Varsha Parthasarathy, Kevin Lee, Junwen Deng

    
• • ·35229 Smoking cessation is notably correlated with disease expression in pemphigus vulgaris

    Page :AB111

    Vitus Brix, Lovely Pierre, Heena K. Shaik

    
• • ·34799 Social media as a platform for medical and patient education in dermatology

    Page :AB112

    Hattie Shu, Chaosen Liu, Chaocheng Liu

    
• • ·33451 Social media hair and scalp oil trends

    Page :AB112

    Briana Paiewonsky, Maria Hordinsky, Ronda Farah

    
• • ·33018 Social relationships, sexual difficulty, and the impact of treatment with guselkumab versus adalimumab in men and women with psoriasis: Results from VOYAGE 1 and 2

    Page :AB112

    April Armstrong, Yi-hsuan Liu, Ya-Wen Yang

    
• • ·33321 Sociocultural attitudes of dermatology patients: A racially blinded cross-sectional survey study

    Page :AB112

    Kaushik P. Venkatesh, Kamaria Nelson, Adam Friedman

    
• • ·34953 Specialty choice motivations among diverse graduating medical students pursuing careers in dermatology

    Page :AB113

    Ambrosia Smith, Matthew Mansh

    
• • ·33466 Sporotrichoid leishmaniasis: A simulator in endemic areas

    Page :AB113

    María del Mar Serna Posada, Sara Saldarriaga Santamaría, Ana María Sanín Escobar

    
• • ·33216 Sports-related dermatoses and abnormalities of nail and foot among road runners, treadmill runners, and trail runners in Thailand

    Page :AB113

    Sumanas Bunyaratavej, Punyawee Ongsri, Methee Chayakulkeeree

    
• • ·33025 Stability of PASI <3 response to tildrakizumab through 5 years: Pooled analyses from reSURFACE 1 and reSURFACE 2 phase 3 trials

    Page :AB113

    Diamant Thaçi, Stefano Piaserico, Kristian Gaarn Du Jardin

    
• • ·33317 Study of nemolizumab pharmacokinetics, safety, and efficacy in adolescents with atopic dermatitis

    Page :AB114

    Robert Sidbury, Sady Alpizar, Vivian Laquer

    
• • ·33863 Successful use of dupilumab for treatment of atopic dermatitis in a liver transplant patient

    Page :AB114

    Sairekha Ravichandran, Amanda Krenitsky, Noura Ayoubi

    
• • ·32631 Survey-based study to understand HS patient experiences and perceptions about I&D procedures

    Page :AB114

    Rishab Revankar, Franklin Blum, Howa Yeung

    
• • ·34274 Systematic review of efficacy of treatment options for generalized granuloma annulare

    Page :AB114

    Muhammad Osto, Salam Smidi, Amira Alnabolsi

    
• • ·34574 Systemic medication treatment patterns in adults with atopic dermatitis (AD): Results from the European Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (EUROSTAD)

    Page :AB115

    Marjolein de Bruin-Weller, Annalisa Patrizi, Silvia Mariel Ferrucci

    
• • ·34060 Teledermatology visits favor specific diagnosis codes

    Page :AB115

    Alexa Cohen, Alison Romisher, Elizabeth Jones

    
• • ·33892 Telehealth use at a specialty hidradenitis suppurativa clinic during the COVID-19 pandemic

    Page :AB115

    Diana S. Kim, Alexa B. Kimball, Martina L. Porter

    
• • ·33027 Telemedicine management of systemic therapy with isotretinoin of patients with moderado-to-severe acne during the COVID-19 pandemic: A longitudinal prospective feasibility study

    Page :AB115

    Miguel Angel Duarte Ferrera

    
• • ·32344 The 31-gene expression profile stratifies recurrence and metastasis risk in patients with cutaneous melanoma

    Page :AB116

    Abel Jarell, Basil Skenderis, Larry D. Dillon

    
• • ·33847 The association between penile cancer and HIV infection

    Page :AB116

    Amir P. Amini, Hussain Shah, Tenzin Sung-rab Brookes

    
• • ·35151 The association of major depressive disorder and anxiety with granuloma annulare: A case-control study of the NIH All of Us database

    Page :AB116

    Annika Belzer, Audrey C. Leasure, William Damsky

    
• • ·33936 The characterization and prevalence of alopecia diagnoses: A retrospective, cross-sectional study

    Page :AB116

    Kim Nguyen, Sushmita Adhikari, Erica Lee

    
• • ·35104 The effectiveness and safety of blue light in the treatment of inflammatory skin diseases- the preliminary data

    Page :AB117

    Magdalena Sadowska, Malgorzata Skibinska, Joanna Narbutt

    
• • ·32059 The effectiveness of oral alitretinoin on mycosis fungoides palmaris et plantaris

    Page :AB117

    Seol Hwa Seong, Sun Mun Jeong, Jang Hwan Jung

    
• • ·34322 The genomic and phenotypic landscape of ichthyosis: An analysis of 1000 kindreds

    Page :AB117

    Qisi Sun, Nareh M. Burgren, Shayan Cheraghlou

    
• • ·32624 The impact of childhood psoriasis on parents and caregivers

    Page :AB117

    Reese L. Imhof, David T. Eton, Megha M. Tollefson

    
• • ·34517 The impact of deucravacitinib on health-related quality of life measured by the Short Form Health Survey 36-Item Questionnaire: Analysis of a phase 2 trial in patients with active PsA

    Page :AB118

    Vibeke Strand, Philip J. Mease, Atul Deodhar

    
• • ·31972 The importance of eyebrow involvement in frontal fibrosing alopecia

    Page :AB118

    Reese Imhof, Beija Villalpando, Sydney Proffer

    
• • ·32255 The improvement of the ratio of benign to malignant suspect melanocytic biopsies over 14 years in a single academic center

    Page :AB118

    Jacob Smith, Nick Berry

    
• • ·34741 The keto rash: Case report and literature review of prurigo pigmentosa induced by a ketogenic diet

    Page :AB118

    Hannah Kopelman, Anny Xiao

    
• • ·34630 The mental health and psychosocial burden among patients living with vitiligo in the United States: Findings from the VALIANT study

    Page :AB119

    Kristen Bibeau, Jackie Gardner, Anouk Lindley

    
• • ·31810 The National Paediatric Alopecia Areata Registry in Russia: An overview

    Page :AB119

    Nikolay N. Murashkin, Eduard T. Ambarchian, Roman V. Epishev

    
• • ·32725 The need for, development and initial validation of the Scale of Alopecia Areata Distress, a brief survey to assess alopecia areata patient-reported psychosocial outcomes

    Page :AB119

    Kristina Gorbatenko-Roth, Sarah Wood, Denise Windenburg

    
• • ·33548 The patient burden of moderate-to-severe atopic dermatitis (AD) in Children aged <12 years: Results from 732 patients in the PEDIatric STudy in Atopic Dermatitis (PEDISTAD) observational study

    Page :AB119

    Amy S. Paller, Martti Antila, Danielle Marcoux

    
• • ·34301 The relationship between the degree of scalp hair loss and health-related quality of life among patients with alopecia areata

    Page :AB120

    Emily Edson-Heredia, Katelyn Cutts, Evidera Bethesda, Peter Wright

    
• • ·32023 The use of patient-marketed dermoscopes in dermatology practice

    Page :AB120

    Collin Costello, Jake G. Besch-Stokes, Jamison A. Harvey

    
• • ·35349 The use of photoprotection reduces skin side effects of patients undergoing anti-cancer treatments

    Page :AB120

    Pascale Guyonnet-Debersac

    
• • ·33968 Time to improvement in daily signs and symptoms associated with atopic dermatitis (AD) in patients with moderate-to-severe AD in pooled monotherapy studies of abrocitinib

    Page :AB120

    Melinda J. Gooderham, Mark G. Lebwohl, Eric L. Simpson

    
• • ·33550 Topical oat-containing formulations provide skin protection against environmental and inflammatory triggers for atopic dermatitis in vitro

    Page :AB121

    Wen-Hwa Li, Tobias Futterer, Katie Spisak

    
• • ·34004 Topical ruxolitinib blocks interferon gamma signaling in cutaneous lichen planus

    Page :AB121

    Blake Boudreaux, Puneet Bhullar, Caitlin Brumfiel

    
• • ·33425 Topical timolol treatment for superficial infantile hemangiomas: Therapeutic response according to clinical subtypes

    Page :AB121

    Giwook Lee, Hyun-Chang Ko, Byung-Soo Kim

    
• • ·34982 Transcriptome analysis reveals intrinsic proinflammatory signaling in healthy African American skin

    Page :AB121

    Irina Budunova, Anna Klopot, Gleb Baida

    
• • ·35074 Treatment methods for sebaceous hyperplasia: A cost comparative survey

    Page :AB122

    Sarah H. Millan, Adam J. Friedman

    
• • ·34811 Treatment of underlying monoclonal gammopathy of clinical significance (MGCS) with lenalidomide for IVIG-resistant scleromyxedema

    Page :AB122

    Annika Belzer, Marcus W. Bosenberg, Jonathan S. Leventhal

    
• • ·34332 Treatment patterns and prior medication usage before dupilumab treatment initiation in patients with AD: Real-world data from GLOBOSTAD

    Page :AB122

    Silvia M. Ferrucci, M. Rossi, Daria S. Fomina

    
• • ·34084 Treatment patterns for hydroxychloroquine, methotrexate, and mycophenolate mofetil in lichen planopilaris

    Page :AB122

    Josiah Williams, Varun K. Ranpariya, Rita O. Pichardo

    
• • ·35303 Treatment practices and the use of web-based resources in prurigo nodularis

    Page :AB123

    Prachi Aggarwal, Emily Boozalis, Varsha Parthasarathy

    
• • ·34312 Treatment with amlitelimab (KY1005, SAR445229): A novel nondepleting anti-OX40Ligand (OX40L) mAb reduces IL-13 serum levels in a phase 2a randomized placebo-controlled trial in patients with moderate to severe atopic dermatitis

    Page :AB123

    Stephan Weidinger, Thomas Bieber, Michael Cork

    
• • ·34350 Treatment with rituximab for refractory adult dermatomyositis complicated with calcinosis cutis

    Page :AB123

    Sophia Ly, Alyson McKinnon, Henry K. Wong

    
• • ·31342 Treatments for melasma: A cross-sectional study of YouTube videos including DISCERN scores

    Page :AB123

    Jennifer Laborada, Caitlyn Kellogg, Amanda F. Marsch

    
• • ·34436 Trends in incidence and annual distribution of cutaneous malignant melanoma tumors based on breslow thickness at diagnosis: A SEER population-based study

    Page :AB124

    Gurman Singh Dhaliwal, Collin Costello, Aleksander Sekulic

    
• • ·33528 Triple-wavelength diode laser (755 nm, 810 nm, and 1064 nm): Preliminary efficacy and safety for skin-tightening

    Page :AB124

    Hwa Jung Ryu, Dong Hye Suh, Hyun Joo Kim

    
• • ·33521 Two cases of oral baricitinib associated papular eruption on face

    Page :AB124

    Joo Yeon Ko, Ki Yeon Kim, Hae Chang Joh

    
• • ·32600 Two years data: Disease burden, quality of life, addiction, anxiety and obesity in psoriasis patients under a controlled therapy in a real-life setting

    Page :AB124

    Silke Schagen, Silke Karin Schagen, Andreas Schwinn

    
• • ·35225 Undifferentiated pruritus and the risk of hematologic malignancy

    Page :AB125

    Junwen Deng, Nishadh Sutaria, Waleed Adawi

    
• • ·33823 Update on systemic treatment options for generalized granuloma annulare

    Page :AB125

    Matthew L. Hrin, Nathan L. Bowers, Steven R. Feldman

    
• • ·35256 Urinary mono-benzyl-phthalate levels are associated with increasing psoriasis severity in US adults

    Page :AB125

    Waleed Adawi, Nishadh Sutaria, Varsha Parthasarathy

    
• • ·34519 Use caution when traveling and wearing medical dressings: Foam dressing with silver may set off metal detectors

    Page :AB125

    Andrew M. Armenta, Sarah Kesaria, Kristyna Gleghorn

    
• • ·33731 Use of digital resource centers for atopic dermatitis patients, caregivers, and health care professionals to improve shared decision-making and proactive management

    Page :AB126

    Linda Stein Gold, Adam J. Friedman, Kanwaljit Brar

    
• • ·33031 Use of topical tranexamic acid in patients with melasma: A narrative review

    Page :AB126

    Taylor Thieman, Ritu Swali, Jennifer Adams

    
• • ·31876 Usefulness of noninvasive management with the gutter method for epidermal growth factor receptor inhibitor-induced paronychia, pyogenic granuloma-like lesion, and ingrown nail

    Page :AB126

    Ai Agematsu, Masahiro Kamata, Kaoru Namiki

    
• • ·32652 Using shared decision-making communication strategies to improve outcomes for patients with atopic dermatitis: Results of a national scope continuing medical education initiative

    Page :AB126

    Stephen T. Bender, Derek Dietze, Andrea Funk

    
• • ·33155 Utilizing student free-clinics to supplement skin of color dermatology education

    Page :AB127

    Tue Felix Nguyen, Marie Vu, Katerina Papanikolaou

    
• • ·33109 Variation in travel distance to a tertiary referral center for treatment of localized, regional, or distant Merkel cell carcinoma

    Page :AB127

    Natalie Garcia, Kristy Broman, Zoey Duncan

    
• • ·32989 Verrucous sarcoidosis: A rare variant of cutaneous sarcoidosis

    Page :AB127

    Abigale Clark, Lauren McCaslin

    
• • ·33168 Visual vulnerability: Daily burden and psycosocial impact of acne and video calling during COVID-19

    Page :AB127

    Jerry Tan, Anna L. Chien, Krysten Lisella Arekapudi

    
• • ·34006 Vitamin D deficiency in patients with lichen planopilaris/frontal fibrosing alopecia

    Page :AB128

    Shaheir Ali, Maya Collins, Isabel Pupo Wiss

    
• • ·33527 What is the most effective picosecond laser protocol for tattoo removal? A comparative study by histopathologic review

    Page :AB128

    Hwa Jung Ryu, Dong Hye Suh, Hyeong-Seob Kim

    
• • ·32167 Yet a-NEH-ther Bactrim rash

    Page :AB128

    Mansee Desai, Leah Shin, Maria McGowan

    
• • ·34041 ZIP-code based analysis of adolescent hidradenitis suppurativa prevalence in a large metropolitan area

    Page :AB128

    Sijia Zhang, Helen H. Park, Carrie Vuong

    
• • ·The abstracts published here were accepted as online posters. 35180 “Could I be allergic to my new hidradenitis suppurativa Medication?” Characterization of a cutaneous delayed-type drug hypersensitivity reaction to secukinumab

    Page :AB129

    Nayha Shetty, Sasank Konda, Jesse Veenstra

    
• • ·34554 “Nothing really seemed to touch it that wasn’t a steroid”: An analysis of social media posts regarding the efficacy of topical corticosteroid use in atopic dermatitis

    Page :AB129

    Jeffrey R. Rajkumar, Yasmin Gutierrez, Madison E. Jones, Sarah P. Pourali, Alison H. Kohn, April W. Armstrong

    
• • ·32316 Five-year cancer-specific survival for melanoma in LEP: An analysis of the SEER database

    Page :AB129

    Devin K. Barzallo, Dustin DeMeo, Bryan T. Carroll

    
• • ·35182 A 10% urea moisturizer improves the signs and symptoms of foot xerosis in diabetic patients

    Page :AB129

    Dillon Nussbaum, Adam Friedman, Nadege Lachman, Matthew, H. Meckfessel

    
• • ·33388 A case of eruptive trichofolliculomas

    Page :AB130

    Tori Diedring, Morgan McNeil, Stuart Gildenberg, Jenny Cotton, David Fivenson, Karen Heidelberg

    
• • ·34474 A case of paraneoplastic pemphigus associated with type B2 thymoma

    Page :AB130

    Yujie Linda Liou, Kelly Scarberry, Timmie Sharma, Neil Korman

    
• • ·33372 A case of systemic lupus erythematous presenting with macrophage activation syndrome

    Page :AB130

    Cody J. Rasner, Christina Boull

    
• • ·33127 A cross sectional examination of sunburn incidence in the context of race/ethnicity and skin type

    Page :AB130

    Diana E. Gutierrez Lopez, Zunaira Shuja, Aurelie Coubart, Cary Schaefer, Joshua D. Williams, Lai Hing Vair, Susan M. Daly

    
• • ·32301 A cross sectional study on hand manifestations during COVID-19 pandemic

    Page :AB131

    Karthik Sunki

    
• • ·35043 A moisturizing cream with panthenol, glycerin, and niacinamide provides superior skin barrier recovery

    Page :AB131

    Matthew H. Meckfessel

    
• • ·32923 A multicenter, double-blind, randomized, placebo-controlled, phase IIb dose-finding study to evaluate efficacy and safety of spesolimab in patients with moderate-to-severe palmoplantar pustulosis

    Page :AB131

    A. David Burden, Robert Bissonnette, Alexander A. Navarini, Masamoto Murakami, Akimichi Morita, Susan Mozzicato, Binqi Ye, Frank Baehner, Tadashi Terui

    
• • ·33356 A multinational chart review to examine gastrointestinal symptoms and their management in patients treated with apremilast for plaque psoriasis

    Page :AB131

    Linda Stein Gold, Edward Tuttle, Wendy Y. Cheng, Rose Chang, Catherine Nguyen, Louise H. Yu, Anne Bouloc, Yuri Klyachkin, Tara Nazareth, Denis Jullien

    
• • ·34070 A not-so-sweet rash: A case of Sweet syndrome secondary to azathioprine for myasthenia gravis

    Page :AB132

    Jazmine Nesvik, Allison Goldenstein, Jonathan Cleaver, Jonathan Beary

    
• • ·35056 A novel, 100% mineral liquid facial sunscreen SPF 50 is significantly preferred to a 100% mineral facial lotion SPF 50

    Page :AB132

    Matthew H. Meckfessel, Thu Nguyen

    
• • ·33133 A phase 4, real-world study of tildrakizumab in moderate to severe psoriasis: Week 28 interim analysis

    Page :AB132

    Jayme Heim, J. Gabriel Vasquez, Paulita Beute, Monique Torres, Stephen J. Rozzo, Neal Bhatia

    
• • ·34272 A remarkably spongy scalp in a patient with hair loss: Lichen planopilaris occurring simultaneously with lipedematous scalp

    Page :AB132

    Erin Garfield, Madhu Dahiya, David Eilers

    
• • ·31767 A study of clinical, histopathologic, and immunohistochemical changes after cryotherapy in actinic keratosis

    Page :AB133

    Joong Ho Kim, Ji An Uh, Jae Ho Lee, Soo Kyung Lee, Myoung Shin Kim, Un Ha Lee

    
• • ·35055 A survey of patient attitudes on topical minoxidil for the treatment of hair loss

    Page :AB133

    Dillon Nussbaum, Julia Schwartz, Adam Friedman

    
• • ·34891 A systematic narrative review of skin cancer related knowledge, attitudes, and practices among beachgoers

    Page :AB133

    Vinayak K. Nahar, Amanda H. Wilkerson, Ross L. Pearlman, Emily K. Cobb, Isabella Aldana, Natalie Garcia, Arjun Pandya, Alexis Hilts, Allison R. Cruse

    
• • ·34546 A topical antioxidant serum containing silymarin reduces sebum peroxidation and improves facial acne

    Page :AB133

    Stephen Lynch, Komal Patel, Brittany Lee

    
• • ·34604 Acantholytic dermatosis of the crural folds evolves into classic Hailey-Hailey disease

    Page :AB134

    Tyler M. Andriano, Rachel E. Reingold, Paul Chu, Steven R. Cohen

    
• • ·33407 Accuracy of clinical-dermatoscopic versus dermatopathologic diagnosis of melanoma and nonmelanoma skin cancer

    Page :AB134

    Claudio de Lelis Filgueiras de Souza, Guilherme Gonçalves Nascimento, João Paulo de Oliveira, Júlia Carvalho Giannini, Roberta Bessa de Veloso Silva, Adilson da Costa

    
• • ·34599 Achieving incrementally greater skin improvement thresholds with upadacitinib versus dupilumab in moderate-to-severe atopic dermatitis (AD): Heads Up study results

    Page :AB134

    Jonathan I. Silverberg, Kilian Eyerich, Marjolein de Bruin-Weller, Brian M. Calimlim, Andrew M. Platt, Tianshuang Wu, Barry Ladizinski, Jacob P. Thyssen

    
• • ·34813 Acquired dermal melanocytosis on the hand of a Hispanic patient

    Page :AB134

    Fanny Cecilia Cordero Martinez, Adrian Cuellar Barboza, Jorge Ocampo Candiani

    
• • ·34244 Acquired epidermodysplasia verruciformis: A retrospective review of cases

    Page :AB135

    Rewan M. Abdelwahab, Nessa Aghazadeh Mohandesi

    
• • ·35158 Adaptations in the PURE registry in response to the COVID 19 pandemic: The impact of well-designed modifications in real-world data collection in a psoriasis registry

    Page :AB135

    Charles Lynde, Kim Papp, Jennifer Beecker, Lorne Albrecht, Isabelle Delorme, Ignacio Dei-Cas, Antonio Vieira, Lenka Rihakova, Melinda Gooderham

    
• • ·34762 Adjuvant pembrolizumab versus placebo in high-risk locally advanced cutaneous squamous cell carcinoma: The phase 3 KEYNOTE-630 study

    Page :AB135

    Michael Schenker, Mikhail Klochikhin, Ase Bratland, Dmitry Kirtbaya, Alexander Guminski, Marcin Dzienis, Chrysalyne Schmults, Joy Y. Ge, Jianda Yuan, Jenny Lee

    
• • ·34932 Adolescent with transverse linear striae on the lower back

    Page :AB135

    Skye Penny, Samantha Ouellette, Babar Rao

    
• • ·32724 Adult female acne in a multiracial Asian population

    Page :AB136

    Shi Yu Derek Lim, Chee Leok Goh, Xiahong Zhao, Peiqi Su, Hazel H. Oon

    
• • ·33218 Advantages of standardization of dermoscopic imaging by leveraging the DICOM standard

    Page :AB136

    Bart Diricx, Jonas De Vylder, Elie De Brauwer, Josep Malvehy, Liam Caffery, Tom Kimpe

    
• • ·34927 Adverse events associated with dupilumab in the WHO pharmacovigilance

    Page :AB136

    Thomas Bettuzzi, Aaron Drucker, Delphine Staumont-Sallé, Kevin Bihan, Bénédicte Lebrun-Vignes, Emilie Sbidian

    
• • ·32696 Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database

    Page :AB137

    Lea Hoisnard, Pr Sébastien Maury, Pr Matthieu Mahévas, Khalil El Karoui, Lydia Roy, José L. Cohen, Pr Aurélien Amiot, Pr Pascal Claudepierre, Pr Philippe Grimbert, Pr Emilie Sbidian

    
• • ·31243 Age requirements for regarding indoor UV tanning in Colorado

    Page :AB137

    Melissa R. Laughter, Jaclyn B. Anderson, Darya Sinkevich, Jarett D. Anderson, Ronald A. Yang, Neil Box, Yadira Caraveo, Geoff Lim, Robert Dellavalle, Mona Sadeghpour

    
• • ·34259 ALK-negative anaplastic large-cell lymphoma (ALCL) presenting as symmetrical axillary nodules

    Page :AB137

    Jérémy Bouchard, Madeleine Lachance, Bernard Delisle

    
• • ·33110 An analysis of fatigue in patients with psoriatic disease utilizing SF-36 vitality scores: Results through week 24 in phase 3 trials of guselkumab in patients with psoriasis and psoriatic arthritis

    Page :AB137

    Joseph F. Merola, Yi-Hsuan Liu, Ya-Wen Yang, Megan Miller, May Shawi, Daphne Chan, Saakshi Khattri, Laura Savage, Chenglong Han

    
• • ·33951 An analysis of the National Cancer Database 2004-2018: Primary cutaneous melanoma in Asians

    Page :AB138

    Kevin Kwan, Jennifer Fernandez, Adam Sutton, Ashley Wysong

    
• • ·34706 An exploration in racial disparities in access to biologic treatment for psoriasis: The experience of a single academic dermatology practice

    Page :AB138

    Ashley McWilliams, Ashley Ojeaga, Ishitha Jagadish, Tim Chruschiel, Daniel West

    
• • ·33808 An overview of pricing for commonly prescribed acne medications

    Page :AB138

    Elizabeth Mata, Elliot Blue, Ashley Wysong

    
• • ·32472 An unexpected postsurgical phenomena: Postsurgical nummular eczema; a case series and review of the literature

    Page :AB138

    Yana Kost, Neda Shokrian, Roya Nazarian, Eli Kamara, Beth N. McLellan

    
• • ·35007 An unusual clinical presentation of a squamous cell carcinoma mimicking mycetoma

    Page :AB139

    Gabriela Pabón-Cartagena, Amy Jacobson, Kenneth J. Shulman, Janet Moy

    
• • ·32783 An unusual cutaneous manifestation of systemic amyloidosis

    Page :AB139

    Soodeh Kabir, Shirin Zaresharifi, Narges Alizadeh

    
• • ·35061 An unusual presentation: Adult onset diffuse cutaneous mastocytosis

    Page :AB139

    Dillon Nussbaum, Nagasai Adusumilli, Jessica Kalen, Joseph Zahn

    
• • ·33226 Analysis of histologic and molecular improvement in moderate-to-severe psoriasis: Results from a phase 1b trial of the novel allosteric Tyk2 inhibitor NTX-973

    Page :AB139

    Joshua J. McElwee, Sandra Garcet, Xuan Li, Inna Cueto, Norma Kunjravia, Darshna Rambhia, Bhaskar Srivastava, James G. Krueger

    
• • ·33985 Analysis of nail or scalp psoriasis by gender in clinical studies of brodalumab

    Page :AB140

    Boni Elewski, Lawrence Green, Shari R. Lipner, Abby Jacobson

    
• • ·34399 Analysis of online psoriasis support group reveals great interest in adjuvant therapy

    Page :AB140

    Karan Rajalingam, Phillip Johansen, Jerry Qi, Oge Marques

    
• • ·32805 Analysis of time to second relapse confirms the superiority of long-term proactive management with Cal/BD foam vs reactive management of psoriasis

    Page :AB140

    Mark Lebwohl, Kim Papp, Marie Holst Mørch, Jens Strodl Andersen

    
• • ·35395 Analysis of utilization & trends of spironolactone prescriptions by dermatologists among Medicare Part D patients: 2013-2019

    Page :AB140

    Rahul Raiker, Haig Pakhchanian, Mairead Baker, Min Deng

    
• • ·34174 Anaphylaxis secondary to noncosmetic injectables occurring in the dermatology office

    Page :AB141

    Deyson Lorenzo-Ríos, Eduardo Michelen-Gómez, Rafael F. Martín-García

    
• • ·34675 Antinuclear antibodies detection in rosacea phenotypes

    Page :AB141

    David A. Castillo Molina, Jorge Andres Rios-Duarte, Jesus Daniel Fierro-Lozada, Maria J. Sanchez-Zapata, Sara Muñoz-Ordoñez, Criss Madeley Millan-Puerto, Ana Maria Garcia-Concha, Claudia Vanesa Cera-Coll

    
• • ·34831 Applications of behavioral economics in dermatology

    Page :AB141

    Kendall Coleman, Wylie Masterson, Quoc-Bao Nguyen, Meghan Heberton, Steven Feldman

    
• • ·34492 Are you the doctor? An analysis of dermatology content creators on TikTok

    Page :AB141

    Faaiz Saad, Ali Z. Hassan, Corey L. Hartman

    
• • ·32329 Assessing the utility of Fontana-Masson and MART-1 stains in evaluating skin pigmentary changes induced by ultraviolet radiation and visible light

    Page :AB142

    Marissa S. Ceresnie, Indermeet Kohli, Ben J. Friedman, Henry W. Lim, Iltefat H. Hamzavi

    
• • ·32900 Assessment of a new transformative texture massage product in a pediatric population: Effect on child, parent and child-parent interaction

    Page :AB142

    Gaetan Boyer, Clarence de Belilovsky, Pedro Pinto, Gaelle Bellemere, Caroline Baudouin

    
• • ·31037 Assessment of actives and formula on antipigmentation efficacy

    Page :AB142

    Jin Namkoong, Joanna Wu

    
• • ·32655 Assessment of literacy inclusivity of dermatologic patient education material at UMass dermatology and beyond

    Page :AB142

    Marisa Walsh, Mehdi Rashighi, Jillian Richmond

    
• • ·32700 Association between body lice infestation and decreased hemoglobin values

    Page :AB143

    Nora Rudd, Adam Zakaria, Michael A. Kohn, Erin H. Amerson, Lindy P. Fox, Eleni Linos, Aileen Y. Chang

    
• • ·34751 Association between rosacea and eye diseases in patients with diabetes: A nationwide cohort study

    Page :AB143

    Fang-Ying Wang, Eugene Yu-Chuan Kang, Chun-Hao Liu, Chau Yee Ng, Shih-Chieh Shao, Edward Chia-Cheng Lai, Wei-Chi Wu, Yi-You Huang, Kuan-Jen Chen, Chi-Chun Lai, Yih-Shiou Hwang

    
• • ·34151 Association of type II diabetes mellitus with characteristics and outcomes for patients undergoing sentinel lymph node biopsy for cutaneous melanoma

    Page :AB143

    Richard J. Straker, Cimarron E. Sharon, Emily Y. Chu, John T. Miura, Giorgos C. Karakousis, Michael E. Ming

    
• • ·34924 Associations of perceived skin cancer absolute risk and comparative risk with sunscreen use among patients with keratinocyte carcinoma

    Page :AB143

    Vidya M. Medepalli, William H. Black, Robert E. Davis, Manoj Sharma, M. Allison Ford, Robert T. Brodell, Vinayak K. Nahar

    
• • ·34725 Atopic dermatitis is associated with poor school behaviors in US children and adolescents

    Page :AB144

    Jaya Manjunath, Nanette B. Silverberg, Jonathan I. Silverberg

    
• • ·34653 Atopic dermatitis treatment patterns and patient burden in Russia and Poland

    Page :AB144

    Erman Güler, Peter Anderson, Simran Marwaha., James Piercy, David Gruben, Andrey Lvov, Magdalena Trzeciak, Magdalena Czarnecka-Operacz

    
• • ·31686 Automatic detection of blue-white veil in melanoma based on multispectral dermoscopy

    Page :AB144

    Bart Diricx, Jonas De Vylder, Sofie Mylle, Laudine Janssen, Sofie van Kelst, Evelien Verhaeghe, Lieve Brochez, Marjan Garmyn, Tom Kimpe

    
• • ·33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss

    Page :AB144

    Maryanne M. Senna, Ohsang Kwon, Bianca Maria Piraccini, Rodney Sinclair, Susan Ball, Yuxin Ding, Yun-Fei Chen, Yves Dutronc, Brett King

    
• • ·34325 Barriers to sunscreen use in low income ZIP codes in San Antonio, Texas

    Page :AB145

    Ashley Chakales, Maryann England

    
• • ·34310 Bimekizumab early responses in patients with plaque psoriasis: Results from the multicenter, randomized, double-blinded phase 3b BE RADIANT trial

    Page :AB145

    Steven R. Feldman, Alice B. Gottlieb, Jennifer Soung, Matthias Augustin, Paolo Gisondi, Luke Peterson, Veerle Vanvoorden, Valerie Ciaravino, Natalie Nunez Gomez, Richard B. Warren

    
• • ·33817 Bimekizumab efficacy and safety in patients with moderate to severe plaque psoriasis who switched from secukinumab: Results from the open-label extension period of the BE RADIANT phase 3b trial

    Page :AB145

    Mark Lebwohl, Kamran Ghoreschi, Bruce Strober, Kilian Eyerich, Jennifer Cather, Maggie Wang, Christopher Cioffi, Delphine Deherder, Fabienne Staelens, Natalie Nunez Gomez, Luis Puig

    
• • ·34321 Bimekizumab efficacy and safety through 96 weeks in patients with moderate to severe plaque psoriasis: Results from the open-label extension period of the BE RADIANT phase 3b trial

    Page :AB146

    Bruce Strober, Carle Paul, Andrew Blauvelt, Diamant Thaçi, Boni Elewski, Katy White, Veerle Vanvoorden, Delphine Deherder, Fabienne Staelens, Kilian Eyerich

    
• • ·34320 Bimekizumab efficacy in subgroups defined by prior systemic treatment in patients with moderate to severe plaque psoriasis

    Page :AB146

    David Rosmarin, Mark Lebwohl, Steven R. Feldman, Petra Staubach-Renz, Leah Davis, Krista Wixted, Cynthia Madden, Natalie Nunez Gomez, Andreas Pinter

    
• • ·32937 Bimekizumab treatment response is maintained up to 3 years in patients with psoriatic arthritis: Responder analyses from BE ACTIVE, a phase 2b dose-ranging study, and its open-label extension

    Page :AB146

    Joseph F. Merola, Akihiko Asahina, Christopher T. Ritchlin, Barbara Ink, Deepak Assudani, Rajan Bajracharya, Jason Coarse, Jason Eells, Philip J. Mease

    
• • ·33313 Bullous and subcutaneous Sweet syndrome with extracutaneous manifestations: A case report and review of the literature

    Page :AB146

    Zisansha Zahirsha, Lauren E. Watchmaker, Jodi Speiser, Mariam Mafee

    
• • ·33955 Burning and stinging in rosacea treatments: A review of clinical evidence

    Page :AB147

    Martin Schaller, Jerry Tan

    
• • ·33181 C5a and C5aR is prominently associated with tunnels in severe hidradenitis suppurativa

    Page :AB147

    Chris Li, Carolyn Dunlap, Bin Zhao, James Kilgour, Peter Staehr, Israel Charo, Thomas Schall, Kavita Sarin, Kathleen Sullivan

    
• • ·34471 Case report: Verrucous venous malformation with thrombocytopenia in a male neonate

    Page :AB147

    Sophia Reyes-Hadsall, Folasade F. Fayiga, Ana M. Duarte

    
• • ·33705 Catching a new variant: A rare case of papular mycosis fungoides

    Page :AB147

    Karlo Edwin Reyes Balisi, Precious U. Imam, Vanessa M. Carpio, Franchesca S. Quinio

    
• • ·35406 Characterization of photodamaged skin using 3D line-field optical coherence tomography and histopathologic correlation

    Page :AB148

    Javiera Perez-Anker

    
• • ·35022 Clinical characteristics and risk factors for digital myxoid cyst development

    Page :AB148

    Rhiannon C. Miller, Shari R. Lipner

    
• • ·33556 Clinical efficacy of a new sunscreen containing Myrtus communis and Celastrol enriched plant cell culture extracts on reducing acne and limiting lesions’ recurrence post-sun exposure in acneic patients

    Page :AB148

    Valerie Mengeaud, Priscilia Lapallud, Lilac Becdelièvre, Vriginie Ribet

    
• • ·32661 Clinical evaluation of deodorant efficacy and tolerance for overall body odor control

    Page :AB148

    Nalini Kaul, Chrissy Maraghy, Barrie Drewitt, Shannon Klingman

    
• • ·33565 Clinically proven anti-aging effects of a new skincare line and retinol tolerance building guidance for Asian consumers

    Page :AB149

    Li Ma, Summer Sun, Hugo Kerriou, Cecilia Li

    
• • ·34071 Combination of photodynamic therapy and oral antifungals for the treatment of onichomycosis

    Page :AB149

    Alba Navarro-Bielsa, Tamara Garcia-Cazaña, Manuel Almenara-Blasco, Pilar Robres, Concepcion Lopez, M. Dolores Calvo-Priego, Yolanda Gilaberte

    
• • ·35101 Combination treatment of transdermal micro-jet using Er:YAG laser and ablative fractional 10,600-nm carbon dioxide laser for acne scar

    Page :AB149

    Dong Hye Suh, Hyung Seob Kim, Hyun-Joo Kim, Dermatology, Sang Jun Lee, Kye-Yong Song, Min Kyung Shin

    
• • ·33790 Community bonding to break barriers to care: Improving skin cancer knowledge in the skin of color community

    Page :AB149

    Elisabeth George, Anne Bocage, Uzoamaka Okoro, Esther Henebeng, Nicole Negbenebor

    
• • ·33777 Comorbidities and treatment patterns in pemphigus: A retrospective US claims database study

    Page :AB150

    Jonathan Silverberg, Julia S. Lehman, Animesh A. Sinha, Yola Moride, Keiko Higuchi, Kerri Ford, Philip Sugerman, Ekaterina Smolkina

    
• • ·32632 Comorbidities in patients with vitiligo: A systematic review and meta-analysis

    Page :AB150

    Hyun Jeong Ju, Ji Min Seo, Soo Hyung Kim, Ro Woo Lee, Ji Hae Lee, Gyong Moon Kim, Jung Min Bae

    
• • ·33935 Comorbidities in rosacea, common origin or random chance?

    Page :AB150

    David A. Castillo Molina, Jorge Andres Rios-Duarte, Jesus Daniel Fierro-Lozada, Sara Muñoz-Ordoñez, Maria J. Sanchez-Zapata, Jennipher Andrea Blanco-Gomez, Tatiana Solorzano-Rojas, Paula Celeste Rubiano-Mojica, Penelope A. Hirt, Diego Mauricio Martinez-Zuñiga

    
• • ·32378 Comorbidities, demographic and clinical features of patients with alopecia areata in a dermatologic center in Bogota, Colombia

    Page :AB150

    David A. Castillo Molina, Jesus Daniel Fierro-Lozada, Maria J. Sánchez-Zapata, Winnie Joanne Celorio-Murillo, Ana María García-Concha, Natalia Muñoz-Angulo, Paula Andrea Chacón-Jaramillo, David Ernesto Castillo Saavedra

    
• • ·34889 Comorbidity clusters and drug consumption patterns of patients with atopic dermatitis

    Page :AB151

    Manuel Almenara-Blasco, Juan B. Perez-Gilaberte, Jonás Carmona-Pírez, Antonio Gimeno-Miguel, Beatriz Poblador-Plou, Alexandra Prados-Torres, Alba Navarro-Bielsa, Yolanda Gilaberte

    
• • ·35339 Comparative analysis of social media sentiment between keloids and psoriasis: A prospective observational study

    Page :AB151

    Emilie Garcia, Joseph Younis, Bryan T. Carroll, Donald A. Glass

    
• • ·33835 Comparative study of histologic differences according to the monopolar radiofrequency tip width

    Page :AB151

    Dong Hye Suh, Hyun Joo Kim, Kye Young Song, Min Kyung Shin, Sang Jun Lee, Hye Jin Ahn

    
• • ·32689 Comparison of pediatric dermatology diagnoses between virtual and in-person visits during the COVID-19 pandemic

    Page :AB151

    Grace Y. Duan, Adena E. Rosenblatt

    
• • ·34269 Comparison of survival in women with melanoma by race and ethnicity: An analysis of the National Cancer Database 2004-2018

    Page :AB152

    Jennifer M. Fernandez, Kevin R. Kwan, Adam Sutton, Ashley Wysong

    
• • ·33884 Complete skin clearance for patients with moderate to severe plaque psoriasis: The relationship between improvements in Psoriasis Area and Severity Index and health-related quality of life

    Page :AB152

    Andrew Blauvelt, Mark Lebwohl, Alice Gottlieb, Matthias Augustin, Luis Puig, Paolo Eusebi, Christopher Cioffi, Balint Szilagyi, Susanne Wiegratz, Lars Iversen

    
• • ·34714 Contextualization of skin cancer incidence rates in Costa Rica

    Page :AB152

    Benjamin Gallo Marin, Andres Amaya, Daniel Marin Gamboa, Fabio Stefano Frech, David X. Zheng, Kathleen M. Mulligan, Rocío Oliva, Arturo Soto, Helena Kuhn

    
• • ·34650 Correlation between wound burden and procedural pain in patients with EB ≥4 years of age: An exploratory analysis from the EASE study

    Page :AB152

    Dedee F. Murrell, Anna L. Bruckner, Charles Davis, Laura Maher, Tracy Cunningham, Mark Summeray

    
• • ·33064 Correlation of fatigue severity and psoriasis severity, and the treatment effect of guselkumab: A detailed analysis of SF-36 vitality scores from the VOYAGE 2 study

    Page :AB153

    Bruce Strober, Yi-hsuan Liu, Ya-Wen Yang, Megan Miller, Daphne Chan, Wolf-Henning Boehncke, Laura Savage, April Armstrong, Chenglong Han

    
• • ·35207 Cost analysis of seborrheic dermatitis treatment for patients in a dermatology center in Bogota, Colombia

    Page :AB153

    David A. Castillo Molina, Maria J. Sanchez-Zapata, Jesus D. Fierro-Lozada, Cris Madeley Millan-Puerto, Luisa Fernanda Camacho-Lazaro, Sara Muñoz-Ordoñez, Diego Mauricio Martinez-Zuñiga

    
• • ·34369 Could current skin typing systems in Dermatology contribute to data bias for the development of clinical digital technologies in the UK?

    Page :AB153

    Navreet Paul

    
• • ·35309 COVID-19 outcomes among patients with cutaneous T-cell lymphoma: A multicentered analysis

    Page :AB153

    Mairead Baker, Haig Pakhchanian, Rahul Raiker, Min Deng

    
• • ·34929 Cutaneous adenocarcinoma mimicking hidradenitis suppurativa

    Page :AB154

    Imran Baig, Quoc-Bao Nguyen, Mary Alice Sallman Hickson, Ana Ciurea

    
• • ·34111 Cutaneous intestinal metaplasia a rare premalignant condition: A case series of two patients

    Page :AB154

    Joy Tao, Mathew Joseph, Adam Vaudreuil, Madhu Dahiya, David Eilers

    
• • ·35172 Cutaneous reactions to PD-1 inhibitors

    Page :AB154

    Katherine A. Kelly, Nathan Bowers, Christine Ahn

    
• • ·33415 Cutaneous T cell lymphoma in skin of color

    Page :AB154

    Daniel Mosallaei, Erica B. Lee, Marissa Lobl, Shauna Higgins, Dillon Clarey, Matthew Stephany, Ashley Wysong

    
• • ·31721 Dapsone for the treatment of neutrophilic dermatoses: A case series

    Page :AB155

    Cristina López-Llunell, Natalia Fernández Chico, Vicente Expósito Serrano, Jorge Romaní de Gabriel

    
• • ·34967 DaxibotulinumtoxinA for injection demonstrates consistent safety and efficacy in African American subjects: Subgroup analysis from a large, open-label, repeat-dose study

    Page :AB155

    Charles Boyd, Valerie Callender, Cheryl Burgess, Jessica Brown, Conor J. Gallagher

    
• • ·34678 Demographics of dermatology community health center is reflective of general population

    Page :AB155

    Bao Vincent Ho, Jessica Ferguson, Edward Seger, Brittani Reme, Jadesola Akinwuntan, Anand Rajpara

    
• • ·33260 Dermal delivery of 12-hydroxystearic acid for barrier benefits from skin cleansers – An ex vivo and in silico study

    Page :AB155

    Nandou Lu, Bivash Dasgupta

    
• • ·33323 Dersimelagon, a melanocortin-1 receptor agonist, maintains efficacy regardless of seasons in subjects with erythropoietic protoporphyria: Results from a post hoc analysis of phase 2 clinical trial data

    Page :AB156

    Kirstine Belongie, Fumihiro Takahashi, Sakiko Mukai, Mai Endou, Robert Desnick

    
• • ·34513 Deucravacitinib efficacy in psoriatic arthritis by baseline DMARD use: Exploratory analysis from a phase 2 study

    Page :AB156

    Atul Deodhar, Miroslawa Nowak, June Ye, Tom Lehman, Lan Wei, Subhashis Banerjee, Philip J. Mease

    
• • ·35205 Deucravacitinib improves Dermatology Life Quality Index (DLQI) in patients with moderate to severe psoriasis: Results from the phase 3 POETYK PSO-1 and PSO-2 trials

    Page :AB156

    Matthias Augustin, Bruce Strober, April W. Armstrong, Jennifer Beaumont, Tan P. Pham, Stacie Hudgens, Joe Zhuo, Brandon Becker, Subhashis Banerjee, Renata M. Kisa, Kim Papp

    
• • ·34658 Deucravacitinib, an oral, selective tyrosine kinase 2 (TYK2) inhibitor, in patients with moderate to severe plaque psoriasis who had inadequate responses to apremilast at week 24 in the phase 3 POETYK PSO-1 and PSO-2 trials

    Page :AB156

    April W. Armstrong, Richard B. Warren, Howard Sofen, Lynda Spelman, Craig Leonardi, Subhashis Banerjee, Tao Wang, John Throup, Elizabeth Colston, Andrew Napoli, Alexa B. Kimball

    
• • ·32561 Development and validation of a new, disease-specific quality of life assessment instrument for patients with keloid disorder

    Page :AB157

    Romsin Zaya, Jonathan Wang, Emily Correia, Rachel Zachian, Mary Metkus, John Bruckbauer, Jouni Uitto, Neda Nikbakht

    
• • ·33763 Diagnostic delay in Danish psoriasis patients

    Page :AB157

    Lea Nymand, Mia-Louise Nielsen, Alexander Egeberg

    
• • ·34371 Differences in half day outpatient dermatology clinic total work relative value units by patient race, sex, and age

    Page :AB157

    Krittin J. Supapannachart, Zachary Wolner, Robert A. Swerlick, Lauren A.V. Orenstein

    
• • ·32080 Diffuse annular elastolytic giant cell granuloma with a rapid response to hydroxychloroquine

    Page :AB157

    Morgan McNeil, David Fivenson, Jenny Cotton

    
• • ·34833 Digital photography in dermatology

    Page :AB158

    Imran Baig, Quoc-Bao Nguyen, Richard R. Jahan-Tigh, Michael R. Midgen

    
• • ·33028 Direct and indirect treatment effect of guselkumab on anxiety and depression in patients with psoriasis by adjusting for Psoriasis Area and Severity Index (PASI) – A mediation analysis

    Page :AB158

    April Armstrong, Peter Foley, Yan Liu, Ya-Wen Yang, Megan Miller, Rachel E. Teneralli, Anthony Bewley, Kenneth B. Gordon, Chenglong Han

    
• • ·35361 Disulfiram-like reactions to topical tacrolimus: A case series

    Page :AB158

    Blanca Estupinan, Wendy Kim

    
• • ·33144 Diversity and inclusion in basic dermatology curriculum cases after implementation of a social context initiative

    Page :AB158

    Devon Barrett, Joseph Tran, Helen Li, Klint Peebles, Howa Yeung

    
• • ·33697 Diversity in makeup: How inclusive are beauty brands in the USA?

    Page :AB159

    Jennifer David, Callyn Iwuala

    
• • ·35336 Do dermatologists realize a reliable clinical diagnosis of melanocytic nevi?

    Page :AB159

    Marielva Castro-González, Nora Ximena Ugalde-Trejo, Estefanía Boland-Rodríguez, Abraham Benjamín Alfaro-Sánchez, Fermín R. Garza-González, Rebeca Rodríguez-Cabral

    
• • ·34631 Do patients with vitiligo and health care professionals treating them recognize the burden in living with the disease in the United States? Findings from the VALIANT study

    Page :AB159

    Kristen Bibeau, John E. Harris, Iltefat H. Hamzavi, Anouk Lindley, Christine LaFiura, Khaled Ezzedine

    
• • ·33322 Dupilumab improves patient-reported outcomes among adults with moderate-to-severe atopic dermatitis (AD) in clinical practice: 30-36 month results from the RELIEVE-AD study

    Page :AB159

    Bruce Strober, Jingdong Chao, Chien-Chia Chuang, Min Yang, Brad Shumel, Jessie Wang, Gaelle Bego-Le-Bagousse, Debra Sierka, Zhixiao Wang, Dimittri Delevry

    
• • ·33557 Dupilumab treatment restores skin barrier function and improves clinical and patient reported outcomes in adults and adolescents with moderate to severe atopic dermatitis

    Page :AB160

    Robert Bissonnette, Donald Y.M. Leung, Gabriel Bologna, Noah A. Levit, Ana B. Rossi, Annie Zhang

    
• • ·33696 Dyschromatosis symmetrica hereditaria disguised as lentigines

    Page :AB160

    Samantha Sears, Jyoti Burruss

    
• • ·34699 Early life socioeconomic factors that influence specialty choice and USMLE test performance in United States medical residents: A single institution cross-sectional survey study

    Page :AB160

    Yang Li, Shane Grace, Aditya Nellore, Jennifer To, Eric Armbrecht, Mallory Abate

    
• • ·35126 Education to improve general medical doctors’ dermatology referrals

    Page :AB160

    Alicia Wei-Jen Goh, Fei Ya Lai, Renuka Shobha Sitram, Isweri Pillay

    
• • ·33130 Effect of tildrakizumab on work/study-related productivity: Pooled analysis from reSURFACE 1 and reSURFACE 2 phase 3 trials

    Page :AB161

    Matthias Augustin, Ulrich Mrowietz, Kristian Gaarn Du Jardin, Ismail Kasujee, Esteban Daudén

    
• • ·31962 Effects of blue light on the skin and its therapeutic uses: Photodynamic therapy and beyond

    Page :AB161

    Collin Pieper, Erica B. Lee, Ritu Swali, Kimberly Harp, Megan Arthur, Ashley Wysong

    
• • ·34952 Efficacy and safety of 2 doses of onabotulinumtoxin A for the treatment of masseter muscle prominence: 6-month results from a randomized, phase 2b placebo-controlled study

    Page :AB161

    Sabrina Fabi, Derek Jones, Brian Biesman, Alexander Rivkin, Julia Garcia, Tanya Brandstetter, Grace Pan, Beta Bowen, Elisabeth Lee, Mitchell F. Brin

    
• • ·32496 Efficacy and safety of abrocitinib according to geographies

    Page :AB161

    Andrew F. Alexis, Zakiya P. Rice, Kenji Kabashima, Paula C. Luna, Jacob P. Thyssen, Magdalena Trzeciak, Pinaki Biswas, Gary L. Chan, Erman Güler, Mark Levenberg

    
• • ·33468 Efficacy and safety of once-daily roflumilast cream 0.3% in patients with knee/elbow involvement: Pooled results from phase 3 trials (DERMIS-1 and DERMIS-2)

    Page :AB162

    Laura K. Ferris, Zoe D. Draelos, Adelaide A. Hebert, Charles W. Lynde, David M. Pariser, Kim A. Papp, Paul S. Yamauchi, Amy Feng, Robert C. Higham, Patrick Burnett, David R. Berk

    
• • ·33431 Efficacy of 80 mg/week dose of adalimumab (Humira) in treatment of hidradenitis suppurativa

    Page :AB162

    Saadeddine S. Saad, Christopher Haley, Jess Hatfield, Radhika Shah, Palak Parekh

    
• • ·33354 Efficacy of apremilast in patients with mild to moderate psoriasis assessed by the physician global assessment and body surface area composite tool: Post hoc analysis from ADVANCE

    Page :AB162

    Linda Stein Gold, Kim Papp, David Pariser, Howard Sofen, Mindy Chen, Sue Cheng, Hernan Picard, Yuri Klyachkin, Lawrence Green

    
• • ·34077 Efficacy of oral sarecycline in Hispanics with facial inflammatory acne

    Page :AB162

    Angela Moore, Stephen A. Moore, Ayman Grada

    
• • ·32245 Efficacy of superficial versus medium-depth peels: Quantitative and qualitative analysis

    Page :AB163

    Aaron Cohen, Junhong Mao

    
• • ·32953 Efficacy responses across disease severity and treatment history subgroups of patients with moderate to severe plaque psoriasis treated with guselkumab: Pooled results from VOYAGE 1&2 through 5 years

    Page :AB163

    Kenneth B. Gordon, Joseph F. Merola, Peter Foley, Olivia Choi, Daphne Chan, Megan Miller, Yin You, Yaung-Kaung Shen, Ya-Wen Yang, Andrew Blauvelt

    
• • ·33954 Efficacy, tolerability, and acceptability of a balm formulated with dimethicone 1% in type II diabetes patients with dry, cracked skin

    Page :AB163

    Peter Lio, Sarah Anjuwon, Mathieu Grivet-Seyve, Christine Emesiani

    
• • ·34970 Efficacy, tolerability, and consumer perception of a skincare regimen in patients with uneven skin tone

    Page :AB163

    James Q. Del Rosso, Christine Emesiani, Thu Nguyen

    
• • ·33228 Efficiency and survival of guselkumab attending to demographic characteristics and comorbidities in 127 patients with moderate-to-severe psoriasis

    Page :AB164

    L. Rodriguez-Fernandez-Freire, Ricardo Ruiz-Villaverde, Jose C. Armario-Hita, Fiorella Vasquez, Amalia Perez-Gil, Leandro Martinez-Pilar, Manuel Galan-Gutierrez

    
• • ·32372 Eosinophilic cellulitis secondary to trimethoprim-sulfamethoxazole

    Page :AB164

    McKenna Abercrombie, David Altman, Jenny Cotton

    
• • ·34785 Epidermal reconstruction during ex vivo confocal microscopy for detection of superficial basal cell carcinoma with 3D-mosaicking and intensity projection

    Page :AB164

    Karon Millar, Ucalene Harris, Alex Bang, Matthew Moronta, Mercedes Martín Sendín, Anthony Rossi, Erica Lee, Kishwer Nehal, Milind Rajadhyaksha, Kivanc Kose, Manu Jain

    
• • ·31047 Erythrodermic psoriasis secondary to the COVID-19 Moderna vaccine

    Page :AB164

    Gabriela Pabón-Cartagena, Natalia M. Pelet del Toro, Marian Russo

    
• • ·33568 Evaluating the mildness of glycinate-based cleanser through in vitro methodologies and computational modeling

    Page :AB165

    Siti Shahera Anwar, Melissa Tang, Abhinav Maheswaran Pragatheeswaran, Guo Liangfeng, Souvik Chakraborty, Kwek Jin Wang, Freda C.H. Lim

    
• • ·32934 Evaluation of a pilot clinical forensic dermatology curriculum at UCSF Department of Dermatology

    Page :AB165

    Sami Jelousi, Rubi Danielle Montejano, Katrin Jaradeh, Coleen Kivlahan, Kanade Shinkai, Aileen Chang

    
• • ·32932 Evaluation of analytical alterations produced during the monitoring of patients with severe psoriasis undergoing treatment with ustekinumab, secukinumab and ixekizumab

    Page :AB165

    Ana Medina-Fernández, Jorge Alonso Suárez-Pérez, Enrique Herrera-Acosta, Pilar Luque-Varela, Enrique Herrera-Ceballos

    
• • ·32688 Evaluation of demographics for patients on immunomodulatory therapy during the COVID-19 pandemic

    Page :AB165

    Ruby S. Gibson, Monica Rosales Santillan, Martina L. Porter

    
• • ·34433 Evaluation of skin mildness of a nature-based acne cleanser in controlled washing test

    Page :AB166

    Sarah McCauley, Hemali B. Gunt

    
• • ·34547 Evaluation of the efficacy and durability of a silicone gel for improving the appearance of scars

    Page :AB166

    Stephen Lynch, Shelby Cook, Hina Choudhary

    
• • ·33623 Evaluation of the efficacy and tolerance of a cosmetic serum containing volcanic mineralizing water, probiotic fractions, hyaluronic acid, niacinamide, and tocopherol in patients with “face mask dermatitis”

    Page :AB166

    Anne-Charlotte Kuna, Anne Guertler, Hoang Phoung Do, Elsa Devillechabrolle, Delphine Kerob, Cristel Ruini, Markus Reinholz

    
• • ·34960 Examining diversity and community engagement dermatology residency positions in the United States

    Page :AB166

    Elisabeth A. George, Lynn McKinley-Grant, Susan C. Taylor

    
• • ·35326 Exosome therapy for scalp hair growth—A review of the in vivo and in vitro evidence

    Page :AB167

    Briana Paiewonsky, Nicole Heinen, Gretchen Bellefeuille, Ora Raymond, Maria Hordinsky, Ron Shapiro, Ronda Farah

    
• • ·34612 Exploring the natural history of vitiligo in the United States: Findings from the VALIANT study

    Page :AB167

    John E. Harris, Kristen Bibeau, Iltefat H. Hamzavi, Pearl Grimes, Anouk Lindley, Christine LaFiura, Khaled Ezzedine

    
• • ·34052 Facial pyoderma gangrenosum, a diagnostic challenge

    Page :AB167

    Carmen Couselo-Rodríguez, Gonzalo Peón, Beatriz González-Sixto, Carlos Álvarez-Álvarez, Diego Soto-García, Sandra Martínez-Fernández, Raúl Gutiérrez-Mere, Ángeles Flórez

    
• • ·32097 Factors associated with eczema clinical trial participation in adults

    Page :AB167

    Erin E. Grinich, Isabelle J. Thibau, Kyla N. Price, Emile Latour, Eric L. Simpson, Wendy Smith Begolka

    
• • ·32824 Factors associated with treatment satisfaction in atopic dermatitis: A cross-sectional, population-based study examining patient and physician perspectives

    Page :AB168

    Zelma C. Chiesa Fuxench, Eva Nee, Eric Simpson, Wendy Smith Begolka, Mark Boguniewicz, Luz Fonacier, Joel M. Gelfand, Mitchel Grayson, David J. Margolis, Jonathan Silverberg, Peck Ong

    
• • ·34021 Family impact of moderate-to-severe atopic dermatitis in children aged <12 years: Results from 732 patients in the PEDIatric STudy in Atopic Dermatitis (PEDISTAD) observational study

    Page :AB168

    Marjolein de Bruin-Weller, Marie L.A. Schuttelaar, Charles W. Lynde, Nelson Augusto Rosario Filho, Chunyuan Liu, Brad Shumel, Annie Zhang

    
• • ·33272 Fatigue in patients with moderate to severe plaque psoriasis treated with certolizumab pegol: Three-year results from the CIMPACT phase 3 trial

    Page :AB168

    Alice B. Gottlieb, Jennifer Soung, Andreas Pinter, Tsen-Fang Tsai, Jose Manuel Carrascosa, Julia-Tatjana Maul, Saakshi Khattri, Jose M. Lopez Pinto, Joseph F. Merola

    
• • ·33207 Formaldehyde release from eyelash glues: Chromotropic acid method analysis

    Page :AB168

    Michelle Xiong, Javed A. Shaik, Sara Hylwa

    
• • ·34839 Game-changer or flop: Teprotumumab may not provide lasting improvement of pretibial myxedema

    Page :AB169

    Drew A. Emge, Matilda W. Nicholas

    
• • ·33456 Generalized congenital myofibromatosis

    Page :AB169

    Anna Sánchez-Puigdollers, Josep Pujol-Montcusí, Laia Pastor-Jane, Sergio César-Díaz, Mar Albujar, Joan Garcia-Fontgivell, Susana Bel, Nerea Mohino, Pilar Turegano, Ricardo Closa

    
• • ·33925 Global survey shows strong impact of pandemic on skincare routines and skin health

    Page :AB169

    Nada Baalbaki

    
• • ·33970 Glutathione amino acids precursors protect skin from ultraviolet-induced skin darkening and redness

    Page :AB169

    Tingyan Mi, Xiao Cui, Xuelan Gu

    
• • ·33055 Guselkumab efficacy and safety through 5 years among psoriasis patients with and without metabolic syndrome at baseline: Results from VOYAGE 1 and VOYAGE 2

    Page :AB170

    Joseph F. Merola, Diamant Thaçi, Olivia Choi, Daphne Chan, Ya-Wen Yang, Megan Miller, Yin You, Shu Li, Andrew Blauvelt, Luis Puig

    
• • ·32938 Guselkumab treatment modulates genes differentially expressed in blood samples of patients with psoriatic arthritis vs healthy controls in two phase 3 clinical trials (DISCOVER-1 and -2)

    Page :AB170

    Stefan Siebert, Kristen M. Sweet, Christopher T. Ritchlin, Elizabeth C. Hsia, Alexa P. Kollmeier, Ya-Wen Yang, Xie L. Xu, Qingxuan Song, Michelle Miron

    
• • ·32128 Hand dermatitis: Readability, quality, and comprehensiveness of online patient health resources

    Page :AB170

    Devea R. De, Terri Shih, Jennifer L. Hsiao, Vivian Y. Shi

    
• • ·33255 Handwash formulations containing 12-hydroxystearic acid provide long-lasting protection against bacteria in vivo

    Page :AB170

    Morris Waskar, Xuelan Gu, Meenakshi Swaminathan, Carol Vincent, Rimpa Ghosh, Chandraprabha Doraiswamy, Amitabha Majumdar

    
• • ·33224 Health care resource utilization among adults with chronic inducible urticaria in the United States

    Page :AB171

    Yvonne Geissbühler, Maria-Magdalena Balp, Aine Mcconnon, Justin Gomme, Sarah Jane McKenna, Weily Soong

    
• • ·34302 Health-related quality of life impact associated with severity of nonscalp symptoms among patients with alopecia areata

    Page :AB171

    Emily Edson-Heredia, Katelyn Cutts, Peter Wright, Amy M. DeLozier, Maryann Senna, Antonella Tosti, Jerry Shapiro, Heather Gelhorn

    
• • ·33911 Hidradenitis suppurativa secondary to nivolumab

    Page :AB171

    Noura Ayoubi, Caroline A. Gerhardt, Kerry Hennessy, Sairekha Ravichandran, Nupur Patel, Erfon Ekhlasi, Nora Vera, George Glinos, Alejandro Rabionet, Leigh Hatch, Lilia Correa-Selm

    
• • ·33475 Histologic characteristics of early mycosis fungoides in Puerto Rico

    Page :AB171

    Alvaro J. Ramos Rodriguez, Karina J. Cancel-Artau, Jose Cuesta-Camunas, Deyson Lorenzo-Rios, Marely Santiago-Vazquez, Julio E. Sanchez

    
• • ·34405 Host and primary tumor factors for the development of multiple cutaneous squamous cell carcinomas

    Page :AB172

    Isabelle H. Moseley, Erica Lin, Rachel Lim, Megan Hoang, Navya Baranwal, Leslie Robinson-Bostom, Tiffany Libby, Oliver Wisco, Abrar Qureshi, Eunyoung Cho

    
• • ·33576 How lifestyle-based environmental exposures impact skin health through microbiome

    Page :AB172

    Xi Li, Bo Yan, Yueying Fu, Yingrui Li, Binghang Liu, Danhua Qin, Qi Wei

    
• • ·35050 How to manage psoriasis in patients with skin of color

    Page :AB172

    Yuliya Lytvyn, Muskaan Sachdeva, Asfandyar Mufti, Jensen Yeung

    
• • ·33330 Hyaluron pens: A public safety issue compounded by TikTok

    Page :AB172

    Sarah Kesaria, Quoc-Bao Nguyen, Adelaide Hebert, Murad Alam

    
• • ·34589 Hydrodissection and hydroinflation in Mohs micrographic surgery—Pearls for skin surgeons

    Page :AB173

    Abrahem Kazemi, Jia Gao, Tony Adar

    
• • ·31924 Hydroxyurea-induced ulcers: Anagrelide as a treatment option after hydroxyurea discontinuation

    Page :AB173

    Madeleine Lachance, Bernard Delisle

    
• • ·34219 Hypersensitivity reaction to tattoo pigment secondary to checkpoint inhibition

    Page :AB173

    Brianna Castillo, Emily Smith

    
• • ·33736 Identifying predictive factors for high preoperative anxiety in patients undergoing Mohs micrographic surgery

    Page :AB173

    Shirley Lin, Amarachi Eseonu, Melika Marani, Benjamin L. Shou, Carolina Lopez-Silva, Katerina Lin, Elise Ng, Kristin Bibee, Jeffrey F. Scott

    
• • ·32677 IgA pemphigus in a patient with rheumatoid arthritis and cardiac amyloid successfully treated with oral dapsone

    Page :AB174

    Michael Knabel, Madhu Dahiya, David Eilers

    
• • ·33273 Impact of atopic dermatitis lesion locations on patient burden: A real-world study

    Page :AB174

    Peter Lio, Eric Simpson, Evangeline Pierce, Angel Cronin, Robert McLean, Swapna S. Dave, Amy J. Kovacik, Meghan Feely, Jonathan Silverberg

    
• • ·34163 Impact of race/ethnicity and skin type on illness perceptions and quality of life in patients with discoid lupus erythematosus

    Page :AB174

    Michelle S. Lee, Christina G. Lopez, Christy Nwankwo, Gabriela Cobos, Joseph Merola, Ruth Ann Vleugels, Avery H. LaChance

    
• • ·33236 Impact of risankizumab on improving symptoms and health-related quality of life and reducing fatigue and pain among psoriatic arthritis patients with moderate-to-severe skin involvement: Evidence from 2 phase III trials

    Page :AB174

    Kim Papp, Ahmed M. Soliman, Christian Kaufmann, Lisa Barcomb, Zailong Wang, Douglas White, Andrew Ostor, Lars Erik Kristensen

    
• • ·35185 Impact of telehealth on duration of tetracycline prescription during COVID-19

    Page :AB175

    Ananya Munjal, Raghav Tripathi, Patrick Kinn, Kelly Percival, Dilek Ince, Jennifer Powers

    
• • ·33259 Improvements in anxiety and depression among patients with moderate to severe plaque psoriasis treated with certolizumab pegol: Three-year results from 2 phase 3 trials (CIMPASI-1 and CIMPASI-2)

    Page :AB175

    April Armstrong, Sandra McBride, Lynda Spelman, Pablo Fernández-Peñas, Phoebe Rich, George Martin, Nicola Tilt, Jose M. Lopez Pinto, Christina Popova, Scarlett Hellot

    
• • ·33659 Incidence of severe and rare infections among adult patients with psoriasis in Denmark

    Page :AB175

    Nikolai Loft, Lone Skov, Craig Richardson, Vivek Trivedi, Ivette Alarcon, Alexander Egeberg

    
• • ·35083 Inclusive dermatology: Creating a diverse visual atlas of skin conditions (with consideration of broader impacts on patient care and medical education)

    Page :AB175

    Sabah Osmani, Vanessa Itrube, Payton Sandoval-Belt, Avalon Yi, Charles Phillips, Aimee Smidt

    
• • ·35025 Incremental financial burden and health care services associated with depression in dermatology patients

    Page :AB176

    Joseph Younis, Chandruganesh Rasendran, Bryan T. Carroll

    
• • ·35044 Influence of Twitter on dermatopathology: What makes an influencer

    Page :AB176

    Jaclyn B. Anderson, Melissa R. Laughter, Colby L. Presley, Jerad M. Gardner, Whitney High

    
• • ·32685 Inhibitory effects of a nature-based skin brightening complex on melanin production utilizing an in vitro skin tissue model

    Page :AB176

    Hemali B. Gunt, Stanley B. Levy

    
• • ·33966 Integrated safety analysis of baricitinib in adults with severe alopecia areata from 2 randomized clinical trials

    Page :AB176

    Brett King, Arash Mostaghimi, Yutaka Shimomura, Abraham Zlotogorski, Katrin Holzwarth, Maher Issa, Yves Dutronc, Sarah Stanley, Wen-Shuo Wu, Rodney Sinclair

    
• • ·32887 Interplay between the facial cutaneous microbiome and acne vulgaris: A pilot study from the largest national gathering of twins

    Page :AB177

    Justin Marson, Stefano Berto, Paul Mouser, Hilary E. Baldwin

    
• • ·32922 Intralesional rituximab for indolent primary cutaneous B-cell lymphoma

    Page :AB177

    Jake Besch-Stokes, Puneet Bhullar, Pranav Puri, Blake Boudreaux, Collin Costello, William Rule, Allison Rosenthal, David J. DiCaudo, Mark R. Pittelkow, Aaron Mangold

    
• • ·32741 Investigating sun safety behaviors, beliefs, and skin cancer-related knowledge and risk factors in the Canadian population

    Page :AB177

    François Lagacé, Ivan Litvinov

    
• • ·31057 Ixekizumab treatment response: Consistency over time and at each visit in psoriatic arthritis

    Page :AB177

    Joseph F. Merola, Laura C. Coates, David M. Sandoval, Rebecca Bolce, So Young Park, Alyssa Garrelts, Keri Brooke Stenger, Aubrey Trevelin Sprabery, Arthur Kavanaugh

    
• • ·34441 Keratoderma blenorrhagicum and balanitis circinata: Indicators of reactive arthritis

    Page :AB178

    Dayoung Ko, Meredith Hengy, Chauncey McHargue

    
• • ·34767 Kombucha-induced irritant contact dermatitis

    Page :AB178

    Catherine C. Motosko, Michael Abrouk

    
• • ·34361 Laser hair removal treatment considerations for Ehlers Danlos syndrome

    Page :AB178

    Michael Abrouk, Sandy Tsao

    
• • ·33887 Lenalidomide-induced pityriasiform eruption followed by blaschkitis in a patient with multiple myeloma

    Page :AB178

    Alexander Jafari, Garrett Vick, Laura Williams

    
• • ·34860 Levels of evidence within dermatology; bibliometric trends compared with general medicine and general surgery from 2008-2017: A bibliometric systematic review

    Page :AB179

    Diya Ramanathan, Panayiota Govas, Andrea Ketchum, Bryan T. Carroll

    
• • ·32542 Lichen sclerosus in women: Examining patient variables in a disease characterized by fibrosis in a sex steroid dependent tissue

    Page :AB179

    Yen Luu, Colleen Reisz

    
• • ·31840 Local recurrence rates of extramammary Paget disease are lower following Mohs micrographic surgery compared with wide local excision: A systematic review and meta-analysis

    Page :AB179

    Grace Y. Kim, Elliott H. Campbell, Patricia J. Erwin, Jerry D. Brewer

    
• • ·33325 Long-term dupilumab effectiveness on health-related quality of life (HRQoL) and work productivity in atopic dermatitis (AD): Results from RELIEVE-AD

    Page :AB179

    Dimittri Delevry, Jingdong Chao, Chien-Chia Chuang, Min Yang, Brad Shumel, Bruno Martins, Gaelle Bego-Le-Bagousse, Debra Sierka, Zhixiao Wang, Bruce Strober

    
• • ·34358 Long-term efficacy of dupilumab in adults with moderate-to-severe atopic dermatitis (AD): Results from an open-label extension (OLE) trial up to 4 years

    Page :AB180

    Jacob P. Thyssen, Andrew Blauvelt, Benjamin Lockshin, Ryszard Galus, Charles Lynde, Jing Xiao, Noah A. Levit, Ainara Rodríguez Marco, Arsalan Shabbir

    
• • ·33006 Long-term improvement of patient-reported outcomes in adult patients with atopic dermatitis treated with baricitinib in the US and Canada

    Page :AB180

    Zelma C. Chiesa Fuxench, April W. Armstrong, Joseph F. Merola, Rocco T. Serrao, Robinette Angle, Evangeline J. Pierce, Luna Sun, Jinglin Zhong, Meghan Feely, Jonathan I. Silverberg

    
• • ·34794 Long-term safety and disease control of ruxolitinib cream among Black or African American patients with atopic dermatitis: Pooled results from 2 phase 3 studies

    Page :AB180

    Lawrence F. Eichenfield, Linda F. Stein Gold, Zelma C. Chiesa Fuxench, May E. Venturanza, Haobo Ren, Kanwaljit K. Brar

    
• • ·33467 Long-term safety and efficacy of roflumilast cream 0.3% in patients with chronic plaque psoriasis: Interim results from a 24-week, phase 3 open-label study

    Page :AB180

    Kim A. Papp, David N. Adam, Melinda J. Gooderham, Lawrence J. Green, Mark Lebwohl, Angela Y. Moore, David M. Pariser, Amy Feng, Robert C. Higham, Patrick Burnett, David R. Berk

    
• • ·33298 Long-term safety and efficacy of tralokinumab in more than 1400 moderate-to-severe atopic dermatitis patients treated for up to 42 months: An interim analysis of ECZTEND

    Page :AB181

    Andrew Blauvelt, Richard Langley, Eric Simpson, Richard B. Warren, Antonio Costanzo, Hidehisa Saeki, Darryl Toth, Marie Tauber, Andreas Pinter, Mahreen Ameen, Kristian Reich

    
• • ·32295 Looking beyond scalp hair loss: Factors influencing dermatologists’ assessment of alopecia areata severity

    Page :AB181

    Kavita Gandhi, Moshe Fridman, Markqayne Ray, Morgan Shy, Arash Mostaghimi

    
• • ·34065 Lupus panniculitis with facial hemiatrophy

    Page :AB181

    Ashlee Margheim, Cindy E. Owen, Jeffrey P. Callen

    
• • ·33654 Maculopapular cutaneous mastocytosis: Recognizing the signs of systemic involvement

    Page :AB181

    Randi Paige Winter, Ashley Jenkins

    
• • ·31786 Maintenance effect of a once a week regimen of a selenium disulfide-based shampoo following a 2-week treatment with a topical corticosteroid/salicylic acid product in moderate to severe scalp seborrheic dermatitis

    Page :AB182

    Philippe Massiot, Corinne Chagnoleau, Leila Kanoun-Copy, Florence Pouradier, Geneviève Loussouarn, Catheine Queille-Roussel, Delphine Kerob

    
• • ·35171 Malignant melanoma cases associated with IL-23 inhibitors: Pharmacovigilance analysis of real-world evidence in the Food and Drug Administration Adverse Event Reporting System (FAERS) from the RADAR (Research on Adverse Drug events And Reports) program

    Page :AB182

    Negar Kahen, Yasmeen Ali, Dennis P. West, Beatrice Nardone

    
• • ·32761 Mechanism for improvement in the appearance of skin laxity resulting from a single treatment with acoustic subcision: Induction of new collagen (type III) and elastin

    Page :AB182

    Michael S. Kaminer, Christopher C. Capelli, Elizabeth L. Tanzi

    
• • ·31932 Mentorship opportunity for female dermatologists seeking to balance family and career

    Page :AB182

    Madison Grinnell, Ryan Trowbridge, Erica Lee, Ashley Wysong

    
• • ·34178 Merkel cell carcinoma. Does location matter?

    Page :AB183

    Sarah Mazal, Maleka Najmi, Eyas Alkhalili, Luis Alvarado, Alexander Philipovskiy, Ioannis T. Konstantinidis, Jose Castro

    
• • ·34783 Metagenomic microbial profiling of keratinocyte carcinomas in solid organ transplant recipients

    Page :AB183

    George Xiaoxi Song-Zhao, Markus Geuking, Kathy McCoy, P. Régine Mydlarski

    
• • ·33217 Mobile device digital photography for teledermatology consultation: Real-life situations

    Page :AB183

    Chudapa Sereeaphinan, Pattriya Chanyachailert, Sumanas Bunyaratavej, Charussri Leeyaphan, Supisara Wongdama, Sanchai Sombatmaithai

    
• • ·33131 Modeling acute and cumulative erythemal sun exposure on vulnerable body sites during beach vacations using behavior encoded 3D body models

    Page :AB183

    Matthew A. Lohr, Joshua D. Williams, Susan Daly, Alois D. Schmalwieser

    
• • ·35328 Morbidities associated with solitary keratoacanthomas

    Page :AB184

    Tracey S. Otto, Alexandra Rubin, Attiya Haroon, Gina Ashforth, Babar K. Rao

    
• • ·33760 Mortality in patients with pemphigus: A retrospective US claims database study

    Page :AB184

    Jonathan Silverberg, Julia S. Lehman, Animesh A. Sinha, Yola Moride, Keiko Higuchi, Kerri Ford, Philip Sugerman, Ekaterina Smolkina

    
• • ·33496 Multidisciplinary atopic dermatitis program: A novel approach to managing difficult-to-control atopic dermatitis patients

    Page :AB184

    Safiyyah Bhatti, Alexis Tracy, Lauren Loop, Norma Villapando, Alyssa Wu, Pharm D, Margaret M. Appia, Lawrence Eichenfield, Bob Geng

    
• • ·31028 Mutations in FLG, the gene-coding profilaggrin/filaggrin, are associated with putative hay fever in patients with atopic dermatitis

    Page :AB184

    Satoko Minakawa, Yasushi Matsuzaki, Hideyuki Suwa, Michihiro Kono, Masashi Akiyama, Daisuke Dawamura

    
• • ·33615 Nasosinusal mucosal melanoma

    Page :AB185

    Mariano Marini, Luis Berrocal, Carolina Galvis, Patricia Victoria, Carla Maher, Lorena Gagliardone, Gisella Cassarotto, Paula Ontivero, Analia Ciccola, Patricio Servienti

    
• • ·33307 Nemolizumab is associated with a rapid reduction of itch and sleep disturbance in patients with prurigo nodularis

    Page :AB185

    Sonja Ständer, Gil Yosipovitch, Jean-Philippe Lacour, Franz J. Legat, Carle Paul, Adam Reich, Kamel Chaouche, Faiz Ahmad, Warren Winkleman, Christophe Piketty

    
• • ·34159 Neutrophil-rich Wells syndrome treated with dupilumab

    Page :AB185

    Kristin Torre, Sueheidi Santiago, Lorin Bibb, Jun Lu

    
• • ·32963 Nivolumab-induced vasculopathy: A novel immunotherapy reaction

    Page :AB185

    Adeeb Haroon, J. Keith Parker, Emily Smith

    
• • ·33584 No recurrence in primary invasive stage 1a and 1b melanoma and melanoma in situ when treated with serial disk staged excision

    Page :AB186

    Grace S. Ahn, Bobak Pousti, Gaurav Singh, Ashley Elsensohn, Shang I. Brian Jiang

    
• • ·33655 Noninvasive, in vivo, characterization of cutaneous metastases using a novel multimodal RCM-OCT imaging device: A case-series

    Page :AB186

    Jilliana Monnier, Centre de Recherche en Can, Alexander S. Bang, Ucalene Harris, Jason Garfinkel, Gennady Rubinstein, Nicusor Iftimia, Melissa Pulitzer, Melissa Murray, Mario E. Lacouture, Manu Jain

    
• • ·33213 Nonsurgical facelift: Clinical and histologic evaluation of fractional radiofrequency treatment on fine lines and skin laxity

    Page :AB186

    Dong Hye Suh, Yujin Han, Hyeong-Seob Kim, Sang Jun Lee, Kye-Yong Song, Hei Sung Kim

    
• • ·33967 Nourishing fatty acid moisturizers provide superior barrier benefits in ex vivo skin

    Page :AB186

    John Nip, Hilal Ilarslan, Ana Villa, Dawn Mihalov, Stella Arcella, John Bajor

    
• • ·33577 Novel 10% multi-acid serum provides clinical acne and complexion benefits in subjects with mild to moderate acne

    Page :AB187

    Gabrielle Kosmoski, Heather Smith, Dara Miller

    
• • ·33252 Novel antiaging retinol complex improves facial photodamage in a Hispanic and Caucasian population

    Page :AB187

    Melody Edmunds Peslak, Stacy S. Hawkins, Christine Lee, Megan Nicoletti, Hang Truong, Hasiba Bekto, Jeff Wolcheski

    
• • ·33249 Novel high-emollient hand sanitizer improves skin condition without compromising antiseptic efficacy

    Page :AB187

    Jane Tazzioli, Stacy S. Hawkins, Toral Patel

    
• • ·33660 Novel histopathologic findings a drug eruption secondary to enfortumab: A case report

    Page :AB187

    Sadhika Jagannathan, J. Keith Parker, Emily Smith

    
• • ·33959 Novel nasal alar reconstruction with hyaluronic acid after Mohs micrographic surgery and repair

    Page :AB188

    Michael Abrouk, Joanna Dong, Cate Motosko, Andjela Egger, Ella Glaser

    
• • ·34939 Number needed to treat, number needed to diagnose and optimal biopsy rates: Definitions and their interpretation

    Page :AB188

    Sagar Vallabh, Emily Poon, Murad Alam

    
• • ·35062 Onychomycosis and irrational drug use, a growing public health problem

    Page :AB188

    Nora Ximena Ugalde Trejo, Karla Paola Delgado Moreno, Marielva Castro González, Estefania Boland Rodríguez, Salomón Pineda Benítez, Enrique Villarreal Ríos, María Fernanda Ugalde Trejo, María Alcocer León, Alessandra Miranda Aguirre, Abraham Benjamín Alfaro Sánchez

    
• • ·34986 Optimizing representation of skin of color in preclinical medical curricula at two Mayo Medical School campuses

    Page :AB188

    Rewan Abdelwahab, Olayemi Sokumbi, Derrick Lewis, Ewoma Ogbaudu, Johanny Lopez Dominguez, Amit Shah, Amy Seegmiller Renner, Joseph J. Malesewski, Taylor Thomas, Sarah J. Atunah-Jay

    
• • ·33993 Oral difelikefalin improves itch and quality of life in subjects with itch-dominant atopic dermatitis: Subgroup analysis of a randomized, phase 2 study

    Page :AB189

    Mark Lebwohl, Brian Kim, Joana Goncalves, Kristine Nograles, Catherine Munera, Gary Smith, Emma Guttman-Yassky

    
• • ·33714 Palisaded neutrophilic and granulomatous dermatitis in the setting of SRSF2-mutated chronic myelomonocytic leukemia: Case report and review of the literature

    Page :AB189

    Christina Enescu, Avni Patel, Ben J. Friedman

    
• • ·34804 Patient attitudes toward digital surveillance research after Mohs micrographic surgery

    Page :AB189

    Haarika Reddy, Emma Russell, Dustin DeMeo, Vasco Xu, Mayank Goel, Jill Fain Lehman, Bryan T. Carroll

    
• • ·33734 Patient education as the main target in skin cancer prevention: Knowledge, attitudes, and practices toward sun exposure and use of sun protection

    Page :AB189

    David A. Castillo Molina, Jorge Andrés Rios-Duarte, Sara Muñoz-Ordoñez, Jesus Daniel Fierro-Lozada, Winnie Joanne Celorio-Murillo, Maria Fernanda Hernandez-Amaris, Maria J. Sanchez-Zapata, Criss Madeley Millan-Puerto

    
• • ·31937 Pattern of pediatric skin diseases at student-run free clinic

    Page :AB190

    Caroline Zhu, Marie Vu, Tue Nguyen, Katerina Papanikolaou, John Browning

    
• • ·33755 Patterns and prognosis of distant metastases of melanoma subtypes in the Surveillance, Epidemiology, and End Results database

    Page :AB190

    Kevin A. Nguyen, Jan Smogorzewski

    
• • ·34876 Pentoxifylline in the management of atrophic papulosis: A case report and review of the literature

    Page :AB190

    Ana Preda-Naumescu, Brittany Roman, Sophie Wang, Tiffany T. Mayo

    
• • ·33404 Perceptions and stigmatization of vitiligo differ by demographics

    Page :AB190

    Abigail Marriott, Victoria D’Acunto, Abigail Cline, Frederick Pereira

    
• • ·33642 Personal protective equipment modification by health care workers during the COVID-19 pandemic

    Page :AB191

    Nicole Trepanowski, Rachel Meltzer

    
• • ·32093 Physicians’ and patients’ self-perceptions of hyaluronic acid-based facial volumization: Are they compatible?

    Page :AB191

    Rodrigo Amaral de Lima, Isabel Cristina Gomes Moura, João Bayama Galvão Pitoni, Márcia Ramos-e-Silva, Adilson da Costa

    
• • ·35320 Pilot evaluation of safety and efficacy in diverse skin types of a novel topical hyaluronidase-polysaccharide formulation for contour irregularities following filler injection

    Page :AB191

    Hema Sundaram, Hema A. Sundaram, Sandrine Sebban

    
• • ·33515 Pilot survey project on procedural skills opportunities in skin of color for dermatology physician assistants

    Page :AB191

    Kayla A. Clark, Melanie Rosado, Jonathan Punnose, Claudia Hernandez

    
• • ·35389 Polidocanol: A review of clinical uses

    Page :AB192

    Carly Stender, Delfina Bur, Quoc-Bao Nguyen, Sirunya Silapunt

    
• • ·33463 Pooled efficacy and safety results from the DERMIS-1 and DERMIS-2 phase 3 trials of once-daily roflumilast cream 0.3% by baseline body surface area

    Page :AB192

    Linda Stein Gold, Jerry Bagel, James Del Rosso, Lawrence J. Green, Mark Lebwohl, Leon H. Kircik, Amy Feng, Scott Snyder, Robert C. Higham, Patrick Burnett, David R. Berk

    
• • ·34346 Pooled safety analysis of respiratory tract infections, including COVID-19, in psoriasis patients treated with secukinumab

    Page :AB192

    Hendrik Schulze-Koops, Atul Deodhar, Reinhard E. Voll, Jan Leipe, Andrew Blauvelt, Craig Leonardi, Effie Pournara, Ivette Alarcon, Weibin Bao, Vivek Trivedi, Philip J. Mease

    
• • ·32315 Postoperative care consideration: Cold panniculitis induced by cooling device after knee surgery

    Page :AB192

    Amy Zavell, Ashley Jenkins

    
• • ·31911 Postsurgical atypical mycobacterial infection misdiagnosed as pyoderma gangrenosum

    Page :AB193

    Jordan Jones, Jeffrey P. Callen, Courtney R. Schadt

    
• • ·33991 Predictors of response to secukinumab in patients with moderate to severe plaque psoriasis with special area involvement in real-world clinical setting: A pooled analysis of prospective observational studies PROSPECT, SERENA, and REALIA

    Page :AB193

    Diamant Thaci, Peter Foley, Craig Richardson, Yulin Shi, Juanzhi Fang, Matthias Augustin

    
• • ·33929 Predominant dermatologic issues in Hispanic patients at student-run free clinic

    Page :AB193

    Katerina Papanikolaou, Tue Nguyen, Caroline Zhu, Marie Vu, John Browning

    
• • ·35213 Prevalence of radiotherapy, chemotherapy and access to supportive care in France, Brazil, Russia, the USA and China

    Page :AB193

    Guillaume Buiret

    
• • ·35414 Prevalence of scars: Brazil results of the first international study

    Page :AB194

    Emerson Lima

    
• • ·35386 Prevalence of scars: Results of the first international study

    Page :AB194

    J.M. Amici

    
• • ·35419 Prevalence of scars: USA results of the first international study

    Page :AB194

    Diane Madfes

    
• • ·32888 Primary cutaneous B-cell lymphoma treated with systemic rituximab

    Page :AB194

    Jake Besch-Stokes, Puneet Bhullar, Pranav Puri, Blake Boudreaux, Collin Costello, William Rule, Allison Rosenthal, David J. DiCaudo, Mark R. Pittelkow, Aaron Mangold

    
• • ·34030 Primary cutaneous follicle center lymphoma mimicking alopecia areata: A case report

    Page :AB195

    Victoria McCarver, Isabella Dreyfuss, Kelly Segars, Eleanor Knopp, Michael Lynch, Richard Miller

    
• • ·32514 Primary cutaneous marginal zone B-cell lymphoma involution with anetoderma

    Page :AB195

    Ala Haqiqi, Siobhán McCarthy, Anastasia Therianou

    
• • ·33944 Primary dermal melanoma: A comprehensive review of etiology, pathogenesis and clinical prognosis

    Page :AB195

    Michael Abrouk, Teo Soleymani, Cate Motosko

    
• • ·33830 Prognostic factors for early PASI 100 response in psoriasis patients treated with guselkumab: Results from the GUIDE study

    Page :AB195

    Knut Schäkel, Kristian Reich, Khusru Asadullah, Andreas Pinter, Denis Jullien, Peter Weisenseel, Carle Paul, Mario Gomez, Sven Wegner, Yvonne Personke, Kilian Eyerich

    
• • ·33691 Prospective pilot evaluation in Fitzpatrick skin phototypes III to VI of a crystal-free brush-tip exfoliation device with variable vacuum pressure and skin infusion for hyperpigmentation

    Page :AB196

    Hema Sundaram, Hema A. Sundaram, Kara Tung

    
• • ·35377 Protection from UV light-induced telomere shortening by a broad-spectrum sunscreen product

    Page :AB196

    
• • ·34535 Pseudoherpetic transient acantholytic dermatosis

    Page :AB196

    Umar Sheikh, Angad Chadha, Christopher R. Shea

    
• • ·34193 Psoriasiform eruption after treatment with pembrolizumab

    Page :AB196

    Olivia Arriaza, Benjamin Garcia, Ayezel Munoz Gonzalez, Brent Kelly, Frank Winsett

    
• • ·34530 Pyogenic granulomatous formation due to transepithelial elimination of abdominal hernia mesh

    Page :AB197

    Baydon Hilton, David Cleaver, Lloyd Cleaver, Jonathan Cleaver

    
• • ·35091 Racial differences in anatomic sites of metastatic melanoma: An analysis of the National Cancer Database 2004-2018

    Page :AB197

    Jennifer M. Fernandez, Kevin R. Kwan, Sara Behbahani

    
• • ·33532 Randomized split-face study to assess the efficacy and tolerability of M89PF as an adjunct to topical retinoids for antiaging benefits

    Page :AB197

    Delphine Kerob, Priscial Correia, José Euzébio Gonçalves Junior, Erika Fernandes, Thais Pontes, Camila Valpaços, Diego Svoboda, Jerry Tan, Private Practice

    
• • ·33613 Rare infectious diseases encountered in a dermatologic setting

    Page :AB197

    Christopher Haley, Saadeddine Saad, Kirstin Altman, Bradley Evanson, Lindsay Bicknell, Palak Parekh

    
• • ·33572 Real world evidence (RWE) on sunscreen compliance and photodamage perception among consumers and dermatologists

    Page :AB198

    Suja Thomas, Orawan Suitthimeathegorn, Yao Sun, Percival Salazar Pastrana

    
• • ·33960 Real world evidence cohort of patients switched to guselkumab after ustekinumab

    Page :AB198

    Mar Llamas-Velasco, Luisa Martos-Cabrera, Raquel Sampedro, Raquel Rivera, Pedro Herranz, Pablo de la Cueva, Diana Ruiz-Genao, Sonsoles Berenguer-Ruiz, Gastón Roustan, Esteban Daudén

    
• • ·34115 Real-life efficacy and safety of biologic treatment in patients with moderate to severe psoriasis and previous diagnosis of a malignant tumor: Single-center descriptive study

    Page :AB198

    Antonio José Durán Romero, Lourdes Rodríguez Fernández Freire, Mercedes Sendín Martín, Juan Ortiz Álvarez, Juan Carlos Hernández Rodríguez, Julián Conejo-Mir Sánchez

    
• • ·33171 Real-world data study in health care costs from adults with psoriasis who initiated treatment with apremilast or biologics

    Page :AB198

    Jashin J. Wu, Ann (Ching An) Wang, Greeta Jobson, David Davidson, Samaneh Kalirai, Julia (Ning) Zhu, Manasi Suryavanshi, Mayank Mittal, Vardhaman Patel, Lauren Seigel

    
• • ·33129 Real-world effectiveness and safety of tildrakizumab in patients with moderate to severe plaque psoriasis: Week 28 interim analysis of a phase 4 study

    Page :AB199

    Neal Bhatia, Jayme Heim, Monique Torres, Paulita Beute, Stephen J. Rozzo, J. Gabriel Vasquez

    
• • ·34828 Real-world effectiveness of dupilumab for the treatment of atopic dermatitis in adult and pediatric patients

    Page :AB199

    Veronica K. Emmerich, Josiah Williams, Matthew L. Hrin, Megan Newsom, Steven R. Feldman, Lindsay C. Strowd

    
• • ·34201 Real-world efficacy and safety of dupilumab for atopic dermatitis in a Hispanic population: A single-center retrospective cohort study

    Page :AB199

    Marely Santiago-Vázquez, Natalia Pelet, Jose M. Cuesta, Eduardo Michelen, Alvaro J. Ramos, Rafael F. Martin

    
• • ·31854 Real-world experience of dupilumab treatment for atopic dermatitis

    Page :AB199

    Jaime Martinez Mariscal, Raquel Cabana-Navia, Alicia Martinez-Fernandez, Adriana Martin-Fuentes, Ivan Checa-Recio, Patricia Gonzalez-Muñoz, Consuelo Sanchez-Herreros, Aranzazu Vergara, Maria-Antonia Pastor-Nieto, Esther Eusebio-Murillo

    
• • ·32501 Real-world safety and 1-year effectiveness of dupilumab in Japanese patients with atopic dermatitis: An interim analysis of ongoing regulatory post-marketing surveillance

    Page :AB200

    Hiroyuki Fujita, Katsuhisa Suzuki, Kazuhiko Arima, Hidehisa Saeki

    
• • ·33553 Real-world treatment patterns and outcomes up to 1 year among children aged <12 years with moderate-to-severe atopic dermatitis (AD) enrolled in the PEDIatric STudy in Atopic Dermatitis (PEDISTAD) observational study

    Page :AB200

    Eulalia Baselga, Nikolay Murashkin, Myong Soon Sung, Lara Wine Lee, Chunyuan Liu, Lauren Bates, Annie Zhang

    
• • ·34414 Real-world treatment patterns of veterans with periocular basal cell carcinoma

    Page :AB200

    Jamie Rhoads, Amber Jimenez, Kelli M. Rasmussen, Deborah Morreall, Vikas Patil, Christina Yong, Catherine Li, Janet Lee, Nindhana Paranthaman, Ahmad S. Halwani

    
• • ·34820 Real-world treat-to-target skin clearance with risankizumab in patients with moderate to severe psoriasis from the CorEvitas Psoriasis Registry

    Page :AB200

    April W. Armstrong, Laura K. Ferris, Kristina Callis Duffin, Jud Janak, Adam Sima, Thomas Eckmann, Manish Patel, Huzefa Photowala, Vishvas Garg, Bruce Strober

    
• • ·32912 Reciprocal control of epidermis and sensory neurons in juvenile and adult human skin in a re-innervated epidermis model

    Page :AB201

    Stéphanie Bredif, Nicolas Lebonvallet, Gaelle Bellemere, Laurent Misery

    
• • ·32522 Refractory calcinosis cutis in limited systemic sclerosis treated with CO2 ablation and curettage

    Page :AB201

    Shane McTighe, Meagan Simpson

    
• • ·32765 Regional variation in percutaneous absorption in in vitro human models: A systematic review

    Page :AB201

    Aileen Feschuk, Nadia Kashetsky, Chavy Chiang, Anuk Burli, Halie Burdick, Howard Maibach

    
• • ·34659 Retrospective study of HPV vaccination patterns in the dermatology setting at a single institution

    Page :AB201

    Lilly Gu, Paras Mehta, Alina Markova, Anthony Rossi, Veronica Rotemberg

    
• • ·33813 Retrospective study of the prevalence of hyperkalemia in women taking spironolactone for acne, hair loss, and hirsutism

    Page :AB202

    Rachel Hill, Yu Wang, Shari R. Lipner

    
• • ·32607 Risk of cardiovascular events and all cause mortality in patients with atopic dermatitis: A population-based cohort study

    Page :AB202

    Maha N. Syed, Daniel B. Shin, Joy Wan, Katrina Abuabara, Adina R. Lemeshow, Joel M. Gelfand

    
• • ·33891 Russian register of vitiligo patients: Contour plastic as a trigger for vitiligo

    Page :AB202

    Valentina Petunina, Potekaev Nikolay, Zukova Olga, Aculova Natalya

    
• • ·35163 Ruxolitinib cream provided progressive improvement in patients with atopic dermatitis who did not achieve Investigator’s Global Assessment treatment success at week 8: Pooled results from 2 phase 3 studies

    Page :AB202

    Lawrence F. Eichenfield, Andrew Blauvelt, Leon Kircik, May E. Venturanza, Haobo Ren, Eric L. Simpson

    
• • ·32236 Safety of ixekizumab in adult patients with moderate-to-severe psoriasis: Data from 15 clinical trials with over 18,000 patient-years of exposure

    Page :AB203

    Christopher E.M. Griffiths, Melinda Gooderham, Jean-Frederic Colombel, Tadashi Terui, Ana P. Accioly, Gaia Gallo, Danting Zhu, Andrew Blauvelt

    
• • ·33126 Sinus histiocytosis with massive lymphadenopathy (Rosai Dorfman disease): A case report

    Page :AB203

    Sueheidi Santiago, Steven Madsen, Maritza I. Perez

    
• • ·33256 Skin cancer screening practices among dermatologists: A survey study

    Page :AB203

    Yanci Alexander Algarin, Catherine McCullum, Vishal Anil Patel

    
• • ·33559 Skin maturation processes observed in infants extend well into the childhood period

    Page :AB203

    Georgios N. Stamatas, Imane Lboukili, Pierre-Francois Roux, Thierry Oddos

    
• • ·35307 Skin tone bias of Google image results for common dermatologic diseases

    Page :AB204

    Dillon Nussbaum, Adam Friedman

    
• • ·35372 Skin type and efficacy of laser treatment for androgenic alopecia

    Page :AB204

    Nathan Balukoff, Catherine C. Motosko, Antonella Tosti

    
• • ·35168 SkinTracker: A novel smartphone app enabling remote clinical research in dermatology

    Page :AB204

    Mimi Chung, Samuel Yeroushalmi, Marwa Hakimi, Erin Bartholomew, Julie Hong, Edward Hadeler, Megan Mosca, Paul Dhaliwal, Wilson Liao

    
• • ·35333 Sleep disorders in adult acne

    Page :AB204

    Bruno Halioua

    
• • ·34936 Spanish in Texas undergraduate and dermatology graduate medical education: A survey study

    Page :AB205

    Alyssa Hansen, Paige Hoyer, Lindy Ross

    
• • ·33542 Stability of response prior to baricitinib downtitration or treatment withdrawal: Outcome from a substudy of BREEZE AD3

    Page :AB205

    Jonathan Silverberg, Robert Bissonnette, Kenji Kabashima, Nosbaum Audrey, Susan Ball, Tracy Cardillo, Luna Sun, Yun-Fei Chen, Thomas Bieber

    
• • ·33499 Subject-relevant outcomes of on-label 50U abobotulinumtoxinA treatment for moderate-to-severe glabellar lines across three individual trials

    Page :AB205

    Dee Anna Glaser, Sue Ellen Cox, Amir Moradi, Steven Dayan, Carolyn Jacob, Joel Schlessinger, John Joseph

    
• • ·34216 Subungal squamous cell carcinoma presenting as longitudinal melanonychia

    Page :AB205

    Carolina Puyana, Lacey Zimmerman, Vassilios Dimitropoulos, Maria Tsoukas

    
• • ·33977 Successful management of disseminated and disfiguring silicone granulomatosis and associated autoimmune syndrome induced by adjuvants (ASIA) as a complication of illicit filler use

    Page :AB206

    Teo Soleymani, Cate Motosko

    
• • ·34316 Successful treatment of hypopigmented mycosis fungoides in a pediatric patient with excimer laser

    Page :AB206

    Laura Taylor, Danielle Perna, Jeffery Callen, Cindy Owen

    
• • ·33781 Sustained and durable response up to 24 weeks after last dose observed in a phase 2a study (NCT03754309) of amlitelimab (KY1005, SAR445229) a novel nondepleting anti-OX40Ligand (OX40L) mAb in patients with moderate to severe atopic dermatitis (AD)

    Page :AB206

    Stephan Weidinger, Thomas Bieber, Michael Cork, Adam Reich, Nuala Brennan, Sonia Quaratino, Rosamund Wilson, Ben Porter-Brown

    
• • ·34385 Sustained long-term dupilumab efficacy in adult patients with moderate-to-severe atopic dermatitis transitioning from weekly dosing to every other week: Results from an open-label extension trial

    Page :AB206

    Lisa A. Beck, Mette Deleuran, H. Chih-ho Hong, David N. Adam, Iftikhar Hussain, Haixin Zhang, Arsalan Shabbir, Ainara Rodríguez Marco, Noah A. Levit

    
• • ·32924 Sustained treatment effect of spesolimab over 12 weeks for generalized pustular psoriasis flares; results from the Effisayil 1 study

    Page :AB207

    Boni Elewski, Jonathan Barker, Ulrich Mrowietz, Shinichi Imafuku, Na Hu, Manuel Quaresma, Christian Thoma

    
• • ·33639 Symptomatic burden and treatment needs in adult atopic dermatitis

    Page :AB207

    Elizabeth D. Bacci, Julia Correll, Evangeline J. Pierce, Amy M. DeLozier, Maria Jose Rueda, Wendy Smith Begolka, Lisa Butler

    
• • ·34089 Syringoma of the vulva associated with vulvar hypertrophy

    Page :AB207

    Abhinav Grover, Reena Singh, Karri Adamson, Gretchen Roth, Karolyn Wanat, Kara Young

    
• • ·33949 Systematic review of topical treatments for Kaposi sarcoma

    Page :AB207

    Kyaw Zin Htet, Michael Waul, Kieron S. Leslie

    
• • ·34613 Tapinarof cream 1% once daily (QD) for plaque psoriasis: Secondary efficacy outcomes from a long-term extension (LTE) trial

    Page :AB208

    Linda Stein Gold, Benjamin Ehst, Laura K. Ferris, Philip M. Brown, David S. Rubenstein, Anna M. Tallman, Jerry Bagel

    
• • ·34615 Tapinarof cream 1% once daily for plaque psoriasis: Dermatology Life Quality Index and local tolerability scores from a long-term extension trial

    Page :AB208

    April W. Armstrong, Seemal R. Desai, Melinda Gooderham, David S. Rubenstein, Philip M. Brown, Anna M. Tallman, Leon Kircik

    
• • ·33152 Targeted combined endpoint improvement in patient and disease domains in atopic dermatitis (AD) among adults with moderate-to-severe AD treated with upadacitinib

    Page :AB208

    Shawn G. Kwatra, Marjolein De Bruin-Weller, Peter Lio, Mette Deleuran, Sarah Ofori, Henrique D. Teixeira, Brian Calimlim, Yingyi Liu, Stephen Weidinger

    
• • ·32663 Testing clinical efficacy of exfoliants against pollution and photoaging for healthy skin maintenance

    Page :AB208

    Nalini Kaul

    
• • ·35341 The application of an emollient helps to reduce the skin side effects of anticancer treatments

    Page :AB209

    Pascale Guyonnet-Debersac

    
• • ·34524 The association between patient-reported outcomes skin flaring in autoimmune blistering diseases

    Page :AB209

    Zachary Hopkins, Amber R. Jimenez, Vanina L. Taliercio, Aaron M. Secrest

    
• • ·32746 The clinical utility of teledermatology in triaging and diagnosing skin malignancies: A series of three cases

    Page :AB209

    Kimberly A. Sable, Allison E. Nackers, Sarah A. Korger, Daniel D. Bennett, Yaohui G. Xu, Molly A. Hinshaw, Apple A. Bodemer, Anne E. Rosin

    
• • ·34864 The debut of pemphigus in different ethnic groups

    Page :AB209

    Irina Khamaganova, Nikolay Potekaev, Prokofieva Yana, Malyarenko Evgeny

    
• • ·35159 The dermatology education series: A digital approach to improving patient engagement

    Page :AB210

    Cassandra Yeboah, Alaina James

    
• • ·31064 The Detroit Keloid Scale: A validated tool for rating keloids

    Page :AB210

    Alexis B. Lyons, David M. Ozog, Henry W. Lim, Kate Viola, Lamont R. Jones

    
• • ·34092 The distribution of nevi and melanoma in Caucasian and SOC individuals

    Page :AB210

    Ryan Ladd, Jamison Harvey, Jake Besch-Stokes, Puneet Bhullar, Blake Boudreaux, Pranav Puri, Kevin Severson, Matthew Buras, Collin Costello, Helen Cumsky, Aaron Mangold

    
• • ·32059 The effectiveness of oral alitretinoin on mycosis fungoides palmaris et plantaris

    Page :AB210

    Seol Hwa Seong, Sun Mun Jeong, Jang Hwan Jung, Do Ik Kwon, Joon Hee Kim, Min Soo Jang, Jong Bin Park

    
• • ·33778 The impact and implications of COVID-19 on using scalp cooling therapy for prevention of chemotherapy-induced alopecia

    Page :AB211

    Taylor Novice, Madison Novice, Katerina Svigos, Molly Powers, Kristen Lo Sicco

    
• • ·32255 The improvement of the ratio of benign to malignant suspect melanocytic biopsies over 14 years in a single academic center

    Page :AB211

    Jacob Smith, Nick Berry, Steve A. Nelson, David L. Swanson

    
• • ·32795 The neonatal “blueberry muffin rash” – Act fast and get tissue

    Page :AB211

    Liliana Montoya, Michael Lavery, Nancy Shaver, Harper Price

    
• • ·35154 The role of common environmental triggers in hidradenitis suppurativa patients

    Page :AB211

    Rohan Singh, Warren H. Chan, Aditi Senthilnathan, Sree S. Kolli, Steven R. Feldman, Rita O. Pichardo

    
• • ·33702 The role of dermatologists on the diagnosis of leukemias such as blastic plasmacytoid dendritic cell neoplasm (BPDCN)

    Page :AB212

    Nerea Mohino-Farré, Laia Pastor-Jané, Josep Pujol-Montcusi, Anna Vicent, Julieta Landeyro, Anna Sánchez-Puigdollers, Miquel Just, Clara Martin, Maria del Mar Cordellat, Pilar Turégano

    
• • ·34317 The unmasking of facial psoriasis by medium-depth chemical peels in the context of severe sun damage

    Page :AB212

    Liang Joo Leow

    
• • ·33067 The use of lidocaine jelly for pain control during Mohs surgery as a future practice

    Page :AB212

    Ahmad B. Shahin, Shari A. Ochoa, Puneet Bhullar, Samantha Sagaser, Pranav Puri, Katie Kunze, Carolyn Mead-Harvey

    
• • ·33184 The variable burden and impact of atopic dermatitis: A multi-method analysis of the More Than Skin Deep survey

    Page :AB212

    Rawaan Elsawi, Aaron Drucker, Katie Dainty, Wei Wu, Lisa Butler, Korey Capozza, Sanaz Eftekhari, Kathryn T. Tullos, Wendy Smith Begolka

    
• • ·34374 Three North American cases of cutaneous pemphigus vulgaris in patients without history of mucosal disease

    Page :AB213

    John Baker, Kristina Seiffert-Sinha, Animesh Sinha

    
• • ·33969 Top authors in dermatology in fellowship by h-index: A bibliometric analysis

    Page :AB213

    Michael Abrouk, Cate Motosko, Ella Glaser

    
• • ·33673 Top dermatology influencers on Twitter: Analysis of content and academic impact

    Page :AB213

    Mindy D. Szeto, Jadesola T. Olayinka, Kevin Kamel, Austin Hamp, Jarett Anderson, Lori S. Kim, Madeleine G. Yemc, Torunn E. Sivesind, Robert P. Dellavalle

    
• • ·34516 Top selling pediatric sunscreens: An analysis of prices, claims, and allergens

    Page :AB213

    Jonathan W. Rick, Madalyn Brannon, Devea R. De, Terri Shih, Jennifer L. Hsiao, Vivian Y. Shi

    
• • ·35155 Topical application of M89PF prevents cutaneous damage induced by UV and O3

    Page :AB214

    Mascia Benedusi, Delphine Kerob, Anna Guiotto, Franco Cervellati

    
• • ·34413 Topical treatment with nature-based product restores skin barrier and relieves sensory discomfort in sensitive skin – Ex vivo and clinical evaluations

    Page :AB214

    Stanley B. Levy, Hemali B. Gunt

    
• • ·33261 Topically applied skin natural fatty acids and 12-hydroxystearic acid boosts barrier lipids

    Page :AB214

    Galina Yarova, William Lathrop, John Nip, John Bajor, Stacy S. Hawkins, Bivash R. Dasgupta, Kevin D. Hermanson, Andrew Mayes

    
• • ·31877 Treatment of lower eyelid bags with laser blepharoplasty and fat repositioning

    Page :AB214

    Ho-Joon Yoon

    
• • ·33641 Treatments of calcinosis cutis in autoimmune connective tissue diseases

    Page :AB215

    Pavane L. Gorrepati, Gideon P. Smith

    
• • ·34566 Trends in demographics and practice patterns among female and male dermatologists: A population-based study

    Page :AB215

    Jorge R. Georgakopoulos, Tina Felfeli, Mayilee Canizares, Ya-Ping Jin, Marissa Joseph, Jensen Yeung, Yvonne M. Buys

    
• • ·34857 Trends in dermatology programs and positions from 2016-2020

    Page :AB215

    Wylie Masterson, Quoc-Bao Nguyen

    
• • ·33528 Triple-wavelength diode laser (755 nm, 810 nm, and 1064 nm): Preliminary efficacy and safety for skin-tightening

    Page :AB215

    Hwa Jung Ryu, Dong Hye Suh, Hyun Joo Kim, Snag Jun Lee, Kye Yong Song, Byeong Geun Park

    
• • ·33521 Two cases of oral baricitinib associated papular eruption on face

    Page :AB216

    Joo Yeon Ko, Ki Yeon Kim, Hae Chang Joh, Na Young Kim, Dong Seok Shin, Jeong Eun Kim, Young Suck Ro

    
• • ·33562 Understanding mental stress and skin aging connection among dermatologists and psychologists through real world evidence

    Page :AB216

    Siti Shahera Anwar, Li Ma, Mary Anne Apolinar, Percival Salazar Pastrana

    
• • ·35064 Understanding the impact of depression on outcomes for patients with psoriasis: Results from a national survey

    Page :AB216

    George C. Gondo, Stacie J. Bell

    
• • ·33637 Unilateral nevoid acanthosis nigricans

    Page :AB216

    Kimberly Shao

    
• • ·32131 Updating the relative risk of ultraviolet exposure and melanoma in fair skin types: A systematic review

    Page :AB217

    Manisha Ravi, Michael Kwa, Kriti Babu, Henry W. Lim

    
• • ·35388 Utilization and trends of dupilumab prescriptions among Medicare Part D patients: 2017-2019

    Page :AB217

    Rahul Raiker, Haig Pakhchanian, Melanie Wolf, Shannon Trotter

    
• • ·35409 Utilization and trends of select FDA indicated cutaneous T-cell lymphoma prescriptions among Medicare Part D patients: 2013-2019

    Page :AB217

    Rahul Raiker, Haig Pakhchanian, Melanie Wolf

    
• • ·32840 Utilization of a cutaneous lymphoma primer to improve resident education

    Page :AB217

    Madelyn Jeter, Eamonn Maher

    
• • ·33455 Utilizing a residency manual to improve dermatology residents’ accuracy in billing, coding, and order placement

    Page :AB218

    Kavita Darji, Jessica Piontek, Prerana Jayanth, Daniel West

    
• • ·33077 Validation of case identification for drug-induced hyperpigmentation and melasma using international classification of diseases coding

    Page :AB218

    Katherine Young, Nicholas Theodosakis, Jaewon Yoon, Ethiopia Getachew, Arash Mostaghimi, Yevgeniy Semenov

    
• • ·33547 Validation of the Generalized Pustular Psoriasis Physician Global Assessment (GPPGA) scale for assessing severity of GPP

    Page :AB218

    A. David Burden, Hervé Bachelez, Siew Eng Choon, Slaheddine Marrakchi, Tsen-Fang Tsai, Akimichi Morita, Mark G. Lebwohl, Milan Anadkat, Ming Tang, Christian Thoma, Kristina Callis Duffin

    
• • ·31960 Vitamin D metabolism in the skin at single-cell resolution

    Page :AB218

    Sivani Reddy, Zorica Janjetovic, Andrzej T. Slominski

    
• • ·34539 Vitiligo associated with mogamulizumab

    Page :AB219

    Linda Serrano, Karolyn A. Wanat, Keri Chaney

    
• • ·32053 Vitiligo koebnerising to varicose veins of the lower limbs

    Page :AB219

    Alex Gan, Tanya O. Bleiker

    
• • ·34568 What a headache: Erenumab-provoked urticarial drug eruption

    Page :AB219

    Michael Fong, David Cleaver, Lloyd Cleaver

    
• • ·33527 What is the most effective picosecond laser protocol for tattoo removal? A comparative study by histopathologic review

    Page :AB219

    Hwa Jung Ryu, Dong Hye Suh, Hyeong-Seob Kim, Sang Jung Lee, Kye Yong Song, Byeong Geun Park

    
• • ·33348 When tanning is trending: A content quality study of skin cancer on TikTok

    Page :AB220

    Valerie C. Doyon, Chaocheng Liu, Kristy Bailey, Katie Beleznay

    
• • ·34879 White piedra: An uncommon cause of pseudonits in Northeast Mexico

    Page :AB220

    Giselle Rodriguez Tamez, Lucia T. Fernández, Lucio Vera Cabrera, Jorge Ocampo Candiani

    
• • ·33801 Women of childbearing age with hidradenitis suppurativa frequently prescribed medications dangerous for pregnancy

    Page :AB220

    Gabrielle Peck, Alan B. Fleischer

    
• • ·Disclosure of relevant financial relationships

    Page :AB221

    Plan Plan